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ABSTRACT 
The highly tunable properties of anionic clays make them potential candidates as gene delivery 
vehicles.  The initial momentum created by LDH-mediated gene delivery has subsided somewhat 
due to recent reports indicating lower LDH-mediated transfection efficiency as a result of 
degradation of the genetic material within the endosome.  Functionalization of the vector to 
bring about quicker endosomal escape appears to be a suitable strategy to overcome this hurdle.  
In this study, the hydrotalcites (HTs) were functionalized with positively charged amino acids in 
an attempt to achieve higher transfection efficiency by exploitation of the proton-sponge effect. 
Hydrotalcites (HTs), amino acid functionalized hydrotalcites (aa-HTs) and layered double 
hydroxides (LDHs) were synthesized using the co-precipitation method.  These compounds were 
characterized using X-Ray diffraction (XRD), inductively coupled plasma-optical emission 
spectroscopy (ICP-OES), Fourier Transform Infrared Spectroscopy (FTIR), transmission electron 
microscopy (TEM), scanning electron microscopy (SEM) and nanoparticle tracking analysis (NTA).  
The characterization assays confirmed that the compounds prepared were LDH in nature, and of 
the desired M2+:M3+ ratio.    TEM and NTA was successfully utilized to assess morphology, size 
and zeta potential of the nanomaterials and their nucleic acid:LDH nanocomplexes. The optimal 
nucleic acid binding capacity was determined using gel retardation assays. 
The nucleic acid:LDH complexes were found to be relatively non-cytotoxic to four mammalian 
cell lines (HEK293, Caco-2, HepG2 and HeLa tat luc) using the MTT assay. The ability of the 
prepared LDHs to effectively transfect pCMV-luc DNA into mammalian cell lines was investigated 
by the luciferase reporter gene assay. It was found that the degree of transfection was largely 
cell line dependent, with the HEK293 cells exhibiting the greatest degree of transfection, followed 
by the Caco-2 cell line. The transfection efficiency in these two cell lines were approximately 800 
fold greater than that in the HepG2 cells.   Overall, the HTs prepared in the M2+:M3+ ratio of 2:1 
displayed significantly higher transfection than those prepared in the 3:1 ratio.  The histidine 
functionalized HTs complexes appeared to be better transfection agents than their arginine 
functionalized counterparts.  These aa-HTs also showed significantly better transfection than 
MgAl 0.25.  However, the non-functionalized HT, MgAl 0.33 showed the greatest degree of 
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transfection in all cell lines. MgFe 0.33, and the ZnAl LDHs showed promising results with MgFe 
0.33 showing up to 50 fold greater transfection than several of the other compounds.  Gene 
silencing studies conducted in the Hela tat luc cell line, showed that the aa-HTs elicited 
significantly higher levels of gene knockdown than the non-functionalized HTs, with MgAl 0.25 
performing better than MgAl 0.33.  The gene knockdown efficiency of the MgFe LDHs were 
comparable to that observed for the non-functionalized HTs, whilst the ZnAl LDHs showed a 
marginal but measurable degree of gene silencing. Overall, these LDHs have shown the potential 
to bind, protect and efficiently deliver both pDNA and siRNA, in vitro, necessitating further 
studies in an in vivo system. 
Keywords:  Hydrotalcite, Layered double hydroxide, gene transfection, gene silencing 
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CHAPTER ONE 
1.  INTRODUCTION 
 
1.1 BACKGROUND OF STUDY 
Gene therapy encompasses a range of methods aimed at regulating gene expression by insertion 
of exogenous nucleic acids, such as deoxyribonucleic acid (DNA), small interfering ribonucleic 
acid (siRNA), micro RNA (miRNA), short hairpin RNA (shRNA) and antisense oligonucleotides 
(AONS), to either replace or repair a defective gene.  Unlike conventional therapeutic approaches 
which tend to treat the symptoms of a disease, gene therapy offers a strategy to treat the 
underlying cause of a disorder or disease.   
Naked nucleic acids cannot easily traverse the cell membrane, partly due to their negative charge, 
and even when they do enter the cell, they are prone to degradation by nucleases.  A suitable 
“carrier” or “vector” is therefore required to efficiently transport the nucleic acids into the cell.  
Thus far, the most successful vectors employed have been of viral origin, but they suffer from a 
number of major drawbacks such as immunogenic responses, low DNA carrying capacity, 
insertional mutagenesis, lack of specific cell targeting and high cost [Ragusa et al., 2007].  Over 
the years a number of non-viral vectors have been explored; such as liposomes [Templeton, 
2002; Daniels et al., 2013; Habib et al., 2013; Naicker et al., 2014; Lee et al., 2017], gold 
nanoparticles [Riley and Vermerris, 2017], dendrimers [Pan et al., 2007; Pan et al., 2009], 
quantum dots [Kralj and Pavelic, 2003], carbon nanotubes [Singh et al., 2005; Gao et al., 2006; 
Lacerda et al., 2007; Ahmed et al., 2009; Ahmed1 et al., 2009] magnetic nanoparticles [Mulens et 
al., 2013; Riley and Vermerris, 2017] and functionalized polymers [Perez et al., 2001; Nimesh et 
al., 2006]. These non-viral carriers also suffer from a number of disadvantages, the most common 
being cytotoxicity and immunogenic responses.  Thus, there remains a need for the development 
of safe and effective gene delivery vehicles. 
Anionic clays such as layered double hydroxides (LDH) or hydrotalcite-like (HT-like) materials, 
have recently attracted much attention as carriers of bioactive molecules and genes [Ladewig1 et 
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al., 2010; Choy et al., 2000; Nalawade et al., 2009; Balcomb et al., 2015].  Hydrotalcites (HTs) 
refer specifically to magnesium aluminium LDHs.  LDHs can complex with various types of 
molecules such as drugs [Choy et al., 2004; Costantino et al., 2008], sugar phosphates [Jellicoe 
and Fogg, 2012], fullerenes [Fortner et al., 2012], and biomolecules such as oligomers, DNA and 
nucleotides [Kwak et al., 2002; Choy et al., 2007].  
Unlike most inorganic nanoparticles that require chemical and/or biological pre-modification to 
obtain the desirable properties for cellular delivery, anionic clays allow for direct loading of 
anionic drugs or biomolecules due to their anion-exchange properties [Ladewig et al., 2009; Xu 
et al., 2006].    Mg-Al LDH’s are less toxic than most inorganic nanoparticles [Kriven et al., 2004; 
Choi et al., 2008]. LDH nanoparticles upon disintegration in the cytoplasm results in cyto-friendly 
ions such as Mg2+, Al3+ and NO3- [Xu et al., 2006; Kura et al., 2014].  Research into the use of LDHs 
as gene delivery vehicles has thus far, shown promising results.   
Reports indicate that functionalization of other non-viral gene delivery vectors has resulted in 
enhanced gene delivery, with up to a 1000 fold increase in transfection [Smith et al., 1997].  It 
has been suggested that better transfection occurs upon functionalization as a result of enhanced 
uptake through receptors on the cell surface, which may retain complexes at the cell surface 
rather than merely relying on non-specific electrostatic attraction between the nanoparticles and 
the cell surface [Wu and Wu, 1987; Choy et al., 2000].  The possibility thus exists that 
functionalization of the LDHs could result in greater, more effective transfection. Del Hoyo and 
co-workers (2007), observed that LDHs displayed lower transfection efficiency due to pH related 
degradation of DNA in the endosome, a hurdle that could possibly be overcome by 
functionalization of the LDH.  Functionalization of the LDHs with amino acids containing cationic 
side-chains could result in enhancement of the ‘proton-sponge’ effect, leading to quicker and 
more efficient endosomal escape and improved transfection, when compared to non-
functionalized LDHs. 
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1.2 AIMS AND OBJECTIVES OF STUDY  
 
The aim of the study was to prepare LDHs (both non-functionalized and amino acid 
functionalized) and compare their efficiencies as vectors for transfection, to achieve gene 
expression and gene silencing. 
In order to accomplish this aim, the objectives of the study were to:  
1. Prepare amino acid functionalized and non-functionalized LDHs using the co-precipitation 
method. 
2. Characterize the prepared LDHs. 
3. Evaluate the DNA and siRNA binding capacity of the prepared LDHs. 
4. Investigate the cytotoxicity of the prepared LDHs. 
5. Investigate and compare the transfection and gene silencing efficiency of the amino acid 
functionalized versus the non-functionalized LDHs. 
 
1.3 SIGNIFICANCE OF THE STUDY 
 
Amino acid functionalized LDHs offers a novel and promising concept for enhanced gene delivery 
in vitro. The potential benefits of this study may include the following:  
 
• Although there have been many reports of the use of LDHs (both functionalized and non-
functionalized) as gene delivery vehicles in literature, there has as yet not been any study 
involving amino acid functionalized LDHs as carriers of genes.  Hence, we undertook to 
prepare amino acid functionalized LDHs, which will exhibit enhanced cellular uptake and 
rapid endosomal escape, leading to a greater degree of gene expression or knockdown. 
• It is anticipated that this project could possibly lead to the development of a potential 
gene delivery vector to aid in realizing the dream of using gene therapy to overcome 
human genetic diseases.  
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1.4 NOVELTY OF THE STUDY 
There have been several published reports on the use of LDHs as DNA delivery vehicles in vitro 
[Choy et al., 2000; Choy et al., 2004; Del Hoyo, 2007; Xu et al., 2007; Ladewig1 et al., 2010] and 
in the delivery of siRNA [Ladewig2 et al., 2010; Chen et al., 2013; Li et al., 2014].  It has been 
further shown that arginine functionalization of hydroxyapatites [Wang et al., 2015], and amino 
acid modification of chitosan [Zheng et al., 2015], improved transfection efficiency.  The 
intercalation of amino acids into layered double hydroxides [Aisawa et al., 2000; Aisawa et al., 
2001; Nakayama et al., 2004; Aisawa et al., 2006], have been attempted but was not exploited 
as gene delivery vehicles.  This study reports for the first time on DNA transfection and gene 
silencing using amino acid functionalized LDHs.  The transfection efficiency of amino acid 
functionalized versus non-functionalized LDHs is also investigated. 
 
1.5 OVERVIEW OF THE DISSERTATION 
Chapter 1 briefly introduces and summarizes the background to the study. It outlines the 
challenges encountered with current gene therapy vectors and explores the rationale for and 
novelty of the study. The aim and objectives of the study are also described. 
Chapter 2 is a detailed literature review covering the historical background of LDHs, the chemical 
compositions of various LDHs, the applications of LDHs and their use in gene therapy. 
Chapter 3 describes the preparation and characterization of LDHs.  Methods of preparation of 
LDHs are briefly discussed and the characterization of the prepared LDHs using X-ray diffraction 
(XRD), Inductively coupled plasma-optical emission spectroscopy (ICP-OES), Fourier transform 
infrared spectroscopy (FTIR), Transmission electron microscopy (TEM), scanning electron 
microscopy (SEM), and nanoparticle tracking analysis (NTA) are described and discussed. 
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Chapter 4 includes the nucleic acid binding studies using gel retardation assays.  The nucleic 
acid:LDH complexes are characterized using TEM, XRD and NTA.  The susceptibility of the nucleic 
acid:LDH complex to serum nucleases is also investigated. 
Chapter 5 describes the in vitro cell culture assays such as the cytotoxicity studies, gene 
transfection and gene knockdown studies.  Cytotoxicity was evaluated in the HepG2, HEK293, 
Caco-2 and Hela tat luc cells, while pCMV-luc DNA transfection was assessed in the HepG2, 
HEK293 and Caco-2 only.  The knockdown of the luciferase gene (stably expressed in Hela tat luc 
cells) by anti-luc-siRNA, employing the synthesized LDHs as carriers is also investigated. 
Chapter 6 provides the conclusions derived from this study and includes recommendations for 
future studies. 
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CHAPTER TWO 
 
2. LITERATURE REVIEW 
 
2.1 HISTORICAL BACKGROUND OF LAYERED DOUBLE HYDROXIDES 
 
There are two main classes of clays, viz. cationic clays which are made up of negatively charged 
aluminosilicate or magnesiosilicate layers with positive ions in the interlayer region [Rajamathi 
et al., 2001] and anionic clays which consist of lamellar metal hydroxides composed of two (or 
more) kinds of metals in the main layers and anions in the interlayer region [He et al., 2005; de 
Roy et al., 2006; Boulet et al., 2006].  Anionic clays are generally referred to as layered double 
hydroxides (LDHs). 
 
Hydrotalcite (HT) is an anionic clay mineral that was first reported by Hochstetter in Sweden in 
1842 [Bravo-Suarez, 2004].  The formula for HT was proposed by an Italian professor of 
mineralogy, Professor E. Manasse, in Florence Italy in 1915 and confirmed by Foshag in 1920 
[Mills et al., 2012].  Investigations by Aminoff and Broome in 1930 revealed the existence of two 
polytypes, viz.  hydrotalcite and manasseite, the latter named in honour of Manasse [Cavani et 
al., 1991]. The two polytypes differ in their symmetry with the HT being rhombohedral and the 
manasseite, hexagonal [Belloto et al., 1996].  Since HT is one of the most representative minerals 
of the anionic clays, other layered double hydroxides are often referred to as hydrotalcite-like 
compounds (HT-like). The general LDH formula, based on a combination of divalent and trivalent 
metal cations can be written as: 
[MII1-x MIIIx(OH)2]Aq-x/q.nH2O 
Where MII and MIII represent the divalent and trivalent cations respectively, Aq- represents an 
exchangeable anion, x is the MIII/MII + MIII molar ratio and n is the number of moles of water 
[Posati et al., 2012;  Ladewig et al., 2009; Luan et al., 2009].   
 
The divalent and trivalent cations, the interlayer anions as well as the value of the stoichiometric 
co-efficient (x) may be widely varied, giving rise to a large class of isostructural materials [Kuang 
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et al., 2010; Seftel et al., 2008].  The value of x typically falls between 0.17 and 0.33 [Kloprogge 
et al., 2002; Kovanda et al., 2009].  The general formula of LDH is in no way limited by the above, 
as LDHs with more than two types of cations have also been reported [Qian et al., 2015].  Mills 
and co-workers (2012) have extensively reviewed the HT super-group, comprising all HT and HT-
like compounds (Table 2.1). 
 
LDHs are formed naturally from the weathering of basalts, or as deposits from ground water, and 
are generally not found in large quantities in nature [Frost et al., 2003]. Fortunately, they can be 
easily prepared in the laboratory, and specifically tailored by varying the constituent cations and 
anions, as well as altering the synthetic parameters to obtain the desired structural properties. 
The first reported synthesis of HT was by Feitknect in 1942 [cited by Bravo-Suarez, 2004; Cavani 
et al., 1991] who prepared magnesium/aluminium LDHs by co-precipitation using aluminium and 
magnesium chlorides, and caustic soda [Gastuche et al., 1967].  The name layered double 
hydroxide was derived from Feitknect, who named his synthesized HT compounds 
“Doppelschichtstrukturen” which means double sheet structures [Cavani et al., 1991].    
 
Initial proposed structures showed the principal Mg(OH)2 layers with a brucite structure 
interleaved with disordered or amorphous Al(OH)3 layers, with the 3.06 Å thick interlayer 
containing the trivalent cations, oxygens and hydroxyls [Brown and Gastuche, 1967].  This 
structure was later disproved, and it was proposed that the brucite-like layers of the HT-like 
compounds sjögrenite was composed of both magnesium and iron, with the interlayer region 
comprising of water molecules and carbonate ions [Ingram and Taylor, 1967].  Similar results for 
sjögrenite were previously presented by Allmann and Lohse in 1966 [Ingram and Taylor, 1967; 
Taylor 1969].  The name sjögrenite is now discredited as sjögrenite has been proven to be just 
the 2H polytype of pyroaurite [Mills et al., 2012]. 
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Table 2.1 Hydrotalcite super-groups [adapted from Mills et al., 2012]. 
 Name Cell Parameters (Å) Polytype Formula 
a c 
1 Hydrotalcite 3.065 23.07 3R Mg6Al2(OH)16[CO3].4H2O 
2 Manasseite 3.06 15.34 2H Mg6Al2(OH)16[CO3].4H2O 
3 Pyroaurite 3.089 23.23 3R Mg6Fe23+(OH)16[CO3].4H2O 
4 Sjögrenite 3.097 15.56 2H Mg6Fe23+(OH)16[CO3].4H2O 
5 Stichtite 3.09 23.19 3R Mg6Cr2(OH)16[CO3].4H2O 
6 Barbertonite 3.085 15.52 2H Mg6Cr23+(OH)16[CO3].4H2O 
7 Meixnerite 3.046 22.93 3R Mg6Al2(OH)18.4H2O 
8 Iowaite 3.1183 24.113 3R Mg6Fe23+(OH)16Cl2.4H2O 
9 Droninoite 6.206 46.184 6R Ni6Fe23+(OH)16Cl2.4H2O 
10 Woodallite 3.102 24.111 3R Mg6Cr2(OH)16Cl2.4H2O 
11 Desautelsite 3.114 24.39 3R Mg6Mn23+(OH)16[CO3].4H2O 
12 Takovite 3.0250 22.595 3R Ni6Al2(OH)16[CO3].4H2O 
13 Reevesite 3.082 22.770 3R1 Ni6Fe23+ (OH)16[CO3].4 H2O 
14 Jamborite 3.07 23.3 3R Ni62+Ni23+(OH)]16S.4H2O 
15 Quintinite 10.751 22.71/15.171 3T/2H Mg4Al2(OH)12[CO3].3H2O 
16 Charmarite 10.985 15.10/22.63 2H/3T Mn4Al2(OH)12[CO3].3H2O 
17 Caresite 10.805 22.48 3T Fe42+Al2(OH)12[CO3].3H2O 
18 Zaccagnaite 3.0662 22.6164 3R Zn4Al2(OH)12[CO3].3H2O 
19 Chlormagaluminite 5.29 15.46 2H Mg4Al2(OH)12Cl2. 3H2O 
20 Comblainite 3.038 22.79 3R Ni4Co23+(OH)12(CO3).3H2O 
21 Fougerite 3.17-3.18 22.7-22.9 3R Fe42+Fe23+(OH)12[CO3].3H2O 
22 Mossbauerite 3.079 22.253 3R Fe63+O4(OH)8[CO3].3H2O 
23 Woodwardite 3.00 27.3 3R Cu1-xAlx(OH)2[SO4]x/2.6H2O 
24 Zincowoodwardite 3.063 8.91/25.42 1T/3R Zn1-xAlx(OH)2[SO4]x/2.nH2O 
25 Honessite 3.083 25.8 3R (Ni1-xFe3+x)(OH)2[SO4]x/2.nH2O               n ˂ 3x/2 
HYDROTALCITE 
SUPERGROUP 
QUINTINITE 
SUPERGROUP 
FOUGЀRITE 
SUPERGROUP 
WOODWARDITE 
SUPERGROUP 
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Table 2.1 (continued)… 
 Name Cell Parameters (Å) Polytype Formula 
a c 
26 Glaucocerinite 3.057-3.070 32.52-32.65 3R1 (Zn1-xAlx)(OH)2[SO4]x/2.nH2O 
27 Hydrowoodwardite 3.066 32.80 3R Cu1-xAlx(OH)2[SO4]x/2.nH2O 
28 Carrboydite 3.022 32.45 3R1 (Ni1-xAlx)(OH)2[SO4]x/2.nH2O 
29 Hydrohonessite 3.09 33.4 3R2 (Ni1-xFe3+x)(OH)2[SO4]x/2.nH2O                n ˃ 3x/2 
30 Mountkeithite 10.698 22.545 2H (Mg1-xFe3+x)(OH)2[SO4]x/2.nH2O                    
31 Zincaluminite No structural data available (Zn1-xAlx)(OH)2[SO4]x/2.nH2O 
32 Wermlandite 9.303 22.57 1T Mg7Al2(OH)18[Ca(H2O)6] [SO4]2.6H2O 
33 Shigaite 9.512 33.074 3R Mn6Al3(OH)18[Na(H2O)6] [SO4]2.6H2O 
34 Nikischerite 9.347 33.000 3R Fe62+Al3(OH)18[Na(H2O)6] [SO4]2.6H2O 
35 Motukoreaite 9.172 33.51 3R Mg6Al3(OH)18[Na(H2O)6] [SO4]2.6H2O 
36 Natroglaucocerinite No structural data available Zn6Al3(OH)18[Na(H2O)6] [SO4]2.6H2O 
37 Karchevskyite 16.0556 25.66 1T Mg18Al9(OH)54Sr2(CO3)9(H2O)6(H3O)5 
38 Cualstibite 9.15 9.745 1T Cu2Al(OH)6[Sb(OH)6]  
39 Cyanophyllite 9.941 5.498 1M Cu2Al(OH)6[Sb(OH)6] 
40 Zincalstibite 5.327 9.792 1T Zn2Al(OH)6[Sb(OH)6] 
41 Omsite 5.351 19.5802 2T Ni2Fe3+(OH)6[Sb(OH)6] 
42 Hydrocalumite 5.765 46.978 3R Ca4Al2(OH)12Cl2.4H2O 
43 Kuzelite 5.76 53.66 3R Ca4Al2(OH)12[SO4].6H2O 
44 Coalingite 3.12 37.4 3R Mg10Fe23+(OH)24 [CO3].2H2O 
45 Brugnatellite 5.47 15.97 1T Mg6Fe3+ CO3(OH)13.4H2O 
46 Muskoxite 3.07 4.6 Further 
investigation 
required 
Mg7(Fe3+) (OH)26.H2O 
 
GLAUCOCERINITE 
SUPERGROUP 
CAULSTIBITE 
SUPERGROUP 
HYDROCALUMITE 
SUPERGROUP 
WERMLANDITE 
SUPERGROUP 
UNCLASSIFIED 
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2.2 LAYERED DOUBLE HYDROXIDE STRUCTURE AND COMPOSITION 
 
The LDH structure is based on the naturally occurring mineral brucite, the major difference being 
a partial replacement of divalent cations by trivalent cations resulting in a net positive charge on 
the lattice sheets [Bellotto et al., 1996].  This positive charge is neutralized by the presence of 
anions contained in the interlayer region [Cavanni et al., 1991].   As in brucite, each metal cation 
in LDH is directly bonded to six hydroxide groups and each hydroxide group is directly bonded to 
3 metal cations (Figure 2.1).  The trivalent cations are positioned such that they are spread out 
within the lattice sheets and are not next to each other resulting in “charge homogeneity” 
throughout the LDH lattice sheet [Evans and Slade, 2006].  Vucelic and co-workers (1997) have 
demonstrated that although there is no long range trivalent cation ordering in LDHs, there is a 
high degree of local ordering, such that the trivalent cations are never neighboring each other.  
The positively charged lattice sheets are stacked on top of each other in either 2 or 3 layer 
sequences e.g. 2H (2-layer hexagonal) or 3R (3-layer rhombohedral), with the 3-layer sequence 
being preferred in HTs [Bellotto et al., 1996]. 
 
Water molecules are also contained within the interlayer region, the actual amount of water 
present being dependent on factors such as the nature of the anions, the water vapour pressure 
and temperature [Hou et al., 2003].  The amount of water present in the interlayer may be 
calculated either by thermogravimetric analysis of weight loss, or by calculating the difference 
between the total number of sites occupied by oxygen less the sites occupied by the anions 
(Vacarri, 1998).  Water found within the interlayer region has been referred to as ‘intrinsic’ or 
‘interparticle pore’ water, whereas water molecules attached to the outer layers/external 
surfaces of the LDHs have been called ‘adsorbed surface’ or ‘extrinsic’ water [Evans and Slade, 
2006].  Similarly, the anions found between the LDH layers are referred to as being intercalated 
and the anions attached to the edges or the outer surfaces of the LDH layers are said to be 
adsorbed.    
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Figure 2.1 Structures of (a) brucite and (b) LDH [Redrawn and adapted from Benicio et al., 
2015]. 
 
(a) 
(b) 
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The nature of the interlayer anions and presence of water in the interlayer regions results in an 
increase in basal spacing from 4.78 Å in brucite to 7.8 Å in HT [Brindley and Kikkawa, 1980; 
Wypych, 2004].  Generally, the thickness of the interlayer depends on the number, size, 
orientation and strength of the bonds between the anions and the hydroxyl groups of the brucite-
like layers [Seftel et al., 2008]. 
 
 
2.2.1 ANION EXHANGE PROPERTY OF LAYERED DOUBLE HYDROXIDES 
 
The anions in the LDH interlayer are relatively weakly bound and can be readily exchanged [Meyn 
et al., 1990].  The potential anion exchange capability for an LDH depends on its charge density 
(or unit charge per area) which is based on the different trivalent to divalent cation ratios.  The 
formula for charge density is,  
Charge density = xe/a2sin60o 
where, x is the ratio of trivalent to total amount of metal, a is the distance between adjacent 
metal ions in the layer, e is the electronic charge, and sin60° is the angle between the a and b 
axes [Richardson, 2007].   
 
Thus, a HT with Mg:Al ratio of 1:2 would have a higher charge density than one with a Mg:Al ratio 
of 1:3.  The higher the trivalent cation content, the higher the positive charge density, and the 
higher the amount of anions that can be potentially adsorbed [Beavers, 1999].   
 
A major advantage of LDHs over other anion exchangers is the “large space” between the brucite 
layers.  This allows for a diverse array of anionic compounds to be exchanged using LDHs.  Bish 
(1980) showed that anion exchange in the LDH interlayer can cause displacement of the brucite 
layers, resulting in a possible change in polytype.   
 
 
2.2.2 ANION PREFERENCE 
 
Miyata (1983) showed that selectivity of monovalent anions are in the order of OH- ˃ Cl- ˃ Br- ˃ 
NO3- ˃ I-,  in slight contradiction to Bontchev and co-workers (2003), who showed that 
monovalent anion exchange preference  was Br- ˃ Cl- ˃ NO3- ˃ I-.  Generally, carbonate (CO32-) is 
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the easiest to intercalate and the most difficult to exchange [Crosby et al., 2014], whereas halides 
and nitrates are easy to intercalate and exchange.  Therefore, most LDH materials are prepared 
using either nitrate or chloride as the initial anion.  Divalent anions are more strongly adsorbed 
than monovalent anions [Forano et al., 2006], with the anion preference for divalent anions being 
CO32- > HPO42- > CrO42- >SO42- > MoO42- [Auerbach et al., 2004].  Multivalent anions are preferred 
by LDHs, due to stronger electrostatic interaction [Choy et al., 2007]. 
 
Naturally occurring LDHs usually contain carbonate as the interlayer anion, but synthetic LDHs 
may have a variety of anions of different geometries, sizes and charges incorporated within the 
layers, resulting in a large class of isostructural materials [Evans and Duan, 2006], with diverse 
physico-chemical properties [Miyata, 1975; Miyata and Okada, 1977].  Some of the reported 
anions incorporated within the interlayers of LDHs can be seen in Table 2.2. 
 
For biological studies, the preferred anion for the synthesis of LDHs is the nitrate anion, which 
creates a non-toxic, biologically compatible form of LDH [Costantino et al., 2008].  The nitrate 
anion, being monovalent, is also a good precursor for exchange reactions [Choy et al., 2007]. 
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Table 2.2  Some anions reported to have been incorporated into LDHs. 
Class of Anion Anion Reference 
Organic anions Carboxylic acids 
 
Alkoxides, naphthalene, β-napthol, phenol 
 
Acetate, stearate, oleate 
 
Tartarate, succinate 
 
Oxalate 
 
Citrate 
 
Sugar phosphates 
 
Cyclodextrins 
 
Unsaturated carboxylates 
Carlino, 1997 
 
Butenko et al., 2014 
 
Kandare and Hossenlopp, 2006 
 
Prevot et al., 1998 
 
Prevot et al., 1999 
 
Kumar et al., 2006 
 
Jellicoe and Fogg, 2012 
 
Mohanambe and Vasudevan, 2006 
 
Takagi et al., 1993 
Inorganic 
anions 
Carbonate 
 
Nitrate, chloride, iodide, bromide 
 
Chromate, dichromate, chlorate 
 
Chloride, percholate, sulphate 
 
chlorate 
 
Hydroxide 
 
Acetate, terephthalate, benzoate 
 
Metals and oxometalates 
 
Hexacyanocobalt (III) 
 
Mo7O246-, Cr2O72-, SiO32- 
 
Oxalate, [Fe(CN)6]-, bromide, chloride, 
carbonate, hydroxide, nitrate 
Trujillano, 2006 
 
Bontchev et al., 2003; Miyata and Okada, 1977  
 
Malherbe and Besse, 2000 
 
Brindley and Kikkawa,1980 
 
Miyata, 1975  
 
Newman et al., 2002  
 
Newman and Jones, 1999  
 
Rives  and Ullibarri, 1999 
 
Suzuki et al., 1989 
 
Misra and Perrotta, 1992 
 
Khan and O’Hare, 2002 
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Table 2.2 continued… 
Surfactants Sodium dodecylsulphate, sodium 
dodecylbenzenesulphate, sodium laurate, bis(2-
ethylhexyl)phosphate 
 
Octylsulphonate, octanebenzenesulphonate, 
dodecylbenzenesulphonate, 
octadecanesulphonate 
 
Alkyl sulphates, alkanesulphonates 
 
Adipate, dodecylsulphate 
 
Dodecylbenzenesulphonic acid, 
dodecylphosphonic acid, aleuritic acid, sebacic 
acid  
 
Costa et al., 2008 
 
 
Trujillano, 2006 
 
 
 
Meyn et al., 1993  
 
Herrero et al., 2009 
 
Anbarasan et al.,  2005 
Drugs 
 
Naproxen  
 
Indomethacin 
 
5-Fluorouracil 
 
Anti-inflammatory and/or anti-cancer drugs 
 
Camptothecin 
 
Diclofenac 
 
Flurbiprofen 
del Arco1 et al., 2004 
 
del Arco2 et al., 2004 
 
Wang et al., 2005 
 
Costantino et al., 2008; Zhang et al., 2014 
 
Tyner et al., 2004 
 
Perioli1 et al., 2011 
 
Perioli2 et al., 2011 
Biomolecules 
 
DNA 
 
 
 
siRNA 
 
 
Antisense oligonucleotides 
 
 
Amino acids and/or oligopeptides 
 
 
 
ATP, AMP, GMP, CMP 
Balcomb et al., 2015; Kriven et al., 2004; Li 
et al., 2013; Choy et al., 2000; Xu et al., 
2007 
 
Wong et al., 2010; Zhang et al., 2012; Chen 
et al., 2013; Ladewig2 et al., 2010 
 
Kriven et al., 2004; Kwak et al., 2002; 
Hibino 2004; Ikeda et al., 1984  
 
Aisawa et al., 2001; Aisawa et al., 2006; 
Nakayama et al., 2004; Stimpfling et al., 
2016; Coelho et al., 2012 
 
Choy et al., 2001 
Polymers  Various Polymers Tronto et al., 2013 
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2.2.3 CATIONS IN LAYERED DOUBLE HYDROXIDES 
 
Various cations can be used to synthesize LDHs, with the main requirement being that the radii 
should not be too different from Mg2+ and Al3+ [Zhang et al., 2014; Sajid and Basheer, 2016].  
Cavani and co-workers (1991) have suggested that cations with similar radii to that of Mg2+ and 
Al3+ can be better accommodated in the octahedral sites of the brucite-like layers of LDHs.  The 
ionic radii of M2+ and M3+ should also ideally be close to each other [Miyata and Kumura, 1973].  
Generally, the divalent and trivalent metal cations in LDHs belong mainly to the third, fourth, fifth 
and sixth periods of the periodic table.  Table 2.3 shows some of the cations found in naturally 
occurring and/or synthetic LDHs.  Khan and O’Hare (2002) have mentioned that all dipositive 
metal ions (except Cu2+) and all trivalent metals (except Ti3+) form LDHs.   
 
Table 2.3 Cations in LDHs. 
 PERIOD 3 PERIOD 4 PERIOD 5 PERIOD 6 
DIVALENT Mg2+ Ca2+, Mn2+, Fe2+, 
Co2+, Ni2+, Cu2+, Zn2+ 
Cd2+  
TRIVALENT Al3+, Si3+ Fe3+, Sc3+, V 3+, Cr3+, 
Mn3+, Ga3+ 
Y3+, Mo3+, Ag3+, 
In3+,  
La3+, W3+, Au3+ 
TETRAVALENT  Ti4+, V4+ Zr4+, Pd4+,  Pt4+ 
 
 
In most naturally occurring LDHs there is a partial replacement of divalent cations by trivalent 
cations, but there have been cases where tetravalent cations instead of trivalent cations have 
been reported [Saber and Tagaya1, 2003; Intissar et al., 2003].   
 
There have also been reports of LDHs synthesized with three different cations, viz. Mg-Zn-Al and 
Zn-Cu-Al LDHs [Kooli et al.,1995], Zn-Al-Sn LDHs [Saber and Tagaya2, 2003],   Cu-Mn-Al LDHs [Velu 
and Swamy, 1996], Cu-Mg-Mn and Ni-Mg-Mn LDHs [Kovanda et al., 2005], Mg-Zn-Al LDHs [Li et 
al., 2014],  Mg-Fe-Al LDHs [Guo et al., 2003], and recently Ni-Co-Al LDHs [Si et al.,2017]. 
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2.3 APPLICATIONS OF LAYERED DOUBLE HYDROXIDES 
 
The highly tunable properties of LDHs lends itself to them being employed in a diversity of 
applications.  Most of the applications are based on the LDHs high ion-exchange and adsorption 
capacity, low cost, their good biocompatibility and stability, combined with its large surface area.   
Some of the many applications of LDHs have been summarized in Table 2.4. 
 
Table 2.4 Some application of LDH materials. 
 
APPLICATION REFERENCE 
Catalysts Vaccari, 1998; Newman and Jones,1998; Cavani et al., 
1991; Xu et al., 2011; Fan et al., 2014; Wang1 et al., 
2015; Feng et al., 2015; Valente et al., 2010; Li et al., 
2015; Zümreoglu-Karan and Ay, 2012; Abderrazek et al., 
2016; Liu et al., 1999; Senra et al.,  2017; Kuang et al., 
2010; Jabłońska et al., 2013 
Agriculture Benício et al., 2015; Cardoso et al., 2006; Jaiswal et al., 
2014; Choy et al., 2007 
Bio-medicine 
 (eg. drug delivery, gene 
delivery/silencing, biosensors, 
antacids) 
Shafiei et al., 2008; Wang et al., 2005; Kura et al., 2014; 
Ladewig1 et al., 2010;  Ladewig et al., 2009; Li1 et al., 
2014; Xu et al., 2006; Mulens et al., 2013; Choy et al., 
2004; Ha and Xanthos, 2011; Bi et al., 2014;  Cunha et 
al., 2010; Kuang et al., 2010; Senapati et al., 2016; 
Mondal et al., 2016; del Arco1 et al., 2004; del Arco2 et 
al., 2004; del Arco et al., 2009; Vaccari 1998., Fong et 
al., 2011; Sarijo et al., 2017; Musumeci et al., 2010; Yan 
et al., 2014; Wei et al., 2015 
Environmental and Industrial 
 (eg. Wastewater treatment, UV 
Absorption, Stabilization of 
polyesters, Sorbents for liquid 
radioactive waste, flame retardants) 
Kovanda et al., 2009; Cocheci et al., 2010; Coelho et al., 
2012; Kulyukhin  et al., 2014; Ruiz-Hitzky et al., 2010; 
Wang et al., 2014; Kuang et al., 2010; Alexandrica et al., 
2015; Wang et al., 2012; Sajid and Basheer, 2016; 
Zümreoglu-Karan and Ay, 2012; Kameda et al., 2017; 
Stimpfling et al., 2016; Sertsova et al., 2015 
Cosmetics Industry Choy et al., 2007; Perera et al., 2015; Del Hoyo, 2007; 
Nalawade et al., 2009 
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2.3.1 GENE THERAPY 
 
Gene therapy generally refers to the transfer of nucleic acids into a cell to either repair or correct 
defective genes.  This is achieved by introducing either plasmid DNA (pDNA) to replace a defective 
gene, or small interfering RNA (siRNA) to silence an overexpressed gene. 
 
Despite much research in the area of gene therapy in recent years, efficient gene delivery remains 
the greatest challenge for its practical application.  Systemic delivery of naked nucleotides is 
ineffective due to their sensitivity to nuclease degradation, as well as the difficulty of crossing the 
cell membrane due to their negative charge.  Hence, there is a need to develop carrier vectors.  
An ideal gene delivery vector should have the ability to deliver a therapeutic gene safely into a 
cell, have high loading capacity, exhibit little or no toxicity, be non-immunogenic, biodegradable, 
be stable during storage and after administration, have the ability to target specific cells and 
afford relatively efficient gene expression [Xu et al., 2007; Huang et al., 1999].  
Carriers thus far have included viral vectors as well as a number of non-viral vectors such as 
cationic lipids, liposomes, cationic polymers, gold nanoparticles, magnetic nanoparticles, 
quantum dots, silica nanoparticles, fullerenes, carbon nanotubes and supramolecular systems 
[Smith et al., 1997; Lv et al., 2006; Ragusa et al., 2007; Ahmed et al., 2009; Pan et al., 2007; Gao 
et al., 2006; Pan et al., 2009].  Of these, viral vectors have been the most efficient, but they suffer 
the disadvantage of possible immunogenic responses, low DNA-loading capability, insertional 
mutagenesis as well as a lack of specific cell targeting.  Cationic lipids and polymers may avoid 
such problems, but are often highly toxic to cells [Xu and Lu, 2006].  Inorganic nanoparticles 
appear more suitable for cellular delivery due to their wide availability, rich surface functionality, 
good biocompatibility, potential capability of targeted delivery and the ability for controlled 
release of genes/drugs [Xu et al., 2007]. 
Biocompatibility of the carrier is also of the utmost importance and is dependent on a number of 
factors (Table 2.5). 
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Table 2.5 Overview of nanoparticle characteristics which can be controlled to improve 
biocompatibility [adapted from Soenen et al., 2011]. 
 
Parameter Advantage Disadvantage 
Size Small (< 10 nm): greater cellular 
uptake 
 
Small:  higher cytotoxicity 
Large (> 200 nm):  Too little cellular 
uptake 
Shape Spherical: highest uptake 
Rods: Reduced cytotoxicity 
Flat Platelets (eg. LDH):  increased 
surface area resulting in increased 
carrying capacity 
Spherical: highest cytotoxicity 
Rods: Diminished uptake 
Purity The presence of biologically 
compatible metals in suitable 
concentrations will not induce 
cytotoxic effects. 
Certain metals or organic impurities 
present on the carrier may induce 
cytotoxic effects 
Surface 
charge 
Positively charged:  better 
interaction with cell membrane 
Positively charged:  could be more 
cytotoxic as they have a tendency to 
interact with many biological 
components. 
Negatively charged: poor interaction 
with cell membrane 
 
Ultimately an ideal gene delivery vector should be able to bind or condense nucleic acids forming 
nanocomplexes, protect nucleic acids from enzymatic degradation [Imami et al., 2015], promote 
cellular uptake, promote endosomal escape, and also enhance entry into the nucleus for 
strategies involving pDNA delivery [Dong et al., 2013].   
 
 
2.3.1.1  GENE THERAPY USING PLASMID DNA  
In gene therapy strategies involving DNA transfection, functional or therapeutic DNA is delivered 
into cells to replace a missing or mutated gene [Morachis et al., 2012].  pDNA is generally used in 
gene therapy strategies since it is an inherently stable molecule, and is capable of withstanding 
changes in pH and ionic strength [Smith et al., 1997].  For successful gene therapy involving DNA 
transfection, the DNA needs to be effectively transported into the nucleus of the cell, where the 
exogenous gene must be integrated into the chromosome to obtain the desired level of 
expression to produce therapeutic effects [Liang and Lam, 2012; Dong et al., 2013].   
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There are a number of major obstacles to efficient pDNA delivery, including naked DNA’s inability 
to cross the cell membrane, endosomal escape, nuclear uptake and de-complexation.  pDNA is 
negatively charged and hydrophilic in nature and thus requires assistance to cross the plasma 
membrane. Non-viral DNA delivery into the cell proceeds via an endocytic pathway upon which 
the DNA-carrier complex would be trapped within an endosome.  It is important that the complex 
be released from the endosome at an early stage to prevent lysosomal destruction of both the 
DNA and the carrier.  Elouahabi and co-workers (1997) have reported that endosomal escape is 
a crucial and possibly the rate-limiting step for efficient transfection.   
The process of nuclear uptake is not very clearly understood.  It has been suggested that 
complexes may be internalized into cells during cell division, but non-dividing cells would 
probably require a receptor-mediated process for entry [Smith et al., 1997].  Smaller complexes 
appear to be able to diffuse through nuclear pores to gain entry into the nucleus [Elaesser and 
Howard, 2012].  Another possible mode of nuclear entry involves the endoplasmic reticulum, 
where the nanocomplex containing endosome fuses with the endoplasmic reticulum, releasing 
the DNA into the lumen of the reticulum, from where the DNA enters the nucleus through the 
nuclear membrane-reticulum network [Elouahabi and Ruysschaert, 2005]. 
De-complexation is also crucial for efficient gene expression.  Partial de-complexation probably 
occurs in the lysosome, leaving the DNA in a partially condensed form.  This allows for entry of 
the smaller, partially condensed DNA into the nucleus through basal leakage of the nuclear 
envelope [Smith et al., 1997].  Zhang and co-workers (2012) have reported that de-complexation 
is pH dependent, where an acidic pH disrupts the complex to release the nucleic acid.   
 
2.3.1.2  GENE SILENCING USING siRNA 
 
Antisense therapy involves siRNA, a class of small 20-26 bp double-stranded (ds) RNA molecules 
[Valencia-Sanchez et al., 2006], that play an important role in RNA interference (RNAi).  RNAi 
involves the silencing of expression of specific genes with nucleotide sequences complementary 
to that of the siRNA [Zhang et al., 2007].  This ultimately results in suppression of expression of 
the target (disease-causing) gene. 
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The RNAi pathway is triggered by the entry of a ds RNA molecule into the cell (Figure 2.2).  The 
endonuclease DICER cuts the ds RNA molecule into smaller fragments (siRNAs) [Zhang et al., 
2007].  These siRNA fragments integrate into a multi-subunit protein called the RNA-induced-
silencing-complex (RISC) [Matranga et al., 2005].  The RISC complex contains Argonaute proteins 
that have a PAZ domain for miRNA/siRNA binding and a PIWI domain that functions in slicer 
activity [Valencia –Sanchez et al., 2006].  The Argonaute proteins cleaves the ds RNA into 2 
strands: a guide or anti-sense strand (which remains bound to RISC), and the passenger or sense 
strand which is degraded.  The anti-sense strand directs the sequence specific silencing of the 
target mRNA by cleaving the target mRNA with Argonaute 2.  This leads ultimately to the 
inhibition of translation of the target mRNA [Ladewig2 et al., 2010].   The DICER step may be 
bypassed by the addition of chemically synthesized siRNAs of the appropriate size.  
 
As with DNA delivery, there are also a number of hurdles to successful siRNA delivery.  Firstly, 
the net negative charge on siRNA molecules prevents entry into the cell [Chen et al., 2013].  Upon 
entry into the cell, the siRNAs are targeted by RNases and macrophages [Nguyen et al., 2008], 
and like DNA, the siRNA also needs to be released before it reaches the degradative environment 
of the lysosome.  LDHs show great promise as siRNA carriers due to their high buffering capacity 
which not only protects the siRNA from the effects of the acidic environment but also contributes 
to bursting of the late endosome, and subsequent release of the siRNA, by the proton sponge 
effect. 
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Figure 2.2 The RNAi mechanism. 
 
Ladewig2 and co-workers (2010) successfully employed LDHs as a siRNA carrier and reported fast 
and effective target gene knockdown.  Gene knockdown was also successfully carried out in 
cortical neurons using LDH mediated siRNA delivery [Wong et al., 2010].  RNAi is an extremely 
promising technique and may prove to be the intervention method of choice for treatment of 
diseases in the future.   
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2.3.2 LAYERED DOUBLE HYDROXIDES IN GENE THERAPY  
 
An ideal gene delivery vehicle needs to be able to adequately bind and protect the biomolecule 
being carried (DNA or siRNA), traverse the cell membrane, release its load in the appropriate 
region of the cell, achieve good transfection, and in doing so, not cause any harm (toxicity) to the 
cell [Imani et al., 2015].   
The unique and highly tunable properties of LDHs lends itself to making them ideal gene delivery 
vehicles.  Firstly, DNA or siRNA can be easily incorporated into/onto LDHs by either ion exchange, 
intercalation or adsorption [Rojas et al., 2015].  The nanocomplex thus formed gains extra 
stabilization energy due to the electrostatic interaction between the cationic brucite layers and 
the DNA/siRNA [Choy et al., 2000].  The positively charged atoms on the LDH surface interacts 
with the negatively charged cell membrane leading to the internalization of the LDH 
nanocomplex.  Studies by Nagaraj and co-workers (2015) have shown that higher nanoparticle 
concentrations result in increased energy-dependent cellular uptake mechanisms. 
This internalization occurs via clathrin-mediated endocytosis [Ladewig2 et al., 2010; Wong et al., 
2010; Chen et al., 2013; Rojas et al., 2015].  A diagrammatic representation of this process is 
shown in Figure 2.3.  Clathrin-mediated endocytosis involves the entrapment of the nanocomplex 
within an endosome, followed by either an exocytic pathway (endosome → Golgi apparatus) or 
an endocytic route (early endosome → late endosome → lysosome) [Chung et al., 2012; Rojas et 
al., 2015].  The trafficking pathway followed is nanoparticle size dependent, with smaller particles 
generally following the endocytic route and larger particles taking the exocytic pathway [Chung 
et al., 2012].  The bursting of the endosome to release the nanocomplexes is facilitated initially 
by the ATPase mediated influx of H+ ions into the late endosome, which partially dissolves the 
nanocomplexes, thus maintaining the pH at 5-6, and preventing formation of the lysosome 
[Wong et al., 2010].  This leads to an increase in the number of ions within the endosome which 
results in increased osmosis of water into the endosome. This culminates in the endosome 
bursting and releasing the free DNA/siRNA from the partially dissolved nanocomplexes and as 
well as the residual nanocomplexes into the cytoplasm [Rojas et al., 2015].    Another possible 
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release pathway of DNA/siRNA from the nanocomplex could be through ion exchange with 
cytoplasmic anions [Gu et al., 2008].         
 Release of the nucleic acid:LDH complex from the endosome, before the endosome can fuse 
with the lysosome is key to successful nucleic acid delivery.  There are a number of endosomal 
escape mechanisms such as the ‘proton sponge’ hypothesis, the flip flop mechanism, the 
endosomal membrane fusion or destabilization mechanism, pore formation and photochemical 
internalization [Liang and Lam, 2012].  The ‘proton sponge effect’ causes endosomal bursting due 
to the influx of positive ions into the endosome, and this appears to be the mechanism of 
endosomal escape employed by LDHs. 
 The susceptibility of LDHs to changes in pH contributes to the controlled release properties 
exhibited by LDHs [Kriven et al., 2004; Zhang et al., 2012].  The pH dependent degradation of 
LDHs also prevents nanocarrier accumulation which could result in toxicity.  Toxicity is also 
reduced due to the breakdown products of LDHs being biocompatible [Nagaraj et al., 2015].  Xu 
and Lu (2006) have indicated that LDH nanocomplexes undergo a reaction similar to the one 
shown below under physiological conditions: 
MgAl-Cl-DNA + H+  →  Mg2+  + Al3+  + Cl-  + DNA  + H2O 
The release of these cyto-friendly by-products aids in endosomal escape of the nanoparticles. 
The degradation products of LDHs, being small ions, may also leave the cell through “ion tunnels” 
and not accumulate in the cell thereby decreasing the possibility of cytotoxicity [Xu et al., 2006]. 
Overall the low cytotoxicity, high biocompatibility, controllable particle size, ease of availability, 
low cost, high loading capacity, effective load protection and controlled release properties,  make 
LDHs an attractive gene therapy vehicle [Ladewig2 et al., 2010; Chen et al., 2013]. 
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Figure 2.3 Diagrammatic representation of clathrin-mediated endocytosis [Adapted from 
Rojas et al., 2015; Zhang et al., 2014; Choy et al., 2000]. 
 
 
 
2.3.3 FUNCTIONALIZATION OF HYDROTALCITE WITH AMINO ACIDS  
 
The highly tunable surfaces of nanoparticles make them ideal scaffolds for various applications. 
Functionalization of nanoparticles is achieved by conjugating the vector with functional groups, 
which imparts either better payload binding capacity, enhanced intracellular delivery and/or 
targeted delivery.  Cell targeting may be improved by the attachment of moieties such as ligands, 
which would deliver the payload to the intended cell by “homing in” to specific receptors on the 
target cell surface.  There are a number of ways of functionalizing nano-carriers to achieve 
improved targeting, better membrane permeability or greater protection from degradation.  
Functionality may be provided by the attachment of a variety of ligands, oligonucleotides, 
proteins or antibodies [Mout et al., 2012].  Hu and co-workers (2013) have reported better 
condensation of pDNA, and higher levels of gene expression after functionalization of LDHs with 
disulfide-linked polycation brushes.  Folic acid functionalization of siRNA-LDH complexes has 
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resulted in potent gene silencing in vitro and significantly high levels of tumor suppression in vivo 
[Park et al., 2016].  The preferential in vivo bio-distribution of chitosan functionalized LDHs to the 
lung paved the way for the development of organ-specific delivery systems [Kura et al., 2014].  
Kuo et al., (2015) have recently investigated LDHs as organ specific carriers with promising 
results. 
Early endosomal escape appears to be the success-limiting step in gene therapy strategies.  It 
may be possible to achieve better transfection by manipulation of the vector to cause faster 
endosomal escape, and one way of doing this is to functionalize the vector.  Functionalization of 
vectors with arginine may have begun as a result of attempting to improve cellular internalization 
by bio-mimicking arginine-rich cell penetrating peptides [Zheng et al., 2015].  Arginine 
functionalized hydroxyapatites have displayed better transfection efficiency than non-
functionalized hydroxyapatites [Wang et al., 2015].  Other arginine functionalized non-viral gene 
delivery systems such as chitosan and lipidosomes have also shown increased transfection 
efficiency and lower cytotoxicity when compared to non-functionalized chitosan [Gao et al., 
2008; Wang et al., 2015].   Arginine is positively charged at physiological pH (Figure 2.4), which 
could enhance transfection is two ways.  Firstly, the increased positive charge of the 
functionalized nanocomplex could lead to greater internalization of the complexes due to 
improved interaction between the complex and the negatively charged cell membrane.  
Secondly, the greater positive charge of the arginine-functionalized complex could also result in 
faster endosomal escape due to enhancement of the ‘proton sponge’ effect.  This manipulation 
of the proton-sponge effect may also be applied to histidine, which is also positively charged at 
physiological pH. The incorporation of amino acids into LDHs is also relatively simple as amino 
acids act as anionic species above their isoelectric points, allowing for easy intercalation via ion 
exchange [Coelhoe et al., 2012].  Structures of arginine and histidine are shown in Figure 2.4.  Xu 
and co-workers (2006) have also suggested that the addition of amino groups to a vector result 
in stronger interaction with the DNA chains.  This indicates that the presence of amino acids on 
the LDH should lead to stronger interaction with DNA during complex formation, which could 
possibly result in better DNA protection and ultimately transfection. 
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Figure 2.4 Amino acids arginine and histidine at physiological pH.  
There have been a number of reports describing the functionalization of LDHs with amino acids 
[Aisawa et al., 2000; Aisawa et al., 2001; Nakayama et al., 2004; Aisawa et al., 2006].  Despite 
varying degrees of success in intercalating amino acids into LDHs, there has, as yet, not been any 
reports involving gene delivery using amino acid functionalized LDHs. This study therefore 
includes a comparison between the transfection efficiency of arginine or histidine functionalized 
HTs and non-functionalized HTs, in the delivery of DNA and siRNA. 
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CHAPTER THREE 
3. PREPARATION AND CHARACTERISATION OF HYDROTALCITES 
AND HYDROTALCITE-LIKE COMPOUNDS 
 
3.1 PREPARATION OF HYDROTALCITES AND HYDROTALCITE-LIKE COMPOUNDS 
3.1.1 INTRODUCTION 
Hydrotalcites (HT) and hydrotalcite-like (HT-like) compounds, also referred to as layered double 
hydroxides (LDHs) can be very easily synthesized in the laboratory by a number of methods.  
Synthetic LDHs may be composed of many different MII/MIII cation combinations with different 
anions in the interlayer region.  The particle shape and size can be controlled by adjusting 
synthesis conditions [Benito et al., 2010; Herrero et al., 2009; Oh et al., 2006; Xu et al., 2008; 
Zhao et al 2002].  
Co-precipitation is the most commonly used method for the preparation of LDHs.  In this method, 
aqueous solutions of M2+ and M3+ are slowly added to a solution containing the anion that is to 
be incorporated into the LDH, whilst maintaining a pH that is higher or equal to the pH at which 
the most soluble hydroxide is precipitated.  Co-precipitation is also used in the preparation of 
organic anion-containing LDHs.  Co-precipitation is followed by thermal or hydrothermal 
treatment to enhance yield and crystallinity of the prepared LDH. 
There are two methods of co-precipitation, viz. precipitation at low supersaturation which 
involves addition of alkali to the reaction vessel (containing a solution of the anion to be 
intercalated) simultaneously to the addition of the metal salt solution, thus maintaining the pH 
at a selected value and precipitation at high supersaturation, where the metal salt solution is 
added to an alkaline solution containing the desired anion.  Co-precipitation at low 
supersaturation has the advantage of forming more uniform LDHs with a higher crystallinity than 
that produced by co-precipitation at high supersaturation [He et al., 2005]. 
A co-precipitation method involving separate nucleation and aging steps reported by Zhao and 
co-workers in 2002 is a very rapid mixing and nucleation process in a colloid mill followed by a 
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separate aging process resulting in the production of small, uniform and highly crystalline 
product.  Dong and co-workers (2014) prepared LDH nanoparticles by non-aqueous co-
precipitation.  Another modified co-precipitation method for the preparation of LDHs is referred 
to as the urea hydrolysis method.  Costantino and co-workers (1998) prepared MgAl-carbonate, 
ZnAl-carbonate and NiAl-carbonate LDHs using the urea hydrolysis method.  This method 
involves dissolving solid urea in a solution of the chosen metal chlorides and then maintaining 
this solution at 100 °C for 36 hours.  The LDHs produced by this method have a larger particle 
sizes and higher charge density than those prepared by the other co-precipitation methods.  The 
intercalated carbonate anions can be replaced with chloride by treating the LDH with gaseous or 
liquid HCl.  Thereafter, chloride can be replaced quite easily by organic anions [Costantino et al., 
1998].  Pérez-Bernal and co-workers (2009) prepared layered double hydroxides via the co-
precipitation method in the presence of a surfactant, which controlled aggregation of particles 
through the formation of mixed micelles. The resultant crystals were larger and more ordered 
than those prepared by normal co-precipitation. 
The interlayer anions of preformed LDHs can be replaced with guest anions by ion exchange.  Ion-
exchange may be carried out in one of two ways.  Firstly, the precursor LDH would contain anions 
such as chloride, nitrate or perchlorate which would have a weak interaction with the LDH layers.  
The second method involves LDHs containing anions which are susceptible to acid attack such as 
carbonate or carboxylates [He et al., 2005].  The extent of ion-exchange depends on the affinity 
for the incoming anion, the nature of the exchange medium, the pH of the reaction solution and 
the chemical composition of the layers.  Bontchev et al., (2003) showed that monovalent anion 
exchange preference is Br- ˃ Cl- ˃ NO3- ˃ I- and was independent of the method of synthesis. 
Upon calcination, i.e. heating LDHs to about 500 °C, the interlayer water, interlayer anions and 
the hydroxyl groups are removed.  Calcined LDHs are able to regenerate its layered structure 
through the “memory effect” when exposed to water and anions [Bontchev et al., 2003; 
Klemkaite et al., 2011; Tao et al., 2006].  The anion does not have to be the same as the one that 
was present in the original sample, thus this is a method which can be used to introduce various 
other types of organic or inorganic anions into the interlayer.  The reconstruction process is 
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carried out under nitrogen for incorporation of a non-carbonate anion since the carbonate LDH 
is preferentially formed in the presence of atmospheric carbon dioxide [He et al., 2005].  Wang 
and co-workers (2005) preferentially intercalated 5-fluorouracil into an MgAl LDH using this 
restructure method. 
Other methods for the preparation of LDHs include hydrothermal methods [Cavani et al., 1991; 
Wang et al., 2013], secondary intercalation, salt-oxide method, non-equilibrium aging method, 
surface synthesis, templated synthesis, non-conventional aging methods, the sol-gel method and 
electrosynthesis [He et al., 2005].  Xu and co-workers (2010) have devised an atom-economic 
method of preparing LDHs, where the reactants are completely incorporated into the target 
product and there is no need for washing or filtering of the LDHs as there are no by-products.  
Modifications in the synthesis procedure has led to the production of LDHs with sheet-like 
morphology [Kelkar and Schutz, 1997], needle-shaped morphology [Kelkar and Schutz, 1997], 
LDH nanoscrolls [Ren et al., 2007; Lv et al., 2015], LDH films [Kuang et al., 2010] and LDH 
nanorattles [Liu et al., 2011].  Another recent development involved the synthesis of LDHs using 
a mechano-chemical method to prepare highly dispersed LDH nanoparticles [Qu et al., 2016].  
This mechano-chemical method is reported to produce less aqueous waste and requires less 
energy than conventional LDH preparation methods. 
 
3.1.2 MATERIALS AND METHODS 
Mg(NO3)2.6H2O, Al(NO3)3.9H2O, Fe(NO3)3.9H2O, Zn(NO3)2.6H2O, NaOH and Na2CO3 were all of 
analytical grade purchased from Merck  (Darmstadt, Germany).  L-Arginine and L-Histidine were 
obtained from Sigma-Aldrich (St Louis, USA). 
The HT and HT-like compounds were prepared using the co-precipitation technique at low 
supersaturation. HT and HT-like compounds were prepared using MII:MIII ratios of 2:1 and 3:1.  
To prepare a Mg-Al HT with a MII:MIII ratio of 2:1 (denoted MgAl 0.33), 25.6 g (0.1 mol) 
Mg(NO3)2.6H2O and 18.75 g (0.05 mol) Al(NO3)3.9H2O were dissolved in 200 mL deionized water.  
The mixed metal solution was added dropwise to 1 L of a 0.5 M solution of Na2CO3, with vigorous 
stirring.  The pH was maintained at 11 by addition of a 1 M NaOH solution as required.  After 
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complete addition of the mixed cation solution, the suspension was transferred to a flat-
bottomed flask, and heated to 80 °C under reflux for 18-20 hours.  Thereafter, the precipitate 
was filtered and washed thoroughly until the filtrate had a pH of 7.  The precipitate was then 
dried in an oven at 110 °C overnight.  The resulting dry precipitate was ground to a fine powder 
(talc-like consistency) using a mortar and pestle. 
Similarly, the Mg-Al HT with MII:MIII = 3:1 (denoted MgAl 0.25), was prepared using a mass of 25.6 
g (0.1 mol) Mg(NO3)2.6H2O and 12.38 g (0.033 mol) Al(NO3)3.9H2O.  The arginine and histidine 
functionalized HTs were also prepared using the co-precipitation method.  To prepare the 
arginine functionalized HT in the molar ratio Mg:Al:Arg  of 2:1:1 (denoted MgAlArg 0.33), a mass 
of 5.12 g (0.02 mol) Mg(NO3)2.6H2O, 3.76 g (0.01 mol) Al(NO3)3.9H2O and 2.11 g (0.01 mol) L-
arginine hydrochloride was  used. 
The masses of all the precursors used in the preparation of the HTs and HT-like compounds (LDHs) 
in this study is shown in Table A1 (Appendix).  The masses of the metal precursors and amino 
acids that were used to prepare amino acid-functionalized HT are shown in Table A2 (Appendix). 
 
3.2 CHARACTERIZATION OF HYDROTALCITE AND HYDROTALCITE-LIKE COMPOUNDS 
The prepared HT and HT-like compounds (LDHs) were characterized using powder X-ray 
diffraction (XRD), inductively coupled plasma-optical emission spectroscopy (ICP-OES), Fourier 
transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), scanning 
electron microscopy (SEM) and nanoparticle tracking analysis (NTA). 
 
3.2.1 X-RAY DIFFRACTION  
Single crystal X-ray diffraction (XRD) is usually the technique of choice for crystalline samples, but 
obtaining a single crystal sample from synthesized LDH is almost impossible due to the 
polycrystalline nature of the sample [Ennadi et al., 2000].  Powder XRD is therefore used to 
elucidate much of the structural information for LDHs. 
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Powder X-ray diffraction (PXRD) patterns were obtained using a Bruker D8 Advance 
diffractometer equipped with a graphite monochromator operating at 40 kV and 40 mA. The 
radiation source was a CuKα X-ray source with λ = 1.5406 Å.   Data was collected at a step of 
0.021 ° and at a scanning speed of 0.454 °s-1. 
 
 
3.2.2 INDUCTIVELY COUPLED PLASMA-OPTICAL EMISSION SPECTROSCOPY 
Inductively coupled plasma- optical emission spectroscopy (ICP-OES) is used to detect and 
quantify elements in a solution.   
The samples were analyzed on a Perkin Elmer Optical Emission Spectrometer Optima 5300 DV.  
The instrument was calibrated using a mixed metal standard solution.  The standard solutions 
with concentrations of 20 ppm, 40 ppm, 60 ppm, 80 ppm and 100 ppm were prepared using ICP 
and atomic absorption spectroscopy standards of 1000 ppm (1000 Magnesium 1000, 1000 
Aluminium 1000, 1000 Iron 1000 and 1000 Zinc 1000), which were obtained from Polychem 
Supplies cc (South Africa).  Samples were prepared by dissolving 10 mg of the powdered 
compound in 10 mL of 0.1 M HNO3.  This solution was then diluted to 100 mL with double distilled 
water.  Approximately 14 mL of each sample was transferred to ICP tubes and analyzed. 
 
 
3.2.3 FOURIER-TRANSFORM INFRA-RED SPECTROSCOPY  
Fourier-transform infrared spectroscopy (FTIR) is one of the principal tools for LDH 
characterization, used primarily for functional group identification.  Each functional group 
absorbs specific IR radiation at different frequencies, making FT-IR a useful tool for indicating the 
presence or absence of a specific functional group in a compound.  FT-IR is usually carried out in 
the infrared region (4000-250 cm-1). 
The samples were analyzed on a Perkin Elmer Spectrum Universal ATR 100 FT-IR Spectrometer.  
The crystal area was cleaned with methanol prior to analysis of each sample.  Approximately,      
0.5 g of each LDH sample was placed on the crystal area, the pressure arm was locked into place 
and the sample was then analysed. 
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3.2.4 SCANNING AND TRANSMISSION ELECTRON MICROSCOPY  
Transmission electron microscopy (TEM) is an extremely useful nanoparticle characterization tool 
for the determination of particle distribution and ultrastructural morphology.  Scanning electron 
microscopy (SEM) was carried out to determine the surface topography of the LDH samples.   
For TEM, the samples were prepared by suspending 1 mg of the powdered sample in about 1 mL 
of double distilled water and sonicating the mixture for 15-20 minutes.  About 1 µL of the 
suspended sample was placed on a copper grid, air-dried and then viewed under a JEOL 1010 
Megaview 3 Soft Imaging TEM system.  For SEM, a strip of double sided carbon tape (Nisshin EM, 
Co Ltd) was placed onto an SEM stub.  The LDH sample was placed onto the stub and coated with 
gold particles using a Polaron SC500 Sputter Coater.  The stub was placed in a LEO 1450 SEM, and 
analyzed using SmartSEM software version 5.03.05. 
 
 
3.2.5 NANOPARTICLE TRACKING ANALYSIS  
Particle size and zeta potentials are accurately determined using nanoparticle tracking analysis 
(NTA).  Zeta (ζ) potential refers to the electric potential present in the double layer between the 
surface of a particle and the solvent/fluid in which the particle is suspended (Figure 3.1).   
NTA was used to obtain both particle size and ζ-potential.  A 1:1000 dilution of the LDH sample 
in double distilled water was analyzed in a NanoSight NS500 system (Malvern Instruments Ltd., 
Worcestershire, UK), using NanoSight nanoparticle tracking analysis software v3.2. 
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Figure 3.1 Diagrammatic representation of zeta potential [adapted from 
http://www.pharmainfo.net/book/emerging-trends-nanotechnology-pharmacy-
physicochemical-characterization-nanoparticles/zeta Date accessed: 31st August 
2017). 
 
 
3.2.6 IDENTIFICATION OF AMINO ACIDS 
 
The ninhydrin test is a very simple and inexpensive test to confirm the presence of amino groups 
in a sample.  Ninhydrin reacts with the amines of amino acids to produce a blue or purple color.  
The ninhydrin test for this study was conducted using a chromatographic method.  Standard 
samples of arginine and histidine as well as solutions of the amino acid-functionalized LDHs were 
spotted onto cellulose paper and then developed in a solvent system composed of n-
butanol:acetic acid:water (5:2:2) containing 0.2 g of ninhydrin.  Qiu et al (2010) have reported 
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that adding ninhydrin to the solvent system resulted in a cleaner and more rapid method for 
amino acid detection than the conventional post-staining method. 
The actual amount of arginine present in the prepared samples (MgAlArg 0.25 and MgAlArg 0.33) 
was determined using a spectrophotometric method developed by Wang and co-workers (2008).  
This method involved the use of solutions of 8-hydroxyquinoline (0.2 % (w/v) in 95 % ethanol), 2 
M sodium hydroxide and sodium hypobromite (2 % bromine (v/v) in 5 % sodium hydroxide).  An 
arginine stock solution (100 µg/mL) was made up in 1 M sodium hydroxide.  The arginine-
functionalized LDH samples (0.01 g) were each dissolved in 1 mL of 10 M hydrochloric acid and 
this was made up to 5 mL in deionized water.  The test samples contained 100 µL of the arginine-
functionalized LDH samples in 2.4 mL of deionized water.  Standard arginine samples (containing 
10 µg – 60 µg) were prepared to a volume of 2.5 mL with deionized water. To a tube containing 
2.5 mL of arginine solution, was added 0.5 mL of 8-hydroxyquinoline solution and 0.5 mL of 2 M 
sodium hydroxide.  The solutions were thoroughly mixed and placed on ice for 10 minutes.  
Thereafter, 0.25 mL of cold sodium hypobromite and 0.5 mL of 40 % urea was added, thoroughly 
mixed and the optical density was measured at 500 nm using an Irmeco V1200 
spectrophotometer.  A deionized water blank solution was prepared in a similar manner. 
Quantification of histidine in the prepared samples (MgAlHist 0.25 and MgAlHist 0.33) was 
conducted by adapting a method described by Patel and co-workers (2009).  The color reagent 
was prepared by dissolving 200 mg sodium nitrite in 60 mL deionized water, followed by the 
addition of 1 mL concentrated hydrochloric acid.  This solution was allowed to stand for 1 hour, 
after which 500 mg of sulphanilic acid was added and the final volume made up to 100 mL.  The 
solution was allowed to stand for a further 30 minutes prior to use. A stock solution of standard 
histidine was prepared (100 µg/mL) in 1 M sodium hydroxide.  Standard histidine samples 
(containing 10 µg – 50 µg) were prepared from the stock solution to a volume of 2.5 mL with 
deionized water.  The histidine functionalized LDH samples (0.01 g) were each dissolved in 1 mL 
of 10 M hydrochloric acid and then made up to 5 mL with deionized water.  The test samples 
comprised of 100 µl of the histidine-functionalized LDH samples added to 2.4 mL of deionized 
water and 100 µL 1 M sodium hydroxide. To a tube containing 2.5 mL of histidine solution, 5 mL 
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of colour reagent was added and allowed to stand for 5 minutes.  The absorbance was measured 
at 405 nm using an Irmeco V1200 spectrophotometer with 1 M sodium hydroxide used as a blank. 
 
 
3.3 RESULTS AND DISCUSSION 
3.3.1 PHYSICAL PROPERTIES OF SYNTHESIZED LAYERED DOUBLE HYDROXIDES 
All the LDHs synthesized were obtained in the form of smooth, finely textured powders.  The 
prepared compounds denoted with “0.25” indicate a mole ratio of 3:1 (M2+:M3+) and those 
denoted with “0.33” indicate a mole ratio of 2:1 (M2+:M3+).  The MgAl 0.25, MgAl 0.33, MgAlArg 
0.25, MgAlArg 0.33, MgAlHist 0.25, MgAlHist 0.33, ZnAl 0.25 and ZnAl 0.33 samples were all 
pristine white, talc-like powders.  The MgFe 0.25 sample appeared as a smooth, fine cream-
coloured powder while the MgFe 0.33 sample had a similar texture, but appeared reddish-brown 
in color.  The LDH samples were insoluble in water, but formed suspensions when vortexed or 
sonicated.  Only the MgAl 0.33, MgAlArg 0.33 and ZnAl 0.33 samples remained in suspension 
indefinitely, whilst all the other samples eventually settled out in the water solution within 24 
hours (Figure 3.2).  This observation suggests partial dissolution of these LDH nanoparticles, a 
phenomenon confirmed to occur with HTs prepared in a Mg:Al  ratio of 2:1 by aqueous stability 
studies [Nagaraj et al., 2015].  
 
 
 
 
 
 
Figure 3.2 Solubility of HTs and LDHs in distilled water (1) MgAl 0.25, (2) MgAl 0.33, (3) 
MgAlArg 0.25, (4) MgAlArg 0.33, (5) MgAlHist 0.25, (6) MgAlHist 0.33, (7) MgFe 
0.25, (8) MgFe 0.33, (9) ZnAl 0.25, (10) ZnAl 0.33.  
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3.3.2 CHARACTERIZATION OF LAYERED DOUBLE HYDROXIDES 
3.3.2.1  POWDER X-RAY DIFFRACTION 
Powder XRD is used to elucidate structural information about the LDHs, such as whether the 
sample is crystalline or amorphous, the size, lattice parameters, shape and orientation of a unit 
cell for a specific compound [Cullity and Stock, 2001.; Dinnebier and Billenge, 2008].  It is an 
important characterization tool as all crystalline solids have a unique, characteristic XRD pattern 
that may be used as a “fingerprint” in identification of a crystalline sample [Wilson, 1947]. 
All of the synthesized compounds displayed XRD patterns that were characteristic of LDHs, as 
exemplified by the XRD pattern of MgAl 0.33 shown in Figure 3.3.  The individual XRD 
diffractograms of all the other LDHs synthesized are shown in Figures A1-A9 (Appendix). 
 
Figure 3.3 XRD pattern of MgAl 0.33. 
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All HT samples (Figures 3.4 and 3.5) displayed XRD patterns corresponding to hydrotalcite (ICDD 
01-089-5434), where ICDD refers to “The international Centre for Diffraction Data”.  They all 
show sharp, symmetrical, intense peaks at the lower 2θ values [(003), (006)] and the broader, 
asymmetric and less intense peaks at the higher 2θ values [(012), (015), (018)] similar to XRD 
patterns of HTs reported in literature [Carja et al., 2006; Kloprogge et al., 2002; Mora et al., 2014; 
Kloprogge and Frost, 1999; Kagunya et al., 1998; Li et al., 2014].  The samples prepared were also 
crystalline in nature as indicated by the sharpness and intensity of the peaks.  Another 
characteristic of the XRD patterns of LDHs, clearly visible in Figure 3.3 is the doublet peak 
designated the (110) and (113) reflections at a 2θ value of approximately around 61- 63 °. 
The diffraction peaks of the amino acid functionalized HTs exhibit a slight shift to lower 2θ angles, 
a phenomenon commonly observed after intercalation of amino acids into LDHs [Jiao et al., 
2009].  The non-functionalized MgAl 0.25 sample displayed a d(003) basal spacing of 7.61, which 
was identical to the d(003) basal spacing of the arginine functionalized MgAlArg 0.25 sample.  There 
was a very slight increase in basal spacing with the corresponding histidine functionalized sample 
(Table 3.1), where MgAlHist 0.25 displayed a d(003) basal spacing of 7.63.  A similar trend was 
observed with the MgAl 0.33 samples.  These results indicate that the arginine and histidine were 
most probably adsorbed onto the outer surface of the basal layer, as intercalation of the amino 
acid into the LDH interlayer would have resulted in a much greater increase in d-basal spacing as 
observed by Aisawa et al (2000), Aisawa et al (2001) and Coelho et al (2012).  Similarly, Nakayama 
and co-workers (2004) have reported results showing intercalation of histidine into the interlayer 
of an MgAl LDH with a corresponding increase in basal spacing. 
The MgFe 0.25 and MgFe 0.33 samples both showed XRD patterns corresponding to the LDH, 
pyroaurite (ICDD 01-070-2150) while the diffractograms of the ZnAl 0.25 and ZnAl 0.33 samples 
corresponded exactly to patterns referenced in ICDD 00-048-1025 and ICDD 00-048-1024, 
respectively.   
The XRD patterns obtained for the ZnAl LDHs exhibit the characteristic sharp, intense peaks at 
low 2θ values with the doublet peak at around 60 ° similar to those obtained by Kooli and co-
workers (1997) and Nagaraj and co-workers (2015).  
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Figure 3.4 XRD patterns of (a) MgAlArg 0.25, (b) MgAlHist 0.25 and (c) MgAl 0.25. 
 
 
Figure 3.5 XRD patterns of (a) MgAl 0.33, (b) MgAlArg 0.33 and (c) MgAlHist 0.33. 
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Table 3.1 d-basal spacing for LDH compounds. 
                                    Basal Spacing / Å 
Compound MII:MIII d(003) d(006) d(012) d(015) d(018) d(110) d(113) 
MgAl 0.25 0.25 7.61 3.83 2.57 2.30 1.96 1.52 1.49 
MgAl 0.33 0.33 7.42 3.75 2.55 2.26 1.92 1.51 1.48 
MgAlArg 0.25 0.25 7.61 3.83 2.57 2.30 1.97 1.52 1.50 
MgAlArg 0.33 0.33 7.61 3.84 2.58 2.31 1.97 1.52 1.50 
MgAlHist 0.25 0.25 7.63 3.84 2.57 2.34 1.96 1.52 1.50 
MgAlHist 0.33 0.33 7.42 3.75 2.55 2.27 1.93 1.51 1.49 
MgFe 0.25 0.25 7.61 3.84 2.60 2.32 1.97 1.54 1.52 
MgFe 0.33 0.33 7.49 3.78 2.59 2.30 1.95 1.54 1.51 
ZnAl 0.25 0.25 7.46 3.75 2.57 2.28 1.93 1.53 1.50 
ZnAl 0.33 0.33 7.36 3.72 2.56 2.27 1.93 1.53 1.50 
 
 
As previously mentioned, the prepared compounds denoted with “0.25” indicate a mole ratio of 
3:1 (M2+:M3+) and those denoted with “0.33” indicate a mole ratio of 2:1 (M2+:M3+), the latter 
having more trivalent metals present.  Brindley and Kikkawa (1979) reported that an increase in 
the amount of trivalent metal results in a decrease in both lattice parameters, a and c.  Lattice 
parameter c decreases because as M3+ ions increase, the electrostatic attraction between the 
positive and negative interlayers also increases.  Lattice parameter a, decreases with increasing 
M3+ ions because M3+ are generally smaller in size than M2+ ions and the higher charge of the 
trivalent ion combined with the smaller ionic radii leads to shorter bond lengths.  This trend can 
be clearly seen in Table 3.2. 
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Table 3.2 The a, c and c0 parameters of the prepared LDHs in angstroms. 
Compound d(003) c d(110) a 
MgAl 0.25 7.61 22.83 1.52 3.04 
MgAl 0.33 7.42 22.26 1.51 3.02 
MgAlArg 0.25 7.61 22.83 1.52 3.04 
MgAlArg 0.33 7.61 22.83 1.52 3.04 
MgAlHist 0.25 7.63 22.89 1.52 3.04 
MgAlHist 0.33 7.42 22.26 1.51 3.02 
MgFe 0.25 7.61 22.83 1.54 3.08 
MgFe 0.33 7.49 22.47 1.54 3.08 
ZnAl 0.25 7.46 22.38 1.53 3.06 
ZnAl 0.33 7.36 22.08 1.53 3.06 
 
The interlayer spacing of LDHs containing carbonate is 7.8 Å [Kloprogge and Frost, 1999], the 
same as the interlayer spacing for chloride containing LDHs [Rossi et al., 2005].  The replacement 
of carbonate by nitrate anions should result in a slight increase of interlayer space to between 
8.1 Å [Kloprogge et al., 2002] to 8.8 Å [Nagaraj et al., 2015], thus the lower interlayer spacing of 
prepared samples suggests that some carbonate may have been incorporated into the interlayers 
during LDH preparation. This was expected as the LDHs were not prepared under nitrogen, which 
would have aided in decreasing the level of contamination by atmospheric carbonate anions.   
The results in Tables 3.1 and 3.2 shows a decreased interlayer spacing closer to 7.6 Å for the 
Mg/Al LDHs which seems to agree more with the values reported by Bookin and Drits (1993) and 
Li and co-workers (2014), indicating the presence of carbonate anions in the interlayer region of 
the prepared LDHs.  This may have an effect on the ion exchange capacity of the LDHs prepared 
as carbonate anions have a high affinity for the hydroxide layers in LDHs [Kloprogge et al., 2002].  
The basal spacings for ZnAl 0.25 and ZnAl 0.33 was 7.46 and 7.36 Å respectively which was quite 
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different from previously reported values of 8.53 – 8.92 Å [Salak et al., 2012].  This suggests that 
carbonate was incorporated as the interlayer anion instead of nitrate in the ZnAl LDHs as well. 
3.3.2.2  INDUCTIVELY COUPLED PLASMA-OPTICAL EMISSION SPECTROSCOPY 
 
The ICP results are shown in Table 3.3. 
Table 3.3  ICP data for LDHs. 
Compound Stoichiometry MII:MIII 
Calculated ratio Actual ratio 
MgAl 0.25 0.25 3:1 3.04 : 1 
MgAl 0.33 0.33 2:1 2 : 1 
MgAlArg 0.25 0.25 3:1 2.94 : 1 
MgAlHist 0.25 0.25 3:1 2.98 : 1 
MgAlArg 0.33 0.33 2:1 2.46 : 1 
MgAlHist 0.33 0.33 2:1 2.07 : 1 
MgFe 0.25 0.25 3:1 3.32 : 1 
MgFe 0.33 0.33 2:1 1.96 : 1 
ZnAl 0.25 0.25 3:1 3.49 : 1 
ZnAl 0.33 0.33 2:1 2.16 : 1 
 
The actual ratio of MII:MIII for HT and HT-like compounds were very similar to the calculated 
ratios.  This indicates that the desired products were most likely formed.  Both MgAlArg 0.33 and 
ZnAl 0.25 also showed a substantial deviation from the desired MII:MIII ratio.  ICP results indicate 
a higher concentration of the divalent cation in both cases.  A possible reason for this is that the 
greater repulsion between trivalent ions resulted in more spaces being available for the divalent 
ions to occupy.   
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3.3.2.3  FOURIER-TRANSFORM INFRARED SPECTROSCOPY 
Analysis of the infrared spectra of the LDHs revealed three major types of vibrations, viz.  
vibrations as a result of the interlayer anions, vibrations due to the hydroxyl groups (molecular 
vibrations) and vibrations due to the octahedral layers (lattice vibrations) [Hernandez-Moreno et 
al., 1985]. 
The FTIR spectra of the HTs are shown in Figures 3.6 and 3.7.  The ѵ(OH) stretching modes can be 
seen at around 3440 cm-1, presenting at slightly lower wavenumbers than free hydroxyl groups 
which have an average ѵ(OH) value of 3620 cm-1 [Kagunya et al., 1998].  This may be attributed 
to the hydroxyl groups in the samples being hydrogen bonded to lattice water.  The band 
occurring at around 1650 is due to interlayer water bending modes [Kloprogge and Frost, 1999].  
Water is strongly bonded to both the anions and the hydroxyl surfaces of the LDHs and the 
presence of the water bending modes indicate that water plays an important role in the structure 
of the LDHs [Palmer et al., 2009]. 
Vibrations occurring below 800 cm-1 are assigned ѵ(M-O) or metal-oxygen absorption bands 
[Kooli et al., 1997., Wu et al., 2014., Mallakpour and Dinari, 2016].  The bands appearing around 
500 cm-1 can be assigned to the translational modes of hydroxyl groups influenced by trivalent 
aluminium, while the bands around 600 cm-1 are due to translational modes of hydroxyl groups 
influenced by divalent magnesium [Millange et al., 2000].   
Bands due to intercalated and adsorbed anions are observed between 1800-1000 cm-1 [Medina-
Juárez et al., 2016]. The strong reflection between 1300 and 1400 cm-1 is associated with the 
asymmetric stretching modes of the interlayer carbonate ions (ѵ3 vibrational mode of CO32-) 
[Kooli et al., 1997; Millange et al., 2000; Frost et al., 2003].  A band associated with the CO32- - 
H2O bridging mode in the interlayer at around 3000 cm-1 [Kloprogge et al., 2002; Kloprogge and 
Frost, 1999; Millange et al., 2000], would have confirmed incorporation of carbonate within the 
interlayer.  The absence of this band suggests that perhaps some nitrate and amino acid residues 
(in the case of the amino acid functionalized HTs) may have also been incorporated into the 
interlayer. 
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Figure 3.6 FTIR patterns of MgAl 0.25, MgAlArg 0.25 and MgAlHist 0.25. 
Figure 3.7 FTIR patterns of MgAl 0.33, MgAlArg 0.33 and MgAlHist 0.33. 
Weak shoulder band 
Weak shoulder band 
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The weak shoulder at around 3100 cm-1 (shown in figures 3.6 – 3.8) is ascribed as the stretching 
modes of hydroxyl groups linked to carbonate ions [Kagunya et al., 1998].  Weak  CO32- vibrational 
modes are also present between 700 and 1100 cm-1,  with ѵ4 vibrational modes of CO32- generally 
occurring at around 730 cm-1,   ѵ2 at around 850  cm-1 and  ѵ1 at around 1000 cm-1  [Kloprogge et 
al., 2001]. 
FTIR spectra of the aa-functionalized hydrotalcites all exhibit O-H stretching modes between 
3400 cm-1 and 3600 cm-1, strong reflections between 1300 cm-1 and 1400 cm-1 due to asymmetric 
stretching of carbonate ions and low frequency vibrations between 400 cm-1 and 800 cm-1 
attributed to M-O and M-O-M vibrations of the LDH lattice [Kooli et al., 1997; Kagunya et al., 
1998; Millange et al., 2000; Li1 et al., 2014; Choi et al., 2015]. 
Bands attributed to symmetric and asymmetric stretching of the COO- groups of the amino acids 
usually occur between 1400 cm-1 and 1600 cm-1, but these bands are not clearly visible in the 
spectra shown possibly due to the low levels of incorporation of the amino acids into the HTS 
[Aisawa et al., 2000; Aisawa et al., 2001; Kumar and Rai, 2010; Choi et al., 2015].  The band at 
2943 cm-1 for MgAlArg 0.25 and at 2933 cm-1 for MgAlArg 0.33 are characteristic for arginine FTIR 
spectra and correspond to asymmetric stretching of the methyl group [Kumar and Rai, 2010].  
Bands due to a mixed vibration of COO- asymmetric stretching and NH bending modes of the 
histidine moiety usually occur at around 1630 cm-1 [Kumar et al., 2010] and the band due to 
guanidine C=N stretching and C=O carbonyl stretching which would normally be seen at around 
1700 cm-1 [Imani et al., 2015; Barth, 2000] but these appear to be masked here by the interlayer 
water bending modes. 
The infrared spectra of of HT-like compounds (MgFe 0.35, MgFe 0.33, ZnAl 0.25 and ZnAl 0.33) 
show similar patterns to the spectra of the HTs (see Figure 3.8).  The spectra are characteristic of 
LDHs.  The O-H stretching of water molecules appear at around 3440 cm-1, the H-OH bands occur 
at around 1650 cm-1, the peak at around 1300 corresponds to the intercalated carbonate anions 
and the M-O (metal-oxygen) absorption bands occur below 800 cm-1 [Frost1 et al., 2003;  Choi et 
al., 2015; Komarala et al., 2016].
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Figure 3.8  FTIR patterns of MgFe 0.25, MgFe 0.33, ZnAl 0.25 and ZnAl 0.33. 
 
 
3.3.2.4 SCANNING AND TRANSMISSION ELECTRON MICROSCOPY 
 
The TEM and SEM images of the hydrotalcite, MgAl 0.25 are shown in Figure 3.9.  The crystals 
generally appear as hexagonal platelets, tending to agglomerate, resulting in the platelets being 
piled on top of each other.  TEM analysis at 150 000X magnification shows irregularly shaped 
crystals with most being in the size range of less than 50 nm.  It has been suggested that 
irregularity in shape occurs due to crystal defects [Wang et al., 2012].  SEM analysis at a much 
lower magnification (42.61 K X), also shows some larger particles with a lateral width of about 
100 nm.  This indicates a large size distribution of the LDH nanoparticles.  The morphology 
observed for MgAl 0.25 was similar to that reported by Mondal and co-workers (2016). 
 
Weak shoulder band 
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Figure 3.9 Electron microscopy images of MgAl 0.25 (a) TEM at 150K magnification, (b) TEM 
at 300K magnification and (c) SEM at 42.61K magnification.  The bars represent (a) 
200 nm, (b) 100 nm and (c) 200 nm respectively. 
 
The MgAl 0.33 hydrotalcite sample shows a similar flat platelet type structure, typical of layered 
double hydroxides (Figure 3.10).  The particles appear more uniform in shape when compared to 
the MgAl 0.25 sample.  Both TEM and SEM indicate a more even particle size distribution with 
most of the particles within the 20-70 nm range.  The rod-like structures visible on the TEM 
micrographs are most likely particles lying on either sides or in a position not in the direct plane 
of view. 
 
(a) 
(c) 
(b)
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Figure 3.10 Electron microscopy images of MgAl 0.33 (a) TEM at 150K magnification, (b) TEM 
at 300K magnification and (c) SEM at 42.40K magnification.  The bars represent (a) 
200 nm, (b) 100 nm and (c) 200 nm respectively. 
 
TEM and SEM analysis of the aa-functionalized LDHs are shown in Figures 3.11 and 3.12.  These 
LDHs exhibit the characteristic flat platelet like structure of the non-functionalized LDHs.  
Although XRD analysis of the aa-functionalized LDHs suggest that the amino acid groups are most 
probably attached to the external surfaces of the LDH molecules, it is not possible for the amino 
acid moieties to be viewed at the magnifications used here for TEM and SEM, due to their very 
small size.  The sizes of the arginine functionalized LDHs ranged between 20 and 50 nm.  The size 
of the histidine functionalized LDH MgAlHist 0.25 appear to average around 70 nm, while the 
MgAlHist 0.33 particles appear much smaller, and range between 15 and 50 nm. 
 
(b) 
(c) 
(a) 
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Figure 3.11 Electron micrographs showing TEM images of arginine functionalized LDHs (a) 
MgAlArg 0.25 and (b) MgAlArg 0.33 at 300K magnification, and SEM images of (c) 
MgAlArg 0.25 and (d) MgAlArg 0.33 at 50.01K and 37.82K magnification 
respectively.  The bars represent (a) 100 nm, (b) 200 nm, (c) 100 nm and (d) 200 
nm respectively. 
 
 
 
 
 
 
 
(c) 
(d) (b) 
(a) 
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Figure 3.12 Electron micrographs showing TEM images of histidine functionalized LDHs (a) 
MgAlHist 0.25 and (b) MgAlHist 0.33 at 300K magnification, and SEM images of (c) 
MgAlHist 0.25 and (d) MgAlHist 0.33 at 42.71K and 45.70K magnification 
respectively.  The bars represent (a) 100 nm, (b) 200 nm, (c) 100 nm and (d) 200 
nm respectively. 
 
The particle morphology of the MgFe 0.25 and MgFe 0.33 LDHs appear very similar to each other 
(Figures 3.13 and 3.14).  Typical hexagonal flat platelets are observed with a wide size 
distribution.  The lateral particle size range for MgFe 0.25 was 40-80 nm, whilst that of MgFe 0.33 
ranged from 70-200 nm.  SEM at low magnification also revealed the presence of some larger 
particles in the 150-300 nm range, once again emphasizing the wide particle size distribution of 
the samples. 
(a
 
(b) 
(c)  (d) 
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Figure 3.13 Electron microscopy images of MgFe 0.25 (a) TEM at 150K magnification, (b) TEM 
at 300K magnification and (c) SEM at 22.02K magnification. The bars represent (a) 
200 nm, (b) 100 nm and (c) 200 nm respectively. 
 
 
 
(a) 
(c) 
(b) 
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Figure 3.14 Electron microscopy images of MgFe 0.33 (a) TEM at 150K magnification and (b) 
SEM at 37.56K magnification.  The bars represent 200 nm. 
 
The ZnAl 0.25 and ZnAl 0.33 LDHs also exhibited the typical hexagonal shaped flat platelet 
structure, clearly visible in both the TEM and SEM micrographs (Figures 3.15 and 3.16).  These 
platelets appear much denser (opaque) than the MgAl and MgFe LDHs.  The lateral size 
distribution ranged from 50 nm to 200 nm. Nagaraj and co-workers (2015) have synthesized ZnAl 
LDHs in a ratio of Zn:Al (2:1) and have reported similar particle morphology and size, as have 
Kloprogge and co-workers (2004). 
 
         
Figure 3.15 Electron microscopy images of ZnAl 0.25 (a) TEM at 150K magnification, and  
(b) SEM at 38.83K magnification.  The bars represent 200 nm. 
 
 
(a) (b) 
(a) (b) 
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The general appearance of the LDHs obtained in this study is very similar to that in recent reports 
[Rojas et al., 2015; Kriven et al., 2004; Chen et al., 2013], and is typical of LDHs aged in the 
supernatant resulting from the nucleation step, with larger particles of a wide size distribution.  
Separate nucleation and aging steps would have resulted in more symmetrical and smaller sized 
particles [Zhao et al., 2002; Xu et al., 2006].  The size of the LDH nanoparticles is significant for 
biological applications, as reports suggest that LDHs display size-dependent toxicity.  Choi and 
co-workers (2008) have reported that LDH particles less than 50 nm in length was more toxic 
than larger particles within the size range of 100-200 nm.  There is a wide size distribution of the 
LDHs prepared in this study, with most of the particles being within the ‘safe’ or low cytotoxicity 
size range. 
 
    
 
Figure 3.16 Electron microscopy images of ZnAl 0.33 (a) TEM at 150K magnification, (b) TEM 
at 300K magnification and (c) SEM at 37.76K magnification.  The bars represent (a) 
200 nm, (b) 100 nm and (c) 200 nm respectively. 
(c) 
(b) (a) 
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3.3.2.5  NANOPARTICLE TRACKING ANALYSIS (NTA) 
The efficacy of nanoparticle mediated delivery is affected by physicochemical properties such as 
size, shape and surface charge [Dong et al., 2015].  The size of nanoparticles greatly affects its 
interaction with cells, and influences cellular uptake efficiency, route of internalization, 
localization within the cell as well as cytotoxicity [Shang et al., 2014; Rojas et al., 2015].  
Zeta potential provides an indication of the stability of a colloidal dispersion.  Zeta potential 
depends not only on the properties of the nanoparticle but also on its environment and is thus 
affected by both pH and ionic strength of the suspension fluid [Xu, 2008].  It is extremely 
important to assess the ζ-potential of nanoparticles to be used for biological studies, as it greatly 
affects interactions between the nanoparticles themselves, the interactions between cells and 
nanoparticles, and also affects the cell targeting ability of the nanoparticles.  
The modal size and ζ-potential values are recorded in Table 3.4.  The large particle size 
distribution observed by TEM and SEM was confirmed by NTA, which revealed size variations of 
up to ± 100 nm of the modal size value. 
Table 3.4 Size and zeta potential of LDHs.  
LDH SIZE (nm) ZETA POTENTIAL (mV) 
MgAl 0.25 148.4 -11.6 
MgAl 0.33 72.4 15.0 
MgAlArg 0.25 193.1 -19.8 
MgAlArg 0.33 123.7 6.7 
MgAlHist 0.25 60.8 -24.6 
MgAlHist 0.33 44.5 22.7 
MgFe 0.25 307.4 1.2 
MgFe 0.33 27.9 -12.8 
ZnAl 0.25 30.0 -7.2 
ZnAl 0.33 67.9 29.7 
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TEM analysis of MgAl 0.25 showed most of the nanoparticles to be in the ±50 nm size range, 
whereas NTA analysis revealed a modal size of 148.4 nm.  This could be as a result of particle 
aggregation.  Generally, ζ-potential values much greater or less than zero indicate high colloidal 
stability whereas ζ-potential values closer to zero represent lower stability and thus greater 
aggregation of the nanoparticles.  This phenomenon is well represented by the MgFe 0.25 LDHs 
(Table 3.4), where rather large particle size was observed (307.4 nm) with the ζ-potential value 
close to zero (1.2 mV).  The larger particle size observed may be attributed to aggregation of 
smaller particles.  This theory is well supported when considering that the particle size seen for 
MgFe 0.25 LDHs using TEM was 40-50 nm.  The sizes of the other non-functionalized LDHs appear 
to be similar to that observed by TEM analysis.   
 
The sizes of the arginine functionalized HTs were generally larger than their histidine 
functionalized counterparts. The ζ-potential values suggest the possibility of aggregation 
resulting in the larger observed particle size.  TEM analysis showed the arginine functionalized 
LDHs as having particle size ranging between 20 to 50 nm, thus the modal value obtained by NTA 
(193.1 nm) is most probably due to aggregation.   This theory is supported by the ζ-potential 
values obtained for the arginine functionalized LDHs, especially MgAlArg 0.33 which had a                
ζ-potential value of 6.7.  The sizes of the histidine functionalized HTs as determined by NTA was 
similar to the results obtained by TEM analysis.  Here again, as with the non-functionalized LDHs, 
there was no particular trend in the zeta potential values obtained, except that the aa-LDHs 
prepared in the ratio M2+:M3+:aa of 2:1:1 show positive ζ-potentials, whereas the aa-LDHs 
prepared in the ratio M2+:M3+:aa of 3:1:1 show negative ζ-potential values. 
The ζ-potential values were negative for five of the samples (MgAl 0.25, MgAlArg 0.25, MgAlHist 
0.25, MgFe 0.33 and ZnAl 0.25) and positive for the other five samples (MgAl 0.33, MgAlArg 0.33, 
MgAlHist 0.33, MgFe 0.25 and ZnAl 0.33).   
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3.3.2.6  IDENTIFICATION OF AMINO ACIDS 
 
The co-precipitation of amino acids with LDHs is dependent on pH as well as the nature of the 
side chain groups [Aisawa et al., 2000; Aisawa et al., 2006].  The presence of amino acid in/on 
the functionalized LDHs was confirmed by the ninhydrin test (Figure 3.17). 
Aisawa and co-workers (2000) reported a 42 % co-precipitation of histidine with a ZnAl LDH with 
molar ratios of Zn2+:Al3+:Histidine of 2:1:1 at pH 8 (where most of the histidine would exist as a 
zwitterion).  The preparation of the LDHs for this study was carried out at a pH of 10 to 11.  At 
this pH, histidine would be expected to have a negative charge (anionic in nature) and thus a 
significant amount of histidine would be expected to be incorporated within the LDH interlayer. 
However, the rather small change in d(003) basal spacing in the histidine functionalized 
hydrotalcites compared to the non-functionalized hydrotalcites (Figures 3.4 and 3.5), indicates 
that this was not the case.  The amount of histidine present in the MgAlHist 0.25 and MgAlHist 
0.33 samples was found to be 1.80 µg and 3.77 µg histidine per 200 µg LHD sample respectively.   
These values were obtained using the standard curve for histidine (see Figure A10 in Appendix). 
These values corresponds to the degree of incorporation of histidine in MgAlHist 0.25 being 0.90 
% and in MgAlHist 0.33 being 1.89 %.  The lower than anticipated degree of histidine 
incorporation within the LDH interlayer, is most likely as a result of the preparation of the LDHs 
not being carried out under nitrogen, which probably resulted in atmospheric carbonate being 
incorporated into the interlayer instead of the amino acid. 
A much lower degree of co-precipitation of arginine has been reported thus far [Aisawa et al., 
2001; Hibino, 2004].  Aisawa and co-workers (2001) have reported a 9 % co-precipitation of 
arginine into LDHs, which could be attributed to the repulsion of the positive charges between 
the arginine side chain and the LDH basal layers, at the pH used for the preparation of the 
arginine-functionalized LDHs. The amount of arginine present in the MgAlArg 0.25 and MgAlArg 
0.33 samples was found to be 2.53 µg and 5.23 µg arginine per 200 µg LHD sample, respectively.   
These values were obtained using the standard curve for arginine (Figure A11 in Appendix).  The 
degree of incorporation of arginine was calculated to be 1.27 % and 2.62 % for MgAlArg 0.25 and 
MgAlArg 0.33 respectively. 
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Figure 3.17 Ninhydrin test for amino acid functionalized LDHs. 
 
3.4 CONCLUSION 
 
The desired LDHs and aa-functionalized HTs were successfully synthesized using the co-
precipitation method and characterized by XRD, ICP-OES, FTIR, SEM, TEM and NTA.  XRD 
diffractograms for the various synthesized LDHs and aa-functionalized HTs were consistent with 
data reported in literature.  The ratios of M2+:M3+ cations and vibrational profiles of the 
compounds were confirmed by ICP-OES and FTIR respectively.  SEM and TEM analysis revealed 
that morphologies of the synthesized compounds were typical of LDHs and HTs.  Sizes of the 
nanoparticles varied between 30 and 200 nm and the zeta-potential values ranged from -24.6 to 
29.7 as determined by NTA analysis.  The attachment of arginine and histidine in the aa-
functionalized HTs was confirmed by the ninhydrin test and the degree of incorporation of amino 
acid was calculated to be 0.90% in MgAlHist 0.25, 1.89% in MgAlHist 0.33, 1.27 % in MgAlArg 0.25 
and 2.62 % in MgAlArg 0.33. 
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CHAPTER FOUR 
4. NUCLEIC ACID BINDING AND PROTECTION STUDIES 
 
4.1. INTRODUCTION  
Nucleic acids are negatively charged and would therefore bind to LDHs as any other anion would.  
The degree of binding can be assessed using the electrophoretic mobility shift assay (EMSA), also 
known as the gel retardation assay. It was first described in the 80’s by Garner and Revzin (1981) 
and Fried and Crothers (1981), two groups working independently on DNA-protein interactions.  
EMSA is a simple, efficient and widely used method for detection of binary changes such as the 
presence or absence of binding of nucleic acids [Holden and Tacon, 2011].   The method has since 
been adapted to study the interactions of nucleic acids with various compounds such as drugs 
and carrier vectors in gene delivery studies.  The rationale behind EMSA is that free/unbound 
nucleic acids would have a different electrophoretic mobility in a gel matrix than nucleic acid that 
is bound to a carrier.  In this study, the migration of DNA:LDH or siRNA:LDH complexes would be 
‘retarded’ when compared to the migration of free/unbound DNA or siRNA.   
This assay is used to determine the optimal binding ratio, which refers to the lowest ratio of 
nucleic acid:LDH, where complete binding of the nucleic acid occurs.  The optimal binding ratio 
is very important, as it plays a key role in determining whether a vector would be suitable for 
gene therapeutic applications in vivo.   
When unbound ‘naked’ DNA is exposed to agarose gel electrophoresis, a typical band pattern is 
observed.  Depending on the forms of DNA present in the sample, three bands may be observed.  
The supercoiled form of DNA is more compact and migrates the furthest of the three forms of 
DNA.  The circular form of DNA migrates much slower than the other two forms, most probably 
due to stearic hindrance, whilst the linear form of DNA migrates at a rate intermediate to the 
supercoiled and circular forms.    When DNA is bound to a vector such as LDH, the mobility of the 
DNA:LDH is retarded  and the complex would remain in the well. 
The 6.2 kilobase pair pCMV-luc DNA plasmid was used for this study (Figure 4.1).  In addition to 
the luciferase gene, this plasmid contains a cytomegalovirus (CMV) promoter from pcDNA3, a 
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simian virus promoter, enhancer and late polyadenylation site, as well as an ampicillin resistance 
gene and bacterial origin of replication.   
 
Figure 4.1   Map of the pCMV-luc vector [Plasmid Factory, Bielefeld, Germany]. 
 
Small interfering RNA (siRNA) are short (20-25 base pairs long) double stranded RNA molecules 
which generally migrate as a single band when exposed to gel electrophoresis.  The anti-luc siRNA 
targeting the luciferase gene was used for the gene knockdown/silencing studies.   
 
4.2. MATERIALS AND METHODS 
DNA grade agarose was obtained from Bio-Rad Laboratories, Richmond, USA.   pCMV-luc plasmid 
DNA was supplied by Plasmid Factory (Bielefeld, Germany).  Anti-luciferase siRNA [5’-
GAUUAUGUCCGGUUAUGUA-3’] was purchased from Dharmacon (Lafayette CO, USA).  Ethidium 
bromide and ethylenediaminetetraacetic acid (EDTA) (disodium salt, dihydrate) were acquired 
from Merck, Darmstadt, Germany.  All other reagents were of analytical grade. 
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4.2.1.  PREPARATION OF NUCLEIC ACID-LDH COMPLEXES 
To find the optimal binding ratios, 0.5 µg of pCMV-luc DNA was added to the respective LDH 
samples at varying weight ratios in a total volume of 10 µl HEPES buffered saline [HBS (20 mM 
HEPES and 150 mM NaCl, pH 7.5)] (Table 4.1).  This mixture was vigorously vortexed for 10 
minutes and then allowed to stand at room temperature for 30 minutes.   
Table 4.1 Ratios used for nucleic acid:LDH complex formation.  
Lane Ratio nucleic acid :LDH Nucleic Acid (µg) LDH (µg)  
1 1:0 0.5 0 
2 1:10 0.5 5 
3 1:20 0.5 10 
4 1:30 0.5 15 
5 1:40 0.5 20 
6 1:50 0.5 25 
7 1:60 0.5 30 
8 1:70 0.5 35 
 
The siRNA-LDH complexes were prepared in a similar manner as the DNA-LDH complexes using 
anti-luciferase siRNA.  The siRNA-LDH-HBS mixtures were briefly vortexed and then incubated 
overnight at 60 °C to allow for optimal binding to occur.  
 
4.2.2 AGAROSE GEL ELECTROPHORESIS  
A 1 % agarose gel was prepared by dissolving (with heating) 0.2 g of agarose in 18 ml distilled 
water.  The solution was cooled to approximately 75 °C, after which 2 ml of 10x electrophoresis 
buffer (0.36 M Tris-HCl; 0.3 M Na2HPO4 and 0.1 M EDTA in 1 litre 18 Mohm water, pH 7.5) and 3 
µl of ethidium bromide (10 mg/ml) were added to it.  The solution was cooled further to 
approximately 60 °C, and then poured onto an electrophoresis gel tray fitted with an 8-well comb.  
The agarose gel was allowed to set for ± 1 hour, after which the comb was removed and the gel 
placed in an electrophoresis tank (Bio-Rad Mini-Sub®Cell GT) containing 1x electrophoresis 
buffer. A volume of 3 μL of gel loading buffer [glycerol 50 %, bromophenol blue 0.05 % and xylene 
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cyanol (0.05 %)] was added to the complexes, and 10 μL of each sample was loaded onto the 
agarose gel and exposed to electrophoresis at 50 volts for 90 minutes.   The gel was then viewed 
under UV light using a Syngene G-Box documentation system (Syngene, Cambridge, UK).   
 
4.2.3 CHARACTERIZATION OF NUCLEIC ACID:LDH COMPLEXES 
The ultrastructural morphology and size and ζ-potential of the DNA:LDH and the siRNA:LDH 
complexes was determined using TEM and NTA, respectively. The mechanism of DNA binding 
was evaluated by XRD analysis of the DNA:LDH complex.  For this aspect of the study MgAl 0.33 
was selected as an ideal representative of all the LDHs prepared.  XRD analysis required a 
substantial amount of sample and budgetary constraints did not allow for the preparation of such 
large quantities of the siRNA:LDH complexes.  This analysis was therefore not carried out on the 
siRNA:LDH complex.  The methods employed are as described in Chapter 3, sections 3.2.1, 3.2.4 
and 3.2.5. 
 
4.2.4 NUCLEASE DIGESTION AND NUCLEIC ACID RELEASE ASSAY 
This assay was performed using only the DNA:MgAl 0.33 complex as all the nucleic acid:LDH 
complexes would be expected to react similarly when exposed to serum nucleases.  A DNA:LDH 
(10 µl) complex was prepared at the optimal binding ratio determined from the electrophoretic 
mobility shift assay.  Two control samples were also prepared; a positive control containing only 
the DNA and a negative control containing DNA and 10 % v/v foetal bovine serum (FBS). The 10 
% v/v FBS was also added to the DNA:LDH complex, and all samples were incubated  at 37 °C for 
4 hours. The nuclease digestion reaction was stopped by the addition of ethylenediamine 
tetraacetic acid (EDTA), to a final concentration of 1 mM.  The sample was then centrifuged, the 
supernatant discarded, and 0.1 M HCl (1 µl) was added, and sample incubated at 37 °C for 1 hour.   
Thereafter, 2 µl of gel loading buffer was added to each sample and they were subjected to 
electrophoresis at 50 V for 90 minutes.  The gels were viewed under UV light using a Syngene G-
Box documentation system (Syngene, Cambridge, UK).   
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This process was also conducted for the siRNA:MgAl 0.33 complex, with electrophoresis for 30 
minutes instead of 90 minutes. 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 NUCLEIC ACID BINDING STUDIES 
Various incubation times and temperatures have been reported by investigators in the 
preparation of DNA:LDH complexes [Choy et al., 2000; Xu et al., 2007; Xu et al., 2008].  Balcomb 
and co-workers (2015) have reported incubation times of up to 72 hours at 60 °C for optimal 
DNA:LDH binding to occur.   
A number of different incubation times and temperatures (30 minutes/1 hour/ 6 hours at room 
temperature/37 °C /60 °C) were initially investigated (data not shown) with limited success.  In 
some cases partial binding was observed but in most cases the experimental conditions did not 
result in the complete formation of DNA:LDH complexes.  Eventually, a 24 hour incubation period 
at 60 °C was attempted, with promising results.  MgAl 0.25, MgAlArg 0.25, MgAlHist 0.25 and 
MgAlHist 0.33 all displayed complete binding with DNA at ratios of DNA:LDH of 1:30, 1:30, 1:10 
and 1:30 respectively (Figure 4.2).  MgAl 0.33, MgAl Arg 0.33, MgFe 0.25, MgFe 0.33, ZnAl 0.25 
and ZnAl 0.33 all showed partial retardation, which corresponded to incomplete binding [Figures 
4.2 (A,B and C) and 4.3 (D and E)].  ZnAl 0.33 showed complete binding at a ratio of DNA:LDH of 
1:60.  Smears observed in Figure 4.2 could be due to the presence of nucleases in the buffer. 
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Figure 4.2 Gel retardation patterns of (A) MgFe 0.25, (B) MgFe 0.33, (C) ZnAl 0.25, (D) ZnAl 
0.33 after a 24 hour incubation period.  Lane 1 of all the gels contain DNA only. 
Lanes 2-8 contain DNA:LDH ranging in ratios from 1:10 to 1:70 (w/w).  The arrow 
indicates the point of complete retardation.  (A) MgFe 0.25, (B) MgFe 0.33, (C) and 
ZnAl 0.25 show partial retardation. 
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Figure 4.3 Gel retardation patterns of (A) MgAl 0.25, (B) MgAlArg 0.25, (C) MgAlHist 0.25, (D) 
MgAl 0.33, (E) MgAlArg 0.33, (F) MgAlHist 0.33 after a 24 hour incubation period.  
Lane 1 of all the gels contain DNA only. Lanes 2-8 contain DNA:LDH ranging in 
ratios from 1:10 to 1:70 (w/w).  The arrows indicate the point of complete 
retardation. (D) MgAl 0.33 and (E) MgAlArg 0.33 show partial retardation. 
 
 
Barichello et al (2012) reported that agitation by vortex resulted in enhanced binding between 
siRNA and cationic liposomes, resulting in superior gene knockdown.  This methodology was then 
applied to the formation of the DNA:LDH complexes.  The components required to make up the 
DNA:LDH complexes were vortexed at high speed for 10 minutes followed by a 10 minute 
incubation at room temperature.  This method resulted in complete binding of the DNA to LDH, 
as confirmed by the gel retardation (Figure 4.4).     It has been further suggested that the high 
energy transmitted during vortexing harmonizes the interaction between the nucleic acid and 
the carrier vector [Barichello et al., 2012].   
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Figure 4.4 Gel retardation patterns of DNA only (lane 1), DNA:MgAl 0.25 (lane 2), 
DNA:MgAlArg 0.25 (lane 3), DNA:MgAlHist 0.25 (lane 4), DNA:MgAl 0.33 (lane 5), 
DNA:MgAlArg 0.33 (lane 6), DNA:MgAlHist 0.33 (lane 7), DNA:MgFe 0.25 (lane 8), 
DNA:MgFe 0.33 (lane 9), DNA: ZnAl 0.25 (lane 10) and DNA:ZnAl 0.33 (lane 
11)after vigorous vortexing for 10 minutes followed by a 10 minute incubation 
period at room temperature.  Results indicate complete complexation of the LDH 
with DNA under these conditions.  All complexes were prepared in a ratio of 
DNA:LDH of 1:30 (w/w). The arrows indicate complete retardation. 
 
Zhang and co-workers (2003) have reported a reduction in the number of water molecules in a 
lipoplex after complexation of liposomes with nucleic acids, resulting in a closer and more 
harmonious interaction between the two components.  It is possible that a similar reaction occurs 
during complex formation between the DNA and LDHs, where loss of water molecules from the 
interlayer could lead to a slight decrease in interlayer spacing consequently “trapping” the DNA 
or at least part of the DNA within the interlayer region and enhancing complex formation.  
Lu and co-workers (2016) have recently hypothesized a new, more likely mechanism of DNA 
interaction with LDHs.  They have suggested that LDHs are electrostatically attracted to and bind 
to the LDH surfaces via the phosphate backbone of the DNA molecules.  The phosphate oxygen 
thus forms co-ordination metal-oxygen-phosphate bonds resulting in the adsorption of DNA onto 
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the outer surface of the LDH (Figure 4.5).  The binding of DNA to the external surface of the LDH 
nanoparticles was also previously observed by Ladewig1 et al (2010) and Dong et al (2015).  The 
negative zeta potentials of most of the DNA:LDH complexes (Table 4.2), also reflects that the DNA 
was adsorbed onto the surfaces of the LDH rather than intercalated within the interlayer. Surface 
adsorption appears to be the most likely mechanism of DNA binding to the LDH in this study. 
It was found that optimal binding occurred at a DNA:LDH ratio of 1:30 (w/w) for all the LDH 
samples (Figure 4.4). 
 
Figure 4.5 Co-ordination between DNA phosphate backbone and LDH outer surface (adapted 
from Lu et al., 2016). 
 
TEM analysis of the DNA:LDH complexes revealed compact complexes with lateral lengths 
ranging from 10-250 nm.  This was confirmed by NTA analysis of the DNA:LDH complexes which 
showed that the complexes ranged in modal size from 20 to 180 nm (Table 4.2).   
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Table 4.2 Size and zeta potential of DNA:LDH complexes. 
 
In general the sizes of the DNA:LDH complexes were smaller than that of the parent LDHs, with 
a few exceptions.  It is possible that the large particle size observed for MgAl 0.25 could be due 
to aggregation of the nanoparticles in solution.  It is also possible that one DNA strand combined 
or interlinked with several LDH nanoparticles resulting in such aggregations [Xu et al., 2006].  The 
higher the absolute zeta potential value, the greater the colloidal stability of a solution [Ostolska 
and Wiśniewska, 2014]. The zeta potentials obtained for both the parent LDHs as well as the 
DNA:LDH complexes were lower than absolute 30 indicating the strong possibility of aggregation.  
Zeta potential values of lower than absolute 5 corresponds to rapid coagulation or aggregation 
leading to the formation of larger particles, as was observed with MgFe 0.25.  The negative zeta 
potential values of the complexes also suggest that the DNA binds to the outer surfaces of the 
LDH rather than being incorporated within the interlayer.  This negative surface charge would be 
expected to impede internalization into the cell, but Desigaux and co-workers (2006) have 
indicated that the negative zeta potential of the complex is not an impediment to cellular uptake. 
It was interesting to note that some of the DNA:LDH complexes displayed an almost ‘square’ or 
“cube” shaped morphology, whilst some appeared hexagonal in shape (Figures 4.6 and 4.7).   
LDH PARENT LDH DNA:LDH COMPLEXES 
SIZE (nm) ZETA POTENTIAL (mV) SIZE (nm) ZETA POTENTIAL (mV) 
MgAl 0.25 148.4 -11.6 180.1 -9.8 
MgAl 0.33 72.4 15.0 25.1 -21.3 
MgFe 0.25 307.4 1.2 20.3 -29.3 
MgFe 0.33 27.9 -12.8 25.8 9.7 
ZnAl 0.25 30.0 -7.2 44.4 -20.0 
ZnAl 0.33 67.9 29.7 61.2 -30.9 
MgAlArg 0.25 193.1 -19.8 26.9 -11.8 
MgAlArg 0.33 123.7 6.7 30.8 -27.3 
MgAlHist 0.25 60.8 -24.6 34.6 -28.0 
MgAlHist 0.33 44.5 22.7 53.9 -23.5 
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Figure 4.6 TEM images of DNA:LDH complexes (a) DNA-MgFe 0.25 at 300K magnification, (b) 
DNA-MgFe 0.33 at 150K magnification, (c) DNA-ZnAl 0.25 at 200 K magnification 
and (d) DNA-ZnAl 0.33 at 200K magnification.  The bar represents 100 nm in (a) 
and 200 nm in (b), (c) and (d) respectively. 
 
 
 
 
 
 
 
 
 
(a) (b
 
(c) (d) 
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Figure 4.7 TEM images of DNA:LDH complexes (a) DNA-MgAl 0.25 at 60K magnification, (b) 
DNA-MgAl 0.33 at 200K magnification , (c) DNA-MgAlArg 0.25 at 100K 
magnification, (d) DNA-MgAlArg 0.33 at 150K magnification, (e) DNA-MgAlHist 
0.25 at 200K magnification and (f) DNA-MgAlHist 0.33 at 200K magnification.  The 
bar represents 200 nm in (a) – (f). 
 
(a) (b
 
(c) (d) 
(e
 
(f) 
70 
 
A large degree of compaction occurs during the formation of the complex, when one compares 
the size of naked DNA as well as the native LDH nanoparticles.  This compaction occurs due to 
the electrostatic interaction between the cations present on the LDH surface and the phosphate 
backbone of the DNA molecules [Matulis et al., 2000].  The phosphate groups of the DNA are 
electrostatically neutralized by associating with the cations on the LDH molecules, leading to a 
condensed, more stable complex structure, the shape of which depends on the extent of 
condensation [Smith et al., 1997]. 
There have been many studies reporting that nucleic acid binding occurs due to ion exchange 
with interlayer anions [Xu and Lu, 2006; Ladewig et al., 2009], whilst recent reports suggest that 
the binding actually occurs between the phosphate backbone of the nucleic acid and the external 
surfaces of the LDH [Lu et al., 2016; Dong et al., 2015].  The actual mode of binding in this study 
was investigated using XRD analysis.  The d-spacing values of the parent MgAl 0.33 LDH as well 
as the DNA:MgAl 0.33 complex are identical (Figure 4.8), indicating that the DNA does not 
intercalate within the LDH interlayer. DNA intercalation within the interlayer would have resulted 
in an increase in d003 to 23.7 Å, which is the diameter of DNA [Berg et al., 2006].  The unchanged 
d003 value in the DNA:MgAl 0.33 complex, confirms that DNA binds to the outer surfaces of the 
LDH.  The slight shift to the right of the diffraction peaks of the MgAl 0.33:DNA complex, most 
probably occurs as a result of the DNA binding to the outer surface of the LDH. 
The LDHs prepared for this study were made using nitrate precursors, but it is very possible that 
the interlayer anions in the prepared LDHs were replaced by carbonate instead of nitrate, due to 
the higher selectivity for carbonate anions [Costantino et al., 2008], and the fact that the LDHs 
were not prepared under nitrogen.  This could contribute to poorer ion exchange of DNA with 
the interlayer anions 
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Figure 4.8 XRD pattern of (a) MgAl 0.33 (b) DNA:MgAl 0.33 complex. 
 
An attempt was made to prepare the siRNA:LDH complexes in the same way that the DNA:LDH 
complexes were prepared, by vigorously vortexing for 10 minutes, but this proved unsuccessful.  
Complete binding of the siRNA to the LDH samples was only obtained after incubation overnight 
at 60 °C.  Chen et al (2013) have suggested that a temperature of 60 °C would be inappropriate 
for intercalation of siRNA due to its susceptibility to higher temperatures, but Hickerson and co-
workers (2008) have reported that the integrity of siRNA is not affected by incubation at 
temperatures up to 95 °C.  The gel retardation results (Figure 4.9), confirmed that the siRNA 
remains in its integral form even after an overnight incubation at 60 °C.  Upon overnight 
incubation at 60 °C the siRNA bound completely with the various LDH samples, albeit at different 
ratios (Figure 4.9).  The MgAl 0.25 and MgAlHist 0.33 samples bound completely at a siRNA:LDH 
ratio of 1:30, the MgAlArg 0.25 and MgAlHist 0.25 exhibited complete binding at a siRNA:LDH 
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ratio of 1:20, whilst the MgAl 0.33 and MgAlArg 0.33 bound optimally at a siRNA:LDH ratio of 
1:10.  The MgFe 0.25, MgFe 0.33, ZnAl 0.25 and ZnAl 0.33 LDH samples bound completely with 
the siRNA at a ratio of 1:40.   Previous studies have shown that some of the siRNA intercalates 
into the interlayers of the LDH, while some is actually adsorbed onto the LDH surface [Chen et 
al., 2013].  It was interesting to observe that unlike the DNA-LDH complexes which remained 
clearly visible in the wells of the gel, the siRNA-LDH complexes were not visible in some of the 
wells, even though no ‘free’ siRNA was visible on the gels.  It is presumed that this occurs because 
siRNA units enter the LDH interlayer where they are electrostatically bound.  Since the siRNA are 
now ‘shielded’ within the interlayer, the fluorescence, (due to the presence of ethidium bromide 
in the gel interacting with the nucleic acid), is not clearly visible. 
 
 
Figure 4.9  Gel retardation patterns of (A) MgAl 0.25, (B) MgAlArg 0.25, (C) MgAlHist 0.25, (D) 
MgAl 0.33, (E) MgAlArg 0.33, (F) MgAlHist 0.33 (G) MgFe 0.25, (H) MgFe 0.33, (I) 
ZnAl 0.25, (J) ZnAl 0.33 after incubation with siRNA at 60 °C overnight. 
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TEM analysis of the siRNA:hydrotalcite complexes shows a large degree of condensation of the 
LDH structure upon binding with siRNA.  The nanoparticles, which before binding ranged in size 
from 20-200 nm, condensed down to a size range of 4-50 nm in lateral diameter.   The complexes 
appear somewhat spherical but not quite uniform in size or morphology (Figure 4.10). 
 
  
  
Figure 4.10 TEM images of complexes (a) siRNA-MgAl 0.25, (b) siRNA-MgAl 0.33, (c) siRNA-
MgAlArg 0.33 and (d) siRNA-MgAlHist 0.33 at 300 K magnification.  The bar 
represents 100 nm in (a) – (d). 
 
The HT-like compounds complexed with siRNA showed a similar condensation formation to those 
observed for the siRNA-MgAl 0.25, siRNA-MgAl 0.33, siRNA-MgAlArg 0.33 and siRNA-MgAlHist 
0.33 (Figure 4.11).  Lateral sizes of the complexes ranged between 5 and 30 nm. 
(a) (b) 
(c) (d) 
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Figure 4.11 TEM images of complexes (a) siRNA-MgFe 0.25, (b) siRNA-MgFe 0.33, (c) siRNA-  
ZnAl 0.25 and (d) siRNA-ZnAl 0.33 at 300K magnification.  The bar represents 100 
nm in (a) – (d). 
 
The condensation in structure seen for all the other LDH-siRNA complexes is different from that 
observed for the siRNA-MgAlArg 0.25 and siRNA-MgAlHist 0.25 complexes.  Instead of the 
compact ‘spherical shaped’ complexes, nanoflakes were observed (Figure 4.12).  It appears as if 
the amino acid functionalized hydrotalcites prepared in the ratio of Mg:Al:aa of 3:1:1 have a more 
rigid structure, that is unable to condense down completely upon complexation with the siRNA, 
and the nanoparticles merely folds over around the siRNA. 
      
(a) (b) 
(c) (d) 
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Figure 4.12 TEM images of complexes (a) siRNA-MgAlArg 0.25 and (b) siRNA-MgAlHist 0.25 at 
300K magnification.  The bar represents 100 nm in (a) and (b). 
 
Unlike the DNA:LDH complexes which have an almost ‘square/cube’ shape, the siRNA:LDH 
complexes are more spherical in shape.  The difference in shape suggests that the mechanism of 
structural condensation of the siRNA:LDH complexes is most probably quite different from the 
mechanism involved in DNA:LDH structural condensation.  siRNAs are much smaller molecules 
than DNA, and are thus probably easily intercalated within the interlayer region of the LDHs.  
Unlike the electrostatic attraction occurring between the cations on the outer surface of the LDH 
molecules and DNA, the electrostatic attraction most probably occurs between the cations on 
the inner surfaces of the LDH molecules and siRNA, resulting in the distinct difference in shape 
of the DNA:LDH complexes compared to the siRNA:LDH complexes. 
Computational simulation studies by Zhang et al (2012) suggest that RNA molecules intercalate 
within the LDH interlayers, where the RNA molecule is oriented parallel to the hydroxide layers.  
The strong electrostatic interactions between the siRNA molecules and the positively charged 
LDH sheets keep the siRNA molecules ‘bound’ within the interlayer. 
The small sizes of the siRNA:LDH complexes was confirmed by NTA analysis (Table 4.3).  The zeta 
potential values obtained for the siRNA:LDH complexes suggest greater colloidal stability than 
the DNA:LDH complexes, which could be a contributing factor to the generally smaller size of 
particles observed.  The small siRNA:LDH complex size could also be attributed to the initial high 
speed vortexing during complex preparation, which is reported to result in better interaction 
(a) (b) 
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between the siRNA and the carrier vector [Barichello et al., 2012].  There is also a greater change 
in zeta potential of the siRNA:LDH complexes compared to the parent LDHs, which shows that 
the LDHs have a high affinity for siRNA [Rojas et al., 2015].  The negative charge of the siRNA:LDH 
complexes indicates that siRNA similar to the DNA binds predominantly to the outer surfaces of 
the LDH [Wong et al., 2010; Chen et al., 2013]. 
 
Table 4.3 Size and zeta potential of siRNA:LDH complexes. 
 
 
 
4.3.2 NUCLEASE DIGESTION AND NUCLEIC ACID RELEASE ASSAY 
The ultimate role of a gene delivery vector is to eventually deliver its load into the cell in vivo.  
Here the complexes would be exposed to degradative enzymes such as nucleases.  It is therefore 
essential to investigate whether the vector is able to transport the nucleic acids into the cell in 
its integral form.  This may be determined by performing a nuclease digestion assay, where the 
nucleic acid-vector complex is exposed to serum nucleases in an environment mimicking in vivo 
conditions. The intercalation reaction between DNA and LDH is reversible and the DNA may be 
released either by addition of K2CO3 [Wu et al., 2014] or by dropping the pH of the solution.  In 
LDH PARENT LDH siRNA:LDH COMPLEXES 
SIZE 
(nm) 
ZETA POTENTIAL (mV) SIZE 
(nm) 
ZETA POTENTIAL (mV) 
MgAl 0.25 148.4 -11.6 28.4 -34.7 
MgAl 0.33 72.4 15.0 47.0 -30.3 
MgFe 0.25 307.4 1.2 45.1 -28.2 
MgFe 0.33 27.9 -12.8 55.4 -21.8 
ZnAl 0.25 30.0 -7.2 27.0 -29.7 
ZnAl 0.33 67.9 29.7 25.7 -46.1 
MgAlArg 0.25 193.1 -19.8 34.3 -28.1 
MgAlArg 0.33 123.7 6.7 36.0 -13.5 
MgAlHist 0.25 60.8 -24.6 41.0 -22.6 
MgAlHist 0.33 44.5 22.7 48.8 -24.0 
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this study, the nucleic acid was released from the vector by dropping the pH.   An acidic pH 
disrupts and dissolves the hydroxide layers of the LDH, resulting in release of the nucleic acid 
[Zhang et al., 2012].  The sample is then exposed to gel electrophoresis to visualize the integrity 
of the nucleic acid and/or extent of nuclease digestion.  Integral DNA would appear as three 
distinct bands (depending on the forms of DNA initially present in the sample) and integral siRNA 
would appear as a single band. Nucleic acid that had been degraded by the serum enzymes would 
appear as smears on the gel.  If the nucleic acid remains in its integral form after exposure to the 
nuclease digestion assay, then this suggests that the vector would be suitable for in vivo 
applications. 
 
From the results obtained (Figure 4.13), it can be clearly seen that the DNA:LDH complex does 
offer some degree of protection to the DNA from serum nucleases.  The naked, unprotected DNA 
(lane 2) was disintegrated after exposure to serum nucleases as the DNA appeared as a smudged 
band on the gel. For the DNA:LDH complexes, the DNA retained its integrity  with the bands of 
the linear, circular and supercoiled forms of the DNA still being quite clearly visible (lane 4).  Some 
of the DNA:LDH complex still remained in the well, as was also reported by Kriven et al (2004) 
who suggested that DNA can only be completely released from the complex at a pH of 2 or less.  
The mechanism of release of the DNA from the DNA:LDH complex has been proposed to be via a 
dissolution process that occurs in the endosome due to low pH [Ladewig et al., 2009; Choy et al., 
2000]. LDHs begin to dissolve in a pH range of 4-5, resulting in the release of their cargo in a pH-
dependent manner [Wong et al., 2010]. 
 
The buffering capacity of LDHs have been well documented and this property has been exploited 
in the production of antacids from LDHs for many years [Cunha et al., 2010]. Bejoy (2001) 
reported that hydrotalcites are capable of buffering the contents of the stomach at pH 4 for 
extended periods of time.  It is this property that has also made LDHs increasingly attractive for 
medical applications, where it can be used for controlled release of medicines.  Thus the 
incomplete degradation of the complex, indicated by the presence of some of the complexes 
remaining in the well, as can be seen in lane 4 (Figure 4.13), was as expected after an overnight 
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incubation period.  The slow dissolution process of the DNA:LDH complex indicates that the DNA 
transfection rate via LDH nanoparticles would be a slow process.  This is the reason for the 
extended incubation period of 72 hours for the transfection studies (Chapter 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 Results of nuclease digestion assay of DNA:MgAl 0.33.  Lane 1 : naked DNA, Lane 
2: DNA exposed to nuclease digestion, Lane 3 :MgAl 0.25 DNA-LDH complex, and 
Lane 4: MgAl 0.25 DNA-LDH complex exposed to nuclease digestion. 
 
 
There does appear to be a small amount of degradation of the DNA from the DNA:LDH complex. 
This confirms reports by Xu et al (2007), Ladewig1 et al (2010) and Lu et al (2016) that some of 
the DNA is bound to the surface of the LDH, leaving the DNA partially exposed to nuclease 
digestion.  Similar results were obtained for the siRNA:LDH complex (Figure 4.14).  The naked 
siRNA is almost totally digested by the nuclease present in the serum (lane 2), whilst there 
appears to be minimal degradation of the siRNA:LDH complex after exposure to nuclease 
digestion.  Most of the siRNA from the siRNA:LDH complex exposed to nuclease digestion still 
appears to be present in the well of the gel (lane 4), indicating that the siRNA is still bound to the 
LDH.  This implies that some degree of protection has been afforded to the siRNA by the LDHs. 
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Figure 4.14 Results of nuclease digestion assay of siRNA:MgAl 0.25.  Well 1 was loaded with 
naked siRNA, well 2 contained siRNA exposed to nuclease digestion, well 3 was 
loaded with the MgAl 0.25 siRNA-LDH complex, and well 4 contained the MgAl 
0.25 siRNA-LDH complex exposed to nuclease digestion. 
 
 
 
 
4.4 CONCLUSION 
 
The optimal binding ratio of DNA:LDH was found to be 1:30 (w/w).  The optimal binding ratios of 
siRNA:LDH complexes varied between 1:10 to 1:40 (w/w) depending on the LDH used.  The MgAl 
0.25 and MgAlHist 0.33 samples bound completely at a siRNA:LDH ratio of 1:30 (w/w), the 
MgAlArg 0.25 and MgAlHist 0.25 exhibited complete binding at a siRNA:LDH ratio of 1:20 (w/w), 
whilst the MgAl 0.33 and MgAlArg 0.33 bound optimally at a siRNA:LDH ratio of 1:10 (w/w).  The 
MgFe 0.25, MgFe 0.33, ZnAl 0.25 and ZnAl 0.33 LDH samples bound completely with the siRNA 
at a ratio of 1:40 (w/w).   
Results of the nuclease digestion assay show that most of the nucleic acid (DNA/RNA), appear to 
retain its integrity after being exposed to the serum nucleases, and afforded reasonable 
protection to the respective nucleic acid cargo. Hence, these LDHs show potential as suitable 
gene carriers for further transfection studies. 
 
 
    1               2                    3             4 
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 CHAPTER 5  
5. IN VITRO ASSAYS: CYTOTOXICITY, GENE EXPRESSION AND GENE 
SILENCING STUDIES 
 
5.1. INTRODUCTION 
 
The use of cell-based assays is important for testing the various parameters with regards to their 
physiological processes and their response to external factors and compounds. Hence, they have 
become useful tools to predict the possible outcome of in vivo studies.  Their use in preclinical 
applications of gene and drug therapy is without doubt.  The cell viability, MTT assay and 
luciferase gene expression studies were conducted on the human cell lines: embryonic kidney 
(HEK293), hepatocellular carcinoma (HepG2), and colon adenocarcinoma (Caco-2).  The human 
cervical carcinoma cells stably transformed with the luciferase gene (Hela-tat-luc), was also used 
in the MTT assay, but solely employed in the gene silencing assay.  A brief description of the cell 
lines is provided below. 
 
HEK293 
In 1973, Frank Graham in the Netherlands, transformed cultures of normal human embryonic 
kidney cells (from an apparently healthy, legally aborted fetus) with sheared adenovirus 5 DNA to 
form HEK293 cells. The cell line was so named because it was Grahams 293rd experiment 
[www.hek293.com (Date accessed: 15th September 2017)].  The transformation was due to the 
incorporation of a 4.5 kb insert from the viral genome into human chromosome 19 
[https://en.wikipedia.org/wiki/HEK_293_cells (Date accessed: 15th September 2017)].  The exact 
cell type of HEK293 is unknown as adenovirus 5 significantly changes cell morphology and 
expression post-transformation, but it is speculated to be neuronal in origin.   
HEK293 cells have a modal chromosome number of 64, and are referred to as being  hypotriploid, 
because they contain less than three times the number of chromosomes of a normal diploid 
human cell.  HEK293 expresses the corticotrophin releasing factor type 1 receptor, sphingosine-
1-phosphate receptors EDG1, EDG3 and EDG5, muscarinic acetylcholine receptor M3 and the 
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transient receptor potential TRPC1, TRPC3, TRPC4, TRPC6 [www.hek293.com (Date accessed: 
15th September 2017)].  HEK293 cells (Figure 5.1) are extremely popular in cell culture due to 
their ease of growth and transfectibility, which makes them ideal for gene expression studies.  
 
 
 Figure 5.1 Image of HEK293 cells (x100) captured using an Olympus inverted microscope. 
 
HepG2 
The HepG2 cell line (Figure 5.2) was derived from a well differentiated liver hepatocellular 
carcinoma of a 15-year old Caucasian male [www.hepG2.com (Date accessed: 15th September 
2017)].  The cells have a modal chromosome number of 55.  HepG2 cells are relatively easy to 
culture and grow as adherent monolayers and/or small aggregates with an epithelial 
morphology.  When properly cultured, HepG2 cells differentiate to form apical and basolateral 
cell surfaces, which bear resemblance to liver structures in vivo.  This makes HepG2 cells useful 
in the study of intracellular transport between different liver cell types.  The high degree of 
morphological and functional differentiation of HepG2 cells in vitro, as well as the absence of 
viral infection (no hepatitis B surface antigens), makes them ideal models for hepatocellular 
carcinoma studies [Costantini et al., 2013].  HepG2 cells are regularly used when examining 
toxicity of substances to the liver, liver metabolism and drug metabolism studies.   
HepG2 cells contain unique asialoglycoprotein receptors that bind and internalize galactose 
terminal asialoglycoproteins [Wu and Wu, 1987; Wu and Wu, 1988], making HepG2 a useful cell 
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line for receptor mediated endocytosis studies. These cells have even been used in trials with 
bio-artificial liver devices [www.hepG2.com (Date accessed: 15th September 2017)].   
HepG2 cells secrete a number of plasma proteins such as albumin, transferrin, fibrinogen, alpha-
2-macroglobulin, alpha-1-antitrypsin, alpha-1-antichymotrypsin, plasminogen, haptoglobulin, 
ceruloplasmin, alpha-1-acid glycoprotein, alpha-2-HS-glycoprotein, beta-lipoprotein and retinol 
binding protein [https://en.wikipedia.org/wiki/Hep_G2 (Date accessed: 15th September 2017)], 
and has 3-hydroxy-3-methylglutaryl-CoA reductase and hepatic triglyceride lipase activities. 
 
 
Figure 5.2 Image of HepG2 cells (x100) captured using an Olympus inverted microscope. 
 
Caco-2 
Caco-2 cells (Figure 5.3) have a modal chromosome number of 96, and were first isolated from a 
primary colonic tumour, from a 72 year old Caucasian male in the 1970s.  It is a continuous, 
heterogeneous cell line that undergoes spontaneous differentiation and expresses the 
morphological and biochemical characteristics of intestinal enterocytes, making them ideal 
models of the intestinal barrier for in vitro cytotoxicity studies [Natoli et al., 2012; Sambuy et al., 
2005].  Caco-2 cells are adherent cells that display an epithelial morphology and grow in a 
monolayer. Caco-2 cells express a number of enzymes such as sucrase-isomaltase, peptidases 
and esterases, and nutrient transporters of sugars, amino acids, bile acids, carboxylic acids, as 
well as transporters of micronutrients such as heavy metals and nucleosides [Sambuy et al., 2005; 
https://en.wikipedia.org/wiki/Caco-2 (Date accessed: 15th September 2017)].   
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Figure 5.3 Image of Caco-2 cells (x100) captured using an Olympus inverted microscope. 
 
Hela-tat-luc 
The original Hela cell line was derived from a cervical carcinoma of a 31-year old African American 
female in 1951 [https://en.wikipedia.org/wiki/HeLa (Date accessed: 15th September 2017)].  
These were the first human immortal cell line used for medical research.  The Hela-tat-luc cells 
(Figure 5.4) used in this study have been transfected with the Tat protein from the human 
immunodeficiency type 1 virus (HIV-1), and also stably transformed using the firefly luciferase 
gene. 
 
Figure 5.4 Image of HeLa-tat-luc cells (x100) captured using an Olympus inverted 
microscope. 
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5.1.1   CYTOTOXICITY STUDIES 
Before undertaking gene expression and silencing studies, it is essential to determine the 
cytotoxicity of the LDHs in cell culture, since high levels of toxicity, even in the presence of good 
transfection, would render the nanoparticles unsuitable for in vivo applications.  There are 
currently many convenient and cost-effective colorimetric and fluorometric based cytotoxicity 
assays available, where the samples can be assessed directly on the culture plate using a plate 
reader [Weyermann et al., 2005].  These methods include lactate dehydrogenase release, neutral 
red uptake, crystal violet staining,  ATP and  the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT) assays [Fotakis and Timbrell, 2006; Weyermann et al., 2005], among 
others. 
For this study, the MTT assay was used to assess cell viability after exposure to the nucleic 
acid:LDH complexes.  The MTT assay was first proposed by Mosmann (1983) and has been 
extensively used despite disadvantages such as decreased formazan production due to the 
actions of reducing agents and respiratory chain inhibitors of mitochondrial MTT reduction.  It 
has also been reported that the MTT assay could be influenced by factors such as medium pH, D-
glucose concentration of the growth medium and cellular concentration of pyridine nucleotides 
[Chiba et al., 1998].  Advantages of the MTT assay include the simplicity of the method, high 
sensitivity and the use of equipment easily found in most laboratories. 
MTT is a water-soluble salt containing a tetrazolium ring, which can be cleaved by mitochondrial 
succinate dehydrogenases, leading to the formation of an insoluble, purple-colored formazan 
product which is impermeable to the cell membrane and therefore accumulates within healthy 
cells [Fotakis and Timbrell, 2006].  The amount of formazan produced is proportional to the 
number of viable cells present in the culture.  Hence, the ability of the cells to reduce MTT 
correlates to the cells viability, since only viable cells will have an active mitochondrion [Chiba et 
al., 1998].  There have been many modifications to Mosmann’s method over the years [Tada et 
al., 1986; Denizot and Lang, 1986; Carmichael et al., 1987; Twentyman and Luscombe, 1987], and   
the method employed for this study is similar to that reported by Carmicheal and co-workers 
(1987), with DMSO being used to solubilize the formazan instead of mineral oil.  This is because 
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DMSO does not cause precipitation of proteins and results in a clearer formazan solution, with 
stable optical density [Twentyman and Luscombe, 1987]. 
 
5.1.2 GENE EXPRESSION AND SILENCING STUDIES 
A transfection study is carried out to determine whether a vector is able to efficiently deliver the 
nucleic acid into a cell resulting in either sustained expression of the transgene (DNA) or silencing 
of the target gene (siRNA).   
The plasmid DNA utilised in this study is the pCMV-luc DNA, described previously in chapter 4 
(section 4.1).  The luciferase assay is based on the fact that mammalian cells do not naturally 
express the luciferase gene, which is only expressed upon successful transfection of the pCMV-
luc DNA into eukaryotic cells. This reaction requires the addition of the substrates luciferin, ATP 
and oxygen, to catalyze the production of light or luminescence, which can be measured using a 
luminometer.  The luciferase gene isolated from the firefly P. pyralis is composed of seven exons 
separated by six very short introns, all less than 60 bases in length [de Wet et al., 1987].  
 
The reactions catalyzed by firefly luciferase are: 
Mg2+ 
Luciferase + luciferin + ATP    ↔     luciferase.luciferyl AMP + PPi 
luciferase.luciferyl AMP + O2   →    luciferase + oxyluciferin + AMP + CO2 + hv (light) 
 
The amount of light produced is directly proportional to the quantity of luciferase present in the 
reaction mixture.  
The luciferase enzyme activity can also be used as an indicator of gene silencing.  The Hela tat-
luc cell line stably expresses the luciferase gene and the anti-luc-siRNA specifically targets the 
luciferase gene.  Efficient delivery of the anti-luc-siRNA results in a decrease in luciferase activity, 
which can be similarly measured using a luminometer. 
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5.2. MATERIALS AND METHODS 
5.2.1 MATERIALS 
Eagle’s Minimum Essential Medium (EMEM) containing Earle’s salts and L-glutamine, trypsin-
versene and penicillin-streptomycin mixtures was purchased from Lonza BioWhittaker 
(Walkersville, USA).  Foetal bovine serum (FBS) was purchased from Hyclone GE Healthcare (Utah, 
USA).  Phosphate-buffered saline (PBS) tablets were purchased from Calbiochem (Canada). The 
MTT salt (3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide) was purchased from 
Merck (Darmstadt, Germany). All sterile tissue culture plastic ware obtained from Corning Inc. 
(NY, USA). HepG2 and Caco-2 cells were sourced from Highveld Biologicals (PTY) LTD (Lyndhurst, 
South Africa).  HEK293 (human embryonic kidney) cells were supplied by the University of 
Witwatersrand, Medical School, South Africa.  HeLa tat luc cell line was provided by the 
Department of Physiology, University of KwaZulu-Natal, Westville Campus. The pCMV-luc DNA 
was purchased from Plasmid Factory (Bielefeld, Germany), while the anti-luc-siRNA was obtained 
from Thermo-Scientific Dharmacon Products (Lafayette, CO).  The Luciferase Assay kit was 
purchased from the Promega Corporation, Madison, USA.  The bicinchoninic acid (BCA) assay 
reagents were purchased from the Sigma-Aldrich Co., St. Louis, USA.  All other reagents were of 
analytical grade.   
5.2.2 MTT ASSAY 
Cells were maintained in EMEM supplemented with 10 % (v/v) gamma-irradiated FBS and 1 % 
antibiotics (100 U/mL penicillin, 100 μg/mL streptomycin) at 37 °C and 5% CO2, in a HEPA Class 
100 Steri-Cult CO2 incubator (Thermo-Electron Corporation, Waltham, Massachusetts, USA). The 
MTT assay was carried out using Caco-2, HEK293 and HepG2 cells for the DNA:LDH complexes 
and using the HeLa- tat-luc cell line for the siRNA:LDH complexes. 
For the MTT assay, cells were trypsinized and seeded into 48-well plates at a seeding density of 
approximately 3 X 104 cells/well, and incubated at 37 °C for 24 hours to allow for attachment. 
The medium was then replaced with fresh medium, and the respective DNA:LDH complexes were 
added to the wells and allowed to incubate for 48 hours at 37 °C.  Complexes prepared were at 
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DNA:LDH ratios (sub-optimal, optimal and supra-optimal), as determined from the gel 
retardation assays (chapter 4, section 4.3).  A positive control containing only cells was set as 100 
% cell survival/viability. All assays were performed in triplicate. After the 48-hour incubation 
period the spent medium was removed and 200 μL fresh medium and 200 μL MTT reagent (5 
mg/mL in PBS) was added to each well.   
The cells were incubated at 37 °C for a further 4 hours, after which the MTT-medium solution 
was removed and 200 μL DMSO was added to solubilize the formazan crystals.  Absorbance was 
read at 540 nm using a Mindray MR-96A microplate reader (Vacutec, Hamburg, Germany). 
 
5.2.3 LUCIFERASE GENE EXPRESSION STUDIES 
 
DNA transfection studies were carried out in the HEK293, HepG2 and Caco-2 cell lines, using the 
pCMV-luc plasmid DNA.  The cells were seeded in 48 well plates at a cell density of 3.0 × 104 cells 
per well and incubated at 37 °C for 24 hours. The medium was then replaced with fresh medium 
and the respective DNA:LDH complexes were added to the wells and allowed to incubate for 72 
hours at 37 °C.  Complexes were prepared as in 5.2.2. Each assay was done in triplicate.  Two 
controls were used, cells only and cells with naked plasmid DNA.  After the 72-hour incubation 
period, the luciferase activity of the cells was determined using the Promega luciferase assay 
system. 
The cells were prepared by removing the growth medium and washing twice with PBS. 
Thereafter, 80 µl of 1× cell lysis reagent (25 mM Tris-phosphate, pH 7.8; 2 mM dithiothreiotol, 2 
mM 1,2- diaminocyclohexane – N, N, N’N’- tetra-acetic acid, 10 % (v/v) glycerol, 1 % (v/v) triton 
X-100) was added to the cells, which were then gently rocked on a Stuart Scientific Platform 
Shaker for 15 minutes at 30 rev/ min.  The lysed cells were dislodged from the multiwell plates 
by gently scraping. The cell suspension was then pelleted by centrifugation at 12000 x g for 5 
seconds. The cell free extract was retained for the determination of luciferase activity. A volume 
of 20 µl of each of the cell free extracts was transferred to a white multiwell plate and placed in 
a GloMax Multi+ detection system (Promega). Luciferase assay reagent (100 µL; 20 mM Tricine, 
1.1 mM Magnesium carbonate hydroxide pentahydrate, 2.7 mM Magnesium sulphate, 0.1 mM 
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EDTA, 33.3 mM dithiothreitol, 270 µM coenzyme A, 470 µM luciferin, 530 µM ATP) was then 
automatically injected into the samples and the luminescence was read immediately.   The 
protein content of the cell free extracts was determined using the BCA assay, at 540 nm. All 
luminescence readings were normalized against the protein content and expressed as relative 
light units per milligram protein (RLU/mg protein).  The results were presented as means ± SD. 
 
5.2.4 LUCIFERASE GENE SILENCING STUDIES 
The overall procedure for the gene silencing studies was similar to that for the DNA transfection 
studies (5.2.3).  The Hela tat-luc cell line, stably expressing the luciferase gene was used and the 
complexes comprised of anti-luc-siRNA and LDH prepared at ratios as determined by the binding 
assays (chapter 4, section 4.3).  The only difference in methodology for the knockdown studies 
was that the cells were allowed to incubate with the complexes for 48 hours instead of the 72-
hour incubation period used for the DNA transfection studies.  This was because previous reports 
have shown that optimal gene knockdown occurs between a 36 and 48-hour incubation period 
[Ladewig2 et al., 2010]. Wong and co-workers (2010) have also reported effective gene silencing 
following a 24-hour incubation period.  To validate transfection, the luciferase assay was carried 
out as described above (5.2.3).   
 
5.3 STATISTICAL ANALYSIS 
All graphs were plotted in Microsoft Excel™.  All data are presented as mean ± standard deviation 
(± SD n=3).  Graphpad Instat Prism 4.0.3 software was used for statistical analysis.  Multi group 
comparisons of means were carried out using one-way analysis of variance (ANOVA) followed by 
the Tukey-Kramer post hoc test. Statistical significance for all tests was set at ***p<0.0005 (high 
significance), **p<0.005 (medium significance) and *p<0.05 (low significance). Each experimental 
value was compared to its corresponding control. 
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5.4 RESULTS AND DISCUSSION 
5.4.1 CYTOTOXICITY STUDIES 
5.4.1.1 MTT ASSAY OF DNA:LDH COMPLEXES 
Cytotoxicity of nanoparticles is influenced by a number of factors such as the cell line used, cell 
culture conditions, nanoparticle size, nanoparticle concentration and duration of exposure [Choi 
and Wang, 2011].  The six DNA:hydrotalcite complexes were very well tolerated by the all cell 
lines at the ratios and conditions tested (Figure 5.5).  The cell viabilities, after a 48 hour incubation 
period with complexes prepared at optimal ratio were, for Caco-2 cells -MgAl 0.25 (83.50 %), 
MgAl 0.33 (91.16 %), MgAlArg 0.25 (105.2 %), MgAl Arg 0.33 (102.9 %), MgAlHist 0.25 (103.3 %) 
and MgAlHist 0.33 (102.8 %);  for the HEK293 cells -MgAl 0.25 (103.7 %), MgAl 0.33 (99.69 %), 
MgAlArg 0.25 (98.58 %), MgAl Arg 0.33 (102.1 %), MgAlHist 0.25 (105.3 %) and MgAlHist 0.33 
(109.8 %);  and for the HepG2 cells - MgAl 0.25 (97.57 %), MgAl 0.33 (101.5 %), MgAlArg 0.25 
(108.3 %), MgAl Arg 0.33 (103.5 %), MgAlHist 0.25 (109.1 %) and MgAlHist 0.33 (106.3 %) 
respectively.        
A similar trend was observed for all cell lines after exposure to the other DNA:LDH complexes as 
shown in Figure 5.6.  The cell viabilities, after a 48-hour incubation period with complexes 
prepared at optimal ratio were, for Caco-2 cells -MgFe 0.25 (91.38 %), MgFe 0.33 (96.83 %), ZnAl 
0.25 (95.90 %) and ZnAl 0.33 (94.16 %); for the HEK293 cells - MgFe 0.25 (106.8 %), MgFe 0.33 
(100.5 %), ZnAl 0.25 (110.6 %) and ZnAl 0.33 (98.15 %); and for HepG2 cells - MgFe 0.25 (99.02 
%), MgFe 0.33 (100.6 %), ZnAl 0.25 (109.3 %) and ZnAl 0.33 (108.9 %) respectively. The Tukeys 
comparison test revealed no statistical significance, except in the case of MgAl 0.25 at the supra-
optimal binding ratios.  Minimal cell death was observed with the Caco-2 cell line after treatment 
with all the complexes, but the presence of the complexes appeared to be growth-promoting in 
the case of the HEK293 and the HepG2 cell lines.  The complexes appeared to ‘shroud’ the cells, 
protecting them, and also promoting growth of the cells.  Balcomb et al (2015) reported similar 
results and suggested that the increased cell viabilities, especially with iron containing LDHs was 
on account of the increased redox potential and cell oxidative processes brought about within 
the cell due to the presence of increased intracellular iron. 
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Figure 5.5 MTT assay of Caco-2, HEK293 and HepG2 cells exposed to (a) pCMV-luc DNA:MgAl 
0.25 complexes, (b) pCMV-luc DNA:MgAl 0.33 complexes, (c) pCMV-luc 
DNA:MgAlArg 0.25 complexes,(d) pCMV-luc DNA:MgAlArg 0.33 complexes, (e) 
pCMV-luc DNA:MgAlHist 0.25 complexes and (f) pCMV-luc DNA:MgAlHist 0.33  
complexes. Data is represented as means ±SD (n=3). *p<0.05 was considered 
statistically significant. 
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Figure 5.6 MTT assay of Caco-2, HEK293 and HepG2 cells exposed to (a) pCMV-luc DNA:MgFe 
0.25 complexes, (b) pCMV-luc DNA:MgFe 0.33 complexes, (c) pCMV-luc DNA:ZnAl 
0.25 complexes and (d) pCMV-luc DNA:ZnAl 0.33 complexes.  Data is represented 
as means ±SD (n=3).  No statistically significant change in percent cell survival was 
observed. 
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5.4.1.2 MTT ASSAY OF siRNA:LDH COMPLEXES 
The Hela-tat-luc cells all displayed prolific growth in the presence of all the siRNA-LDH complexes 
as can be seen in Figures 5.7-5.9.  The cell viabilities, at optimal binding ratio, in the presence of 
the hydrotalcites were MgAl 0.25 (117.6 %), MgAlArg 0.25 (103.5 %), MgAlHist 0.25 (110.7 %), 
MgAl 0.33(114.7 %), MgAlArg 0.33 (107.9 %) and MgAlHist 0.33 (107.8 %).  The iron containing 
complexes showed higher cell viability than the other complexes, with cell viabilities in the 
presence of MgFe 0.25 being 136.7 % and MgFe 0.33 being 135.2 % respectively (Figure 5.9).  The 
viabilities in the presence of ZnAl 0.25 and ZnAl 0.33, were 109.7 % and 112.5 % respectively.  The 
high cell viabilities of the hydrotalcites were expected, as there have been previous reports of 
hydrotalcites exhibiting negligible cytotoxicity at biologically relevant concentrations [Chen et al., 
2013]. 
 
 
Figure 5.7 MTT assay of Hela-tat-luc cells exposed to anti-luc siRNA:MgAl 0.25 complexes, 
anti-luc siRNA:MgAlArg 0.25 complexes and anti-luc siRNA:MgAlHist 0.25 
complexes.  Data is represented as means ±SD (n=3).  *p<0.05 was considered 
statistically significant. 
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Figure 5.8 MTT assay of Hela-tat-luc cells exposed to anti-luc siRNA:MgAl 0.33, anti-luc 
siRNA:MgAlArg 0.33 complexes and anti-luc siRNA:MgAlHist 0.33 complexes.  Data 
are represented as means ±SD (n=3). *p<0.05 was considered statistically 
significant. 
 
 
 
 
 
Figure 5.9 MTT assay of Hela-tat- luc cells exposed to anti-luc siRNA:MgFe 0.25 complexes, 
anti-luc siRNA:MgFe 0.33 complexes, anti-luc siRNA:ZnAl 0.25 complexes and anti-
luc siRNA: ZnAl 0.33 complexes.  Data are represented as means ±SD (n=3).  
**p<0.005 was considered statistically significant.  
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There have been many reports on the low toxicity of LDHs [Yan et al., 2014], with a drug delivery 
study showing that LDHs not only decreased the toxicity of the parent drug, but also increased 
the desired effect of the drug both in vitro and in vivo [Kura et al., 2014].  The results of this study 
confirm the low/almost negligible toxicity of LDHs.  Results obtained in this study affirms reports 
by Xu and Lu (2006), that LDHs are about 10 times less cytotoxic than commonly used polymer 
transfection agents.   
 
5.4.2 LUCIFERASE GENE EXPRESSION STUDIES 
The level of transgene expression of the luciferase gene in all cell lines tested indicated successful 
transfection of the pCMV-luc DNA.  
Results obtained indicate that the degree of transfection is largely cell line dependent.  The 
HEK293 cell line displayed the highest luciferase gene expression, with the Caco-2 cell line 
showing lower but promising gene expression.  The HepG2 cell line showed minimal gene 
expression, which was approximately 800 fold less than that displayed by the HEK293 and Caco-
2 cell lines.  Possible reasons for the difference in expression observed for the three cell lines 
investigated in this study, may be due to the different cell types having a preference for different 
endocytic pathways [Elouahabi and Ruysschaert, 2005], and also due to differences in cell 
membrane properties of the different cell lines [Spector and Yorek, 1985], that affect cellular 
uptake. 
The level of luciferase activity of the non-functionalized LDHs (Figure 5.10), in the HEK293 was as 
follows:  MgAl 0.25 < MgFe 0.25 < ZnAl 0.33 < ZnAl 0.25 < MgAl 0.33 < MgFe 0.33.  MgFe 0.33 
showed 15% greater transfection than MgAl 0.25.  In the Caco-2 cell line, luciferase activity was 
as follows:  MgFe 0.25 < ZnAl 0.25 < MgAl 0.25 < ZnAl 0.33 < MgAl 0.33 < MgFe 0.33.  The HepG2 
cell line showed a minimal but measurable degree of luciferase activity for all the non-
functionalized LDHs.  This was expected as HepG2 cells have a reputation of being a difficult to 
transfect cell line [Cemazar et al., 2009].  Although MgAl 0.33 showed best transfection of all the 
LDHs tested, with the HepG2 cell line, the level of transfection observed was not as significant, 
as their functionalized counterparts. 
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Figure 5.10 Luciferase Assay Results of non-functionalized LDHS in (a) Caco-2, (b) HEK293 
and (c) HepG2 cell lines. Data is represented as means ±SD (n=3). **p<0.005, 
***p<0.0005 was considered statistically significant. 
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A generally low level of transfection was observed with MgAl 0.25 in all cell lines tested, which 
was expected considering the large size of the DNA:MgAl 0.25 complex, probably due to 
aggregation caused by the DNA complexing to several LDH nanoparticles.  This would have 
resulted in poor cellular uptake and internalization and consequently lower levels of transfection. 
Overall the non-functionalized LDHs prepared in the M2+:M3+ ratio of 2:1 displayed significantly 
higher transfection than those prepared in the 3:1 ratio.  The use of the MgAl 0.33 LDH carrier 
resulted in the highest level of transfection from all the HTs, in all cell lines tested. Li and co-
workers (2014) have reported that LDHs prepared at M2+:M3+ ratio of 2:1 show better adsorption 
of nucleic acids than those prepared in a 3:1 ratio.  It seems that this increased adsorption of 
nucleic acid corresponded to increased transfection.   
The zeta potential and size of a nanoparticle plays a key role in the cellular uptake of the particles 
[Nagaraj et al., 2015; Dong et al., 2015].  It also provides a good indication of the colloidal stability 
of the nanoparticles for in vivo application. Negative zeta potentials are expected to lead to poor 
cellular uptake and consequently poor transfection.   Zeta potential is not necessarily an 
indication of the actual surface charge of the nanoparticle, but rather it is a measure of the 
potential difference between the particle surface and the solvent, and is dependent on other 
factors such as the pH of the solvent [Honary and Zahir, 2013].  Desigaux and coworkers (2006) 
have previously hypothesized that a negative zeta potential would not impede cellular 
internalization. Thus, even though the nanocomplexes displayed a negative zeta potential at pH 
7, the zeta potential may be altered at physiological pH resulting in reduced effects on the 
transfection efficacy. 
Positively charged nanoparticles are usually associated with enhanced cellular uptake (Kim et al 
2014).  This was exemplified by MgFe 0.33 (the only DNA:LDH complex with a positive zeta 
potential), which showed the greatest transfection of all the samples investigated.  Rojas and co-
workers (2015), have reported that transfection efficiency decreases as particle size increases 
beyond 200 nm, and that smaller particles (< 100 nm) may release their load faster, but may lead 
to toxicity, suggesting an ideal size range of 100-200 nm.  On the contrary, the cytotoxicity assay 
results discussed earlier in this chapter show that although most of the complexes ranged in size 
from 20 to 60 nm, they do not exhibit much cytotoxicity.     
97 
 
Targeted drug delivery studies by Nagaraj and co-workers (2015) suggest that ZnAl LDHs may be 
better nano-carriers than MgAl LDHs.  Here again, the current results contradict this, as MgAl 
0.33 clearly displays significantly better transfection than the ZnAl 0.33 LDHs as shown in Figure 
5.10.  
The transfection results of the amino acid functionalized HTs in the Caco-2, HEK293 and HepG2 
cell lines are shown in Figures 5.11, 5.12 and 5.13 respectively.  In the Caco-2 cell line the 
luciferase activity was as follows:  MgAlArg 0.25 < MgAlHist 0.25 < MgAlArg 0.33 < MgAl 0.25 < 
MgAlHist 0.33 < MgAl 0.33 (Figure 5.11).   
 
 
 
 
Figure 5.11 Luciferase gene expression using (a) MgAl 0.25, MgAlArg 0.25 and MgAlHist 0.25 
and (b) MgAl 0.33, MgAlArg 0.33 and MgAlHist 0.33 in Caco-2 cells with 2 sets of 
controls, one containing only Caco2 cells and the second control containing cells 
with pCMV-luc DNA.  Data is represented as means ±SD (n=3).  **p<0.005, 
***p<0.0005 was considered statistically significant.  
 
0
2
4
6
8
10
12
14
16
cells only cells +DNA 1:20 1:30 1:40
RL
U/
m
g P
ro
te
in
 (x
10
5 )
Ratio of DNA:LDH
MgAl 0.25
MgAlArg 0.25
MgAlHist 0.25
0
5
10
15
20
25
30
cells only cells +DNA 1:20 1:30 1:40R
LU
/m
g P
ro
te
in
 (x
10
5 )
Ratio of DNA:LDH
MgAl 0.33
MgAlArg 0.33
MgAlHist 0.33
**
 
*** 
** 
*** 
(a) 
(b) 
98 
 
In the HEK293 cell line the luciferase activity was as follows:  MgAlArg 0.25 < MgAl 0.25 < MgAlArg 
0.33 < MgAlHist 0.25 < MgAlHist 0.33 < MgAl 0.33 (Figure 5.12). 
 
 
 
Figure 5.12 Luciferase assay using (a) MgAl 0.25, MgAlArg 0.25 and MgAlHist 0.25 and (b) 
MgAl 0.33, MgAlArg 0.33 and MgAlHist 0.33 in HEK293 cells with 2 sets of controls, 
one containing only HEK293 cells and the second control containing cells with 
pCMV-luc DNA.  Data is represented as means ±SD (n=3).  **p<0.005, ***p<0.0005 
was considered statistically significant. 
 
Transfection of HTs in HepG2 (Figure 5.13), as with the non-functionalized LDHs, both resulted in 
minimal DNA uptake. 
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Figure 5.13 Luciferase assay using (a) MgAl 0.25, MgAlArg 0.25 and MgAlHist 0.25 and (b) 
MgAl 0.33, MgAlArg 0.33 and MgAlHist 0.33 in HepG2 cells with 2 sets of controls, 
one containing only HepG2 cells and the second control containing cells with 
pCMV-luc DNA.  Data is represented as means ±SD (n=3).  No significant 
transfection was observed. 
 
Similar to the non-functionalized LDHs, aa-HTs prepared in the M2+:M3+ ratio of 2:1 showed 
higher transfection than those prepared in the 3:1 ratio.  Characterization of the aa-HTs indicated 
a higher degree of incorporation of the amino acid in MgAlArg 0.33 (2.62%, ζ-potential +6.7) and 
MgAlHist 0.33 (1.89%, ζ-potential +22.7) when compared to MgAlArg 0.25 1.27%, ζ-potential -
19.8) and MgAlHist 0.25 (0.90%, ζ-potential -24.6), as indicated by the quantitative assays in 
chapter 3, and confirmed by the zeta potentials of the aa-functionalized HTs (chapter 4, section 
4.3).  The higher degree of incorporation of amino acid in the aa-HTs prepared in the M2+:M3+ 
ratio of 2:1, appears to have resulted in higher transfection efficiency.  Histidine functionalized 
HTs displayed better transfection efficiency than arginine functionalized HTs in the Caco-2 and 
HepG2 cells lines, as shown in Figures 5.11 and 5.13.  There have been reports indicating that the 
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incorporation of histidine into gene delivery vehicles does improve cellular uptake, as well as 
enhance endosomal escape through the proton sponge effect [Shi et al., 2013; Meng et al., 2017], 
as does the incorporation of arginine [Gao et al., 2008; Wang et al., 2015].  The results of this 
study suggest that histidine functionalization of the gene delivery vehicle results in better 
transfection than arginine functionalization. 
 
 
5.4.3 LUCIFERASE GENE SILENCING STUDIES 
The results of the gene silencing studies are shown in Figures 5.14-5.16.  Control 1 was untreated 
Hela tat-luc cells, and this was represented as 100%, as luciferase activity can be assumed to be 
highest in this control.  Control 2 comprised of Hela tat-luc cells treated with naked anti-luc-
siRNA, which produced gene silencing of less than 4%. This can be expected, as naked RNA can 
be easily degraded by nucleases before it reaches the cell, as was seen in the nuclease protection 
assay (Chapter 4, Section 4.2.4). The much greater percentage of gene silencing observed with 
the siRNA:LDH complexes confirms the requirement and significance of a gene delivery vehicle 
for efficient delivery and  gene silencing.  The siRNA:LDH complexes, all had negative zeta 
potentials (Chapter 4, Section 4.3) which was probably due to the siRNA binding to the outer 
surfaces of the LDHs, but this did not appear to be a hindrance to cellular uptake, internalization 
and the subsequent gene silencing.  
The HT complexes prepared in a MgAl ratio of 3:1 ie. MgAl 0.25 showed a higher percentage of 
gene silencing than the HTs prepared in a MgAl ratio of 2:1 ie. MgAl 0.33.  The highest degree of 
silencing for the non-functionalized HTs was 44.63%, which was observed for the siRNA:MgAl 
0.25 complex prepared at the supra-optimal binding ratio.  The amino acid functionalized HTs 
showed a higher degree of gene silencing (Figures 5.14 and 5.15), than the non-functionalized 
HTs.  The arginine functionalized HTs (MgAlArg 0.25 and MgAlArg 0.33) showed almost identical 
gene silencing profiles, with the sub-optimal binding ratios of siRNA:HT exhibiting the greatest 
degree of silencing (approximately 56.9% gene silencing).  The histidine functionalized HTs 
(MgAlHist 0.25 and MgAlHist 0.33) showed slightly improved gene silencing on average when 
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compared to the arginine functionalized HTs. This was a similar trend to the gene expression 
observed using the pCMV-luc DNA. 
 
 
Figure 5.14 Luciferase gene silencing using MgAl 0.25, MgAlArg 0.25 and MgAlHist 0.25 in Hela 
tat luc cells with 2 sets of controls, one containing only Hela tat-luc cells and the 
second control containing Hela tat luc cells with anti-luc siRNA. Data is 
represented as means ±SD (n=3).  *p<0.05, **p<0.005 was considered statistically 
significant. 
 
 
 
 
Figure 5.15 Luciferase gene silencing using MgAl 0.33, MgAlArg 0.33 and MgAlHist 0.33 in Hela 
tat luc cells with 2 sets of controls, one containing only Hela tat-luc cells and the 
second control containing Hela tat luc cells with anti-luc siRNA. Data is 
represented as means ±SD (n=3).  **p<0.005, ***p<0.0005 was considered 
statistically significant. 
 
0
20
40
60
80
100
120
140
cells only cells +siRNA sub-optimal
ratio
optimal
binding ratio
super-optimal
ratio
RL
U/
m
g P
ro
te
in
 (x
10
6 )
Ratio of DNA:LDH
MgAl 0.25
MgAlArg 0.25
MgAlHist 0.25
**** *
0
20
40
60
80
100
120
140
cells only cells +siRNA sub-optimal
ratio
optimal
binding ratio
super-optimal
ratio
RL
U/
m
g P
ro
te
in
 (x
10
6 )
Ratio of DNA:LDH
MgAl 0.33
MgAlArg 0.33
MgAlHist 0.33
** **
***
***
**
***
102 
 
A comparatively high percentage of gene silencing (58.07 %) was observed for the sub-optimal 
binding ratio for MgAlHist 0.25.  The other histidine functionalized HT (MgAlHist 0.33) displayed 
silencing levels of 57.5 % each, for both the optimal and super-optimal binding ratios.  Arginine 
and histidine are both amino acids with positively charged side chains at physiological pH.  This 
overall positive charge possibly enhances the proton sponge effect leading to faster endosomal 
release of the complex, consequently resulting in more effective gene silencing. 
It was also interesting to note that both siRNA-MgAlArg 0.25 and siRNA-MgAlHist 0.25 complexes 
brought about significantly greater gene silencing (56.8 % and 58.0 % respectively) than non-
functionalized MgAl 0.25 (34.8 %).  Both siRNA-MgAlArg 0.25 and siRNA-MgAlHist 0.25 
complexes appeared as nanoflakes that were folded over, whereas siRNA-MgAl 0.25 complexes 
were spherical in shape (Chapter 4, Figures 4.10 and 4.12).  Previous reports state that rod-
shaped nanoparticles are more likely to pass through the nuclear pores and deliver the siRNA 
within the nucleus, whereas the load of spherical/hexagonal/square shaped complexes are 
generally released in the perinuclear region [Ladewig2 et al., 2010; Rojas et al., 2015]. 
Interestingly the “folded-over” nanoflake structured siRNA-MgAlArg 0.25 and siRNA-MgAlHist 
0.25 complexes) displayed better gene silencing than non-functionalized MgAl 0.25.  It is possible 
that functionalization of MgAl 0.25 with the amino acids did actually enhance the proton-sponge 
effect resulting in release of the siRNA from these complexes in the perinuclear area of the 
cytosol, before they could actually enter the nucleus.  Since the perinuclear area is the site of 
function of the siRNA, this increased the gene silencing efficiency of siRNA-MgAlArg 0.25 and 
siRNA-MgAlHist 0.25 complexes.  
On average, considering all ratios investigated, the MgFe 0.25:siRNA complexes showed better 
gene silencing than the MgFe 0.33:siRNA complexes (Figure 5.16).  In contrast to this, MgFe 
0.33:siRNA complexes at optimal binding ratio displayed the highest degree of gene silencing 
(54.77 %), from all the samples tested.  The MgFe 0.33:siRNA complexes have a modal size of 
55.4 nm (Chapter 4, Section 4.3), and smaller LDHs have been reported to be better siRNA 
delivery vehicles than LHDs larger than 100 nm in diameter [Chen et al., 2013].  In this complex 
the ratio of Mg:Fe was 2:1 and this result once again confirmed that LDHs prepared in M2+:M3+ 
ratio of 2:1 are better transfection vectors than those prepared in the ratio of 3:1.   
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Figure 5.16 Luciferase gene silencing using MgFe 0.25, MgFe 0.33, ZnAl 0.25 and ZnAl 0.33 in 
Hela tat luc cells with 2 sets of controls, one containing only Hela tat-luc cells and 
the second control containing Hela tat luc cells with anti-luc siRNA.  Data is 
represented as means ±SD (n=3).  *p<0.05, **p<0.005 was considered statistically 
significant. 
 
 
The lowest levels of gene silencing were observed with the complexes of siRNA and ZnAl LDHs 
(Figure 5.16).  The percentage silencing for ZnAl 0.25 complexes and ZnAl 0.33 complexes was 
16.11 and 15.93 % respectively.  Posati and co-workers (2012) have previously reported 
significant uptake of ZnAl LDH nanoparticles in Hela cells, but the reasons for the low level of 
gene silencing observed in this study remains unclear.  The Hela-tat-luc cells have displayed 
prolific growth in the presence of the siRNA:ZnAl complexes (Section 5.4.1.2), but unfortunately, 
this has not significantly affected gene silencing.   
 
All the nanocomplexes prepared for this study showed some degree of gene silencing despite 
them all having a negative surface charge which was most probably as a result of the siRNA 
binding to the outer surfaces of the LDH.  This negative zeta potential has not appeared to hinder 
cellular internalization, and may have actually resulted in a faster silencing owing to the quick 
release of siRNA from the surface of the LDH, when the LDH nanocomplexes start to dissolve in 
the endosome.    
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5.5 CONCLUSION 
The results of the cytotoxicity assay indicate that all the LDHs prepared are non-toxic to the cell 
lines (at the concentrations tested) making them suitable candidates for future in vivo studies. 
Gene expression studies revealed that HTs prepared in the M2+:M3+ ratio of 2:1 (w/w) (both 
functionalized and non-functionalized) are better transfection agents than those prepared in the 
3:1 (w/w) ratio.  The results also indicate that functionalizing HTs with positively charged amino 
acids does not necessarily improve DNA transfection efficiency, since the non-functionalized 
LDHs MgAl 0.33 and MgFe 0.25 displayed the highest levels of transfection of all the samples 
investigated. 
Results of the gene silencing studies clearly indicate that the complexes prepared from amino 
acid functionalized HTs exhibit greater gene silencing than the non-functionalized HTs.  The 
presence of the positively charged amino acids probably resulted in exploitation of the proton 
sponge effect for quicker endosomal escape and subsequently increased levels of gene silencing. 
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CHAPTER SIX 
6. CONCLUSION 
LDHs have recently garnered much attention in the quest for safer and more effective gene 
delivery systems.  Recent studies suggest that functionalization of inorganic gene delivery 
vehicles leads to enhanced transfection. In this study, the effect of functionalizing HTs with 
positively charged amino acids as compared to non-functionalized LDHs, with respect to gene 
delivery, was investigated. 
LDHs and aa-functionalized HTs were successfully synthesized using the co-precipitation method, 
as confirmed by various analytical techniques.  Characteristic XRD patterns with sharp, 
symmetrical, intense peaks at the lower 2θ values; broader, asymmetric, less intense peaks at 
the higher 2θ values, and the distinctive doublet peak at 2θ value of around 60 were observed 
for all prepared HTs/LDHs.  The nanoparticles, which displayed flat, plate-like morphology, varied 
in size between 30 nm and 200 nm, with zeta potentials ranging from -24.7 to 29.7.  The degree 
of incorporation of amino acid in the aa-functionalized HTs were found to be 0.90 % in MgAlHist 
0.25, 1.89 % in MgAlHist 0.33, 1.20 % in MgAlArg 0.25 and 2.62 % in MgAlArg 0.33.   
All the synthesized HTs and LDHs bound both DNA and siRNA, producing stable complexes and 
concurrently providing adequate protection against serum nuclease digestion.  Vigorous 
agitation of DNA:HT/LDH complexes at room temperature resulted in complete binding within 
10 minutes, without the need for overnight incubation at higher temperatures, as reported in 
other studies.  The negative zeta potentials of most of the nucleic acid: LDH nanocomplexes 
combined with results of the XRD analysis of the DNA:MgAl 0.33 complex suggests that the 
nucleic acids bound to the outer surfaces of the LDHs, and does not actually intercalate within 
the interlayers.  
Results of the MTT assays indicate that the nucleic acid:LDH nanocomplexes were well tolerated 
by all the cell lines tested.  Minimal cell death was observed in the Caco-2 cell line whilst the 
presence of the nucleic acid:LDH nanocomplexes actually had a growth promoting effect on the 
HEK 293, HepG2 and Hela-tat-luc cell lines. 
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Transfection levels of the pCMV-luc plasmid as measured by the luciferase reporter gene assay 
was found to be cell line dependent.  Minimal transfection was observed in the HepG2 cell line, 
while transgene expression in the HEK293 and Caco-2 cell lines was up to 800-fold higher than 
that measured in the HepG2 cell line.  The highest levels of transgene expression were obtained 
with the non-functionalized LDHs MgAl 0.33 and MgFe 0.25.  It can therefore be concluded that 
functionalization of LDHs with positively charged amino acids does not lead to enhanced 
transfection of plasmid DNA.  This was in stark contrast to results obtained for the gene silencing 
studies, which revealed that the employment of aa-functionalized HTs as siRNA vectors lead to 
higher levels of gene knockdown when compared to the non-functionalized LDHs.  Amino acid 
functionalized LDHs appear to be able to bypass one of the major hurdles faced in the formulation 
of a successful siRNA vector, which is the release of uncomplexed siRNA from the endocytic 
pathway before it reaches the lysosome.  This has been achieved in the current study by 
exploitation of the proton-sponge effect, which is enhanced by the presence of the positively 
charged amino acids, arginine and histidine. 
Results from this study suggests that aa-functionalized HTs are more effective siRNA vectors than 
pDNA carriers and would therefore be more applicable to gene silencing strategies.  Possible 
future endeavors include the study of aa-functionalized HTs in in vivo gene silencing strategies 
using a suitable mouse model, as well as further modification of the vectors for targeted delivery.   
 
 
 
 
 
 
 
 
107 
 
REFERENCES 
• Abderrazek K, Najoua FS, Srasra E, Synthesis and characterization of [Zn–Al] LDH: Study of the 
effect of calcination on the photocatalytic activity, Applied Clay Science 119 (2016) 229-235. 
• Ahmed M, Jiang X, Deng Z and Narain R, Cationic Glyco-Functionalized Single-walled carbon 
nanotubes as efficient gene delivery vehicles,   Bioconjugate Chemistry 20 (2009) 2017-2022. 
• Ahmed1 M, Deng Z, Liu S, Lafrenie R, Kumar A and Narain R, Cationic Glyconanoparticles: 
Their complexation with DNA, Cellular uptake and transfection efficiencies, Bioconjugate 
Chemistry 20 (2009) 2169-2176. 
• Aisawa S, Takahashi S, Ogasawara W, Umetsu Y, Narita E, Coprecipitation behaviour of amino 
acids with Zn-Al layered double hydroxide precipitates, Clay Science 11 (2000) 317-328.  
• Aisawa S, Takahashi S, Ogasawara W, Umetsu Y, Narita E, Direct intercalation of amino acids 
into layered double hydroxides by coprecipitation, Journal of Solid State Chemistry 162 (2001) 
52-62.  
• Aisawa S, Sasaki S, Takahashi S, Hirahara H, Nakayama H, Narita E, Intercalation of amino 
acids and oligopeptide into Zn-Al layered double hydroxide by coprecipitation reaction, 
Journal of Physics and Chemistry of solids 67 (2006) 920-925.  
• Alexandrica C, Silion M, Hritcu D, Popa MI, Layered double hydroxides as adsorbents for 
anionic dye removal from aqueous solutions, Environmental Engineering and Management 
Journal 14 (2) (2015) 381-388. 
• Anbarasan R, Lee WD, Im SS, Adsorption and intercalation of anionic surfactants onto layered 
double hydroxides - XRD study. Bulletin of Materials Science 28(2) (2005) 145–149. 
• Auerbach SM, Carrado KA and Dutta PK, Handbook of Layered Materials, Marcel Dekker Inc., 
(2004) New York. 
• Balcomb B, Singh M, Singh S, Synthesis and characterization of layered double hydroxides and 
their potential as nonviral gene delivery vehicles, Chemistry Open 4 (2015) 137-145. 
• Barichello JM, Kizuki S, Tagami T, Soares LAL, Ishida T, Kikuchi H, Kiwada H, Agitation during 
lipoplex formation harmonizes the interaction of siRNA to cationic liposomes, International 
Journal of Pharmaceutics 430 (2012) 359-365. 
108 
 
• Barth A, The infrared absorption of amino acid side chains, Progress in Biophysics & Molecular 
Biology 74 (2000) 141–173. 
• Beavers K (1999) A crystal chemical study on Layered Double Hydroxides (LDHs):  An approach 
to develop an anion exchanger, Ph.D. Thesis, (1999) University of Hanover, Germany.  
• Bejoy N, Hydrotalcite: The clay that cures, Resonance (2001) 57-61. 
• Bellotto M, Rebours B, Clause O and Lynch J, A re-examination of hydrotalcite crystal 
chemistry, Journal of Physical Chemistry 100 (1996) 8527-8534. 
• Benício LPF, Silva RA, Lopes JA, Eulálio D, dos Santos RMM, de Aquino LA, Vergütz L, Novais 
RF, da Costa LM, Pinto FG, Tronto J, Layered double hydroxides: Nanomaterials for 
applications in agriculture, Revista Brasileira de Ciêcia do Solo 39 (1) (2015) 1-13. 
• Benito P, Herrero M, Labajos FM, Rives V, Effect of post-synthesis microwave hydrothermal 
treatment on the properties of layered double hydroxides and related materials, Applied Clay 
Science 48 (2010) 218-227. 
• Berg JM, Tymoczko JL, Stryer L, Biochemistry, Sixth Edition, WH Freeman and Company, New 
York (2006) pp 787. 
• Bi X, Zhang H, Dou L, Layered double hydroxide based nanocarriers for drug delivery, 
Pharmaceutics 6 (2014) 298-332. 
• Bish DL, Anion exchange in Takovite:  Application to other hydroxide minerals, Bulletin de 
Mineralogie 103 (1980) 170-175. 
• Bookin AS, Drits VA, Polytype diversity of the hydrotalcite-like minerals I.  Possible polytypes 
and their diffraction features, Clays and Clay Minerals 41 (5) (1993) 551-557. 
• Bontchev RP, Liu S, Krumhansl JL, Voigt J, Nenoff TM, Synthesis, characterization, and ion 
exchange properties of hydrotalcite Mg6Al2(OH)16(A)x(A’)2-x 4H2O (A, A’ = Cl-, Br-, I-, and NO3-, 
2 ≥ x ≥ 0) derivatives, Chemistry of  Materials 15(19) (2003)  3669-3675. 
• Boulet P, Greenwell, HC, Stackhouse S, Coveney PV, Recent advances in understanding the 
structure and reactivity of clays using electronic structure calculations, Journal of Molecular 
Structure THEOCHEM  762 (2006) 33-48. 
• Bravo-Suarez, Review of the Synthesis of Layered Double Hydroxides: A Thermodynamic 
Approach, Quim. Nova, 27 (4) (2004) 601-614. 
109 
 
• Brindley WG and Kikkawa S, Thermal behavior of hydrotalcite and of anion-exchanged forms 
of hydrotalcite, Clays and Clay Minerals 28 (2) (1980) 87-91. 
• Brindley WG and Kikkawa S, A crystal chemical study of Mg,Al and Ni,Al hydroxyl-perchlorates 
and hydroxyl-carbonates, American Mineralogist 64 (1979) 836-843. 
• Brown G and Gastuche MC, Mixed Magnesium-Aluminium Hydroxides II. Structure and 
Structural Chemistry of Synthetic Hydroxycarbonates and Related Mineral Compounds, Clay  
Minerals 7 (1967) 193-201. 
• Butenko E, Malyshev A, Kapustin A, Influence of Hydrocarbon Radicals on the Structure of 
Layered Double Hydroxides, American Journal of Materials Science and Engineering 2(1) 
(2014) 1-6. 
• Cardoso LP, Celis R, Cornejo J, Valim JB, Layered double hydroxides as supports for the slow 
release of acid herbicides, Journal of Agricultural and Food Chemistry 54 (16) (2006) 5968-
5975. 
• Carja G, Ciobanu G, Toyota M, The role of the organic solvent in obtaining hydrotalcite-like 
anionic clay nanopowders with specific textural and porous properties, Scientific Study and 
Research VII (1) (2006) 157-162. 
• Carlino S, The intercalation of carboxylic acids into layered double hydroxides: A critical 
evaluation and review of different methods, Solid State Ionics 98(1) (1997) 73-84. 
• Carmichael, J DeGraff WG, Gazdar AF, Minna JD, Mitchell JB, Evaluation of a tetrazolium-
based semiautomated colorimetric assay.  Assessment of chemosensitivity testing, Cancer 
Research 47 (1987) 936-946. 
• Cavani F, Trifiro F, Vaccari A, Hydrotalcite type Anionic Clays: Preparation, Properties and 
Applications, Catalysis Today 11 (1991) 173-301. 
• Cemazar M, Hreljac I, Sersa G, Filipic M, Construction of EGFP expressing HepG2 cell line using 
electroporation, World Congress on Medical Physics and Biomedical Engineering (2009) 128-
131. 
• Chen M, Cooper HM, Zhou JZ, Bartlett PF, Xu ZP, Reduction in the size of layered double 
hydroxide nanoparticles enhances the efficiency of siRNA delivery, Journal of Colloid and 
Interface Science 390 (2013) 275-281. 
110 
 
• Chiba K, Kawakami K, Tohyama K, Simultaneous evaluation of cell viability by neutral red, MTT 
and crystal violet staining assays of the same cells, Toxicology in Vitro 12 (1998) 251-258. 
• Choi J and Wang NS, Nanoparticles in Biomedical Applications and Their Safety Concerns, 
(2011) Reza Fazel-Rezai (Ed.), ISBN: 978-953-307-637-9, InTech, Available from: 
http://www.intechopen.com/articles/show/title/nanoparticles-in-biomedical-applications-
and-their-safety-concerns. 
• Choi S-J, Oh J-M, Choy J-H, Safety aspect of layered nanoparticles: size dependency in vitro 
and in vivo, Journal of Nanoscience and Nanotechnology 8 (2008) 5297-5301. 
• Choi G, Yang J-H, Park G-Y, Vinu A, Elzatahry A, Yo CH, Choy J-H, Intercalative ion-exchange 
route to amino acid layered double hydroxide nanohybrids and their sorption properties, 
European Journal of Inorganic Chemistry (2015) 925-930 DOI:10.1002/ejic.201403115. 
• Choy J-H, Kwak S-Y, Jeong Y-J, Park J-S, Inorganic layered double hydroxides as nonviral 
vectors,  Angewandte Chemie International Edition 39(22) (2000) 4042-4045. 
• Choy J-H, Kwak S-Y, Park J-S, Jeong Y-J, Cellular uptake behavior of [γ-32P] labeled ATP-LDH 
nanohybrids, Journal of Materials Chemistry 11 (2001) 1671-1674. 
• Choy J-H, Jung J-S, Oh J-M, Park M, Jeong J, Kang Y-K, Han O-J, Layered double hydroxide as 
an efficient reservoir for folate derivatives, Biomaterials 25 (2004) 3059-3064. 
• Choy J-H, Choi S-J, Oh J-M, Park T, Clay minerals and layered double hydroxides for novel 
biological applications, Applied Clay Science 36 (2007) 122-132. 
• Chung H-E, Park D-H, Choy J-H, Choi S-J, Intracellular trafficking pathway of layered double 
hydroxide nanoparticles in human cells: Size-dependent cellular delivery, Applied Clay Science 
65-66 (2012) 24-30. 
• Cocheci L, Barvinschi P, Pode R, Popovici E, Seftel EM, Structural characterization of some 
Mg/Zn-Al type hydrotalcites prepared for chromate sorption from wastewater, Chemical 
Bulletin of “Politehnica” University of Timisoara, Romania 55 (69) (2010) 40-45. 
• Coelhoe C, Stimpfling T, Leroux F, Verney V, Inorganic-Organic hybrid materials based on 
amino acid modified hyrotalcites used as UV-absorber fillers for polybutylene succinate, 
European Journal of Inorganic Chemistry (2012) 5252-5258. 
111 
 
• Costa FR, Leuteritz A, Wagenknecht U, Jehnichen D, Häußler L, Heinrich G, Intercalation of 
Mg–Al layered double hydroxide by anionic surfactants: Preparation and characterization, 
Applied Clay Science 38 (2008) 153-164. 
• Costantini S, Di Bernado G, Cammorata M, Castello G, Colonna G, Gene expression signature 
of human HepG2 cell line, Gene 518 (2) (2013) 335-345. 
• Costantino U, Ambrogi V, Nocchetti M, Perioli L, Hydrotalcite-like compounds: Versatile 
layered hosts of molecular anions with biological activity, Microporous and Mesoporous 
Materials 107 (2008) 149-160. 
• Costantino U, Marmottini F, Nocchetti M, Vivani R, New synthetic routes to hydrotalcite-like 
compounds – characterization and properties of the obtained materials, European Journal of 
Inorganic Chemistry 10 (1998) 1439-1446. 
• Crosby S, Tran D, Cocke D, Duraia EM, Beall GW, Effect of isomorphous substitution on the 
thermal decomposition mechanism of hydrotalcites, Materials 7 (2014) 7048-7058. 
• Cullity BD, Stock SR, Elements of X-Ray Diffraction, 3rd edition, Prentice Hall: Upper Saddle 
River, NJ, (2001). 
• Cunha VRR, Ferreira AMC, Constantino VRL, Tronto J, Valim JB, Layered double hydroxides: 
inorganic nanoparticles for storage and release of species of biological and therapeutic 
interest, Quimica Nova 33 (1) (2010) 159-171. 
• Daniels A, Singh M, Ariatti M, Pegylated and non-pegylated siRNA lipoplexes formulated with 
cholesteryl cytofectins promote efficient luciferase knockdown in Hela tat luc cells, 
Nucleosides Nucleotides Nucleic Acids 32 (4) (2013) 206-220. 
• de Roy A, Forano C, Besse JP, Layered double hydroxides: Synthesis and post-synthesis 
Modification, In: Layered Double Hydroxides: Present and Future, Edited by Vincente Rives 
(2006) 1-39.  
• Del Arco M, Fernández A, Martín C, Rives V, Release studies of different NSAIDs encapsulated 
in Mg,Al,Fe-hydrotalcites, Applied Clay Science 42 (2009) 538-544. 
• Del Arco1 M, Gutiérrez S, Martín C, Rives V, Rocha J, Synthesis and characterization of layered 
double hydroxides (LDH) intercalated with non-steroidal anti-inflammatory drugs (NSAID), 
Journal of Solid State Chemistry 177 (2004) 3954-3962. 
112 
 
• Del Arco2 M, Cebadera E, Gutiérrez S, Martín C, Montero MJ, Rives V, Rocha J and Sevilla MA, 
Mg, Al layered double hydroxides with interalated indomethacin: Synthesis, characterization, 
and pharmacological study, Journal of Pharmaceutical Sciences 93 (6) (2004) 1649-1658. 
• Del Hoyo C, Layered double hydroxides and human health: an overview, Applied Clay Science 
36 (2007) 103-121. 
• Denizot F, Lang R, Rapid colorimetric assay for cell growth and survival: Modifications to the 
tetrazolium dye procedure giving improved sensitivity and reliability, Journal of 
Immunological Methods 89 (1986) 271-277. 
• Desigaux L, Belkacem BM, Richard P, Cellier J, Leone P, Cario L, Leroux F, Taviot-Guého C, 
Pitard B, Self-assembly and characterization of layered double hydroxide/LDH hybrids, Nano 
Letters 6 (2) (2006) 199-204. 
• de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S, Firefly luciferase gene: Structure 
and expression in mammalian cells, Molecular and Cellular Biology 7 (2) (1987) 725-737. 
• Dinnebier RE, Billenge SJL, Powder Diffraction, Theory and Practice, RSC Publishing, 
Cambridge, UK (2008). 
• Dong H, Chen M, Rahman S, Parekh HS, Cooper HM, Xu ZP, Engineering small MgAl-layered 
double hydroxide nanoparticles for enhanced gene delivery, Applied Clay Science 100 (2014) 
66-75. 
• Dong H, Parekh HS, Xu ZP, Particle size and number-dependent delivery to cells by layered 
double hydroxide nanoparticles, Journal of Colloid and Interface Science 431 (2015) 10-16. 
• Dong L, Gou G, Huang J, Sun Y, Xue B, A review on gene delivery system of layered double 
hydroxide, Applied Mechanics and Materials 320 (2013) 533-539. 
• Elsaesser A, Howard CV, Toxicology of nanoparticles, Advanced drug delivery reviews 64 
(2012) 129-137. 
• Elouahabi A, Thiry M, Pector V, Fuks R, Ruysschaert JM, Vandenbranden M, The role of 
endosome destabilizing activity in the gene transfer process mediated by cationic lipids, FEBS 
letters 414 (2) (1997) 187-192. 
• Elouahabi A, Ruysschaert JM, Formation and intracellular trafficking of lipoplexes and 
polyplexes, Molecular Therapy 11 (3) (2005) 336-347. 
113 
 
• Ennadi A, Legrouri A, De Roy A, Besse JP, X-Ray diffraction pattern simulation for thermally 
treated [An-Al-Cl] layered double hydroxide, Journal of Solid State Chemistry 152 (2000) 568-
572. 
• Evans DG and Duan X, Preparation of layered double hydroxides and their applications as 
additives in polymers, as precursors to magnetic materials and in biology and medicine, 
Chemical Communications 5 (2006) 485-496. 
• Evans DG and Slade RCT, Structural Aspects of Layered Double Hydroxides, Structure and 
Bonding 119 (2006) 1-87. 
• Fan G, Li F, Evans DG, Duan X, Catalytic applications of layered double hydroxides: recent 
advances and perspectives, Chemical Society reviews 43 (2014) 7040-7066. 
• Feng J, He Y, Liu Y, Du Y, Li D, Supported catalysts based on layered double hydroxides for 
catalytic oxidation and hydrogenation: general functionality and promising application 
prospects, Chemical Society Reviews 44 (2015) 5291-5319. 
• Fong N, Guagliardo P, Williams J, Musemeci A, Martin D, Smith SV, Clay particles – potential 
of positron annihilation lifetime spectroscopy (PALS) for studying interlayer spacing, Journal 
of Physics: Conference Series 262 (2011) 012022. 
• Forano C, Hibino T, Leroux F, Taviot-Gucho C, Layered Double Hydroxides, In: Handbook of 
Clay Science, Edited by F. Bergaya, BKG Thong and G Lagaly (2006) 1021-1096. 
• Fortner JD, Solenthaler C, Hughes JB, Puzrin AM, Plötze M, Interactions of clay minerals and 
a double layered hydroxide with water stable, nano scale fullerene aggregates (nC60), Applied 
Clay Science 55 (2012) 36-43. 
• Fotakis G, Timbrell JA, In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and 
protein assay in hepatoma cell lines following exposure to cadmium chloride, Toxicology 
Letters 160 (2006) 171-177. 
• Fried M and Crothers DM, Equilibria and kinetics of repressor-operator interactions by 
polyacrylamide gel electrophoresis, Nucleic Acids Research 9 (23) (1981) 6505-6525. 
• Frost RL, Weier ML, and Kloprogge JT, Raman spectroscopy of some natural hydrotalcites with 
sulphate and carbonate in the interlayer, Journal of Raman Spectroscopy 34 (10) (2003) 760-
768. 
114 
 
• Frost1 RL, Weier ML, Clissold ME, Williams PA, Infrared spectroscopic study of natural 
hydrotalcites carrboydite and hydrohonessite, Spectrochimica Acta Part A 59 (2003) 3313-
3319. 
• Gao L, Nie L, Wang T, Qin Y, Guo Z, Yang D, Yan X, Carbon nanotube delivery of the GFP gene 
into mammalian cells, ChemBiochem 7 (2006) 239-242. 
• Gao Y, Xu Z, Chen S, Gu W, Chen L, Li Y, Arginine-chitosan/DNA self-assemble nanoparticles 
for gene delivery: In vitro characteristics and transfection efficiency, International Journal of 
Pharmaceutics 359 (1-2) (2008) 241-246. 
• Garner MM and Revzin A, A gel electrophoresis method for quantifying the binding of proteins 
to specific DNA regions: application to components of the Escherichia coli lactose operon 
regulatory system, Nucleic Acids Research 9 (13) (1981) 3047-3059. 
• Gasuche MC, Brown G, Moerland MM, Mixed Magnesium-Aluminium Hydroxides I. 
Preparation and Characterization of Compunds formed in Dialysed Systems-, Clay Minerals 7 
(1967) 177-192. 
• Gu Z, Thomas AC, Xu ZP, Campbell JH, Lu GQ, In vitro sustained release of LMWH from MgAl-
layered double hydroxide nanohybrids, Chemistry of Materials 20 (11) (2008) 3715-3722. 
• Guo X, Li S, Hou W, Han S, Hu J, Li D, Layered double hydroxides with hydrotalcite type 
structure containing Fe3+, Al3+ and Mg2+, Chemical Research in Chinese Universities 19 (2) 
(2003) 211-215. 
• Ha JU and Xanthos M, Drug release characteristics from nanoclay hybrids and their dispersions 
in organic polymers, International Journal of Pharmaceutics 414 (2011) 321-331. 
• Habib S, Singh M, Ariatti M, Glycosylated liposomes with proton sponge capacity: Novel 
hepatocyte specific gene carriers, Current Drug Delivery 10 (2013) 685-695 
• He J, Wei M, Li B, Kang Y, Evans DG, Duan X, Preparation of Layered Double Hydroxides, 
Structure and Bonding 119 (2005) 89-119. 
• Herrero M, Labajos FM, Rives V, Size control and optimization of intercalated layered double 
hydroxides, Applied Clay Science 42 (2009) 510-518. 
• Hernandez-Moreno MJ, Ulibarri MA, Rendon JL, Serna CJ, IR Characteristics of hydrotalcite-
like compounds, Physics and Chemistry of Minerals 12 (1985) 34-38. 
115 
 
• Hibino T, Delamination of layered double hydroxides containing amino acids, Chemistry of 
Materials 16 (2004) 5482-5488. 
• Hickerson RP, Vlassov AV, Wang Q, Leak D, Ilves H, Gonzalez-Gonzalez E, Contag CH, Johnston 
BH, Kaspar RL, Stability of unmodified siRNA and relevance to clinical use, Oligonucleotides 
18 (4) (2008) 345-354. 
• Holden NS and Tacon CE, Principles and problems of the electrophoretic mobility shift assay, 
Journal of Pharmacological and Toxicological Methods 63 (2011) 7-14. 
• Honary S, Zahir F, Effect of zeta potential on the properties of nano-drug delivery systems – A 
Review (Part 2), Tropical Journal of Pharmaceutical Research 12 (2) (2013) 265-273. 
• Hou X, Bish D, Wang S, Johnstone T, Kirkpatrick R, Hydration, expansion, structure and 
dynamics of layered double hydroxides, American Mineralogist 88 (2003) 167-179. 
• Hu H, Xiu KM, Xu SL, Yang WT, Xu FJ, Functionalized layered double hydroxide nanoparticles 
conjugated with disulfide-linked polycation brushes for advanced gene delivery, Bioconjugate 
Chemistry 24 (6) (2013) 968-978. 
• Huang L, Hung M-C, Wagner E (Editors), Nonviral vectors for gene therapy, Academic Press. 
San Diego, California, USA (1999). 
• Ikeda T, Amoh H, Yasunaga T, Stereoselective exchange kinetics of L- and D-Histidines for Cl- 
in the interlayer of a hydrotalcite-like compound by chemical relaxation method, Journal of 
the American Chemical Society 106 (1984) 5772-5775. 
• Imani R, Emami SH, Faghihi S, Synthesis and characterization of an octaarginine functionalized 
graphed oxide nanocarrier for gene delivery applications, Physical Chemistry Chemical Physics 
17 (2015) 6328-6339. 
• Ingram L and Taylor HFW, The Crystal Structures of Sjögrenite and Pyroaurite, Mineralogical 
Magazine 36 (280) (1967) 465-479. 
• Intissar M, Jumas J-C, Besse J-P, Leroux F, Reinvestigation of the layered double hydroxide 
containing tetravalent cations: Unambiguous response provided by XAS and Mössbauer 
spectoscopies, Chemistry of Materials 15 (24) (2003) 4625-4632. 
• Jabłońska M, Chmielarz L, Węgrzyn A, Hydrotalcite-like materials containing manganese: A 
short review, Copernican Letters 4 (2013) 59-65. 
116 
 
• Jaiswal A, Gautam RK, Chattopadhyaya MC, Layered double hydroxides and the environment: 
An overview, In: Advanced Materials for Agriculture, Food and Environmental Safety (Eds. A 
Tiwari and M Syvӓjӓrvi), (2014) John Wiley and Sons, Inc., Hoboken, NJ, USA. 
• Jellicoe TC, Fogg AM, Synthesis and characterization of layered double hydroxides intercalated 
with sugar phosphates, Journal of Physics and Chemistry of Solids 73 (12) (2012) 1496-1499. 
• Jiao FP, Chen XQ, Fu ZD, Hu YH, Wang YH, Synthesis and structural characterization of L-(-)-
malic acid pillared layered double hydroxides, Latin American Applied Research 39 (2009) 127-
130. 
• Kagunya W, Baddour-Hadjean R, Kooli F, Jones W, Vibrational Modes in layered double 
hydroxides and their calcined derivatives, Chemical Physics 236 (1998) 225-234. 
• Kameda T, Oba J, Yoshioka T, Removal of boron and fluoride in wastewater using Mg-Al 
layered double hydroxide and Mg-Al oxide, Journal of Environmental Management 188 (2017) 
58-63. 
• Kandare E and Hossenlopp JM, Thermal degradation of acetate-intercalated hydroxyl double 
and layered hydroxyl salts, Inorganic Chemistry 45(9) (2006) 3766-3773. 
• Kelkar CP and Schutz AA, Ni-, Mg- and Co-containing hydrotalcite-like materials with a sheet-
like morphology: synthesis and characterization, Microporous Materials 10 (1997) 163-172. 
• Khan AI and O’Hare D, Intercalation chemistry of layered double hydroxides: recent 
developments and applications, Journal of Materials Chemistry 12 (2002) 3191-3198. 
• Klemkaite K, Prosycevas I, Taraskevicius R, Khinsky A, Kareiva A, Synthesis and 
Characterization of layered double hydroxides with different cations [Mg, Co, Ni, Al], 
decomposition and reformation of mixed metal oxides to layered structures, Central European 
Journal of Chemistry 9(2) (2011) 275-282. 
• Kloprogge JT and Frost RL, Fourier Transform Infrared and Raman Spectroscopic Study of the 
Local Structure of Mg-, Ni- and Co-Hydrotalcites, Journal of Solid State Chemistry 146 (1999)  
506-515. 
• Kloprogge JT, Hickey L, Frost RL, Heating stage Raman and Infrared emission spectroscopic 
study of the dehydroxylation of synthetic Mg-hydrotalcite, Applied Clay Science 18 (2001) 37-
49. 
117 
 
• Kloprogge JT, Wharton D, Hickey L, Frost RL, Infrared and Raman study of the interlayer anions 
CO32-, NO3-, SO42- and ClO42- in Mg/Al-hydrotalcite, American Mineralogist 87 (2002) 623-629. 
• Kloprogge JT, Hickey L, Frost RL, The effects of Synthesis pH and Hydrothermal treatment on 
the Formation of Zinc Aluminum Hydrotalcites, Journal of Solid State Chemistry 177 (2004) 
4047-4057. 
• Komarala EP, Doshi S, Mohammed A, Bahadur D, Efficient antibacterial activity via protein 
degradation of a 3D layered double hydroxide-reduced graphene oxide nanohybrid, Royal 
Society of Chemistry Advances 6 (2016) 40389-40398. 
• Kooli F, Kosuge K, Tsunashima A, Mg-Zn-Al-CO3 and Zn-Cu-Al-CO3 hydrotalcite-like 
compounds: preparation and characterization, Journal of Materials Science 30 (1995) 4591-
4597. 
• Kooli F, Depége C, Ennaqadi A, de Roy A, Besse JP, Rehydration of Zn-Al layered double 
hydroxides, Clays and Clay Minerals 45 (1) (1997) 92-98. 
• Kovanda F, Grygar T, Dorničák V, Rojka T, Bezdička P, Jirátová K, Thermal behavior of Cu-Mg-
Mn and Ni-Mg-Mn layered double hydroxides and characterization of formed oxides, Applied 
Clay Science 28(2005) 121-136. 
• Kovanda F, Jindová E, Doušová B, Koloušek D, Pleštil J, Sedláková Z,  Layered double 
hydroxides intercalated with organic anions and their application in preparation of 
LDH/polymer nanocomposites, Acta Geodynamica et Geomateriali 6 (153) (2009) 111-119. 
• Kralj M and Pavelic K, Medicine on a small scale, EMBO reports 4 (11) (2003) 1008-1012. 
• Kriven WM, Kwak S-Y, Wallig MA, Choy J-H, Bio-resorbable nanoceramics for gene and drug 
delivery, Materials Research Society Bulletin 29 (1) (2004) 33-37. 
• Kuang Y, Zhao L, Zhang S, Zhang F, Dong M, Xu S, Morphologies, preparations and applications 
of double layered hydroxide Micro-/Nanastructures, Materials 3 (2010) 5220-5235. 
• Kulyukhin SA, Krasavina EP, Rumer IA, Klimovich IV, Sorption of Strontium and Yttrium 
radionuclides from aqueous solutions onto layered double hydroxides of various compositions, 
Radiochemistry 56 (6) (2014) 593-606. 
• Kumar PP, Kalinichev AG, Kirkpatrick RJ, Hydration, swelling, interlayer structure, and 
hydrogen bonding in organolayered double hydroxides: Insights from molecular dynamics 
118 
 
simulation of citrate-intercalated hydrotalcite, Journal of Physical Chemistry B 110 (9) (2006) 
3841-3844. 
• Kumar S and Rai SB, Spectroscopic studies of L-arginine molecule, Indian Journal of Pure and 
Applied Physics 48 (2010) 251-255. 
• Kumar S, Rai AK, Rai SB, Rai DK, Infrared and Raman spectra of Histidine: an ab initio DFT 
calculations of histidine molecule and its different protonated forms, Indian Journal of Physics 
84 (5) (2010) 563-573. 
• Kuo Y, Kuthati Y, Kankala RK, Wei P, Wang C, Liu C, Sung P, Mou C, Lee C, Layered double 
hydroxide nanoparticles to enhance organ-specific targeting and anti-proliferative effect of 
cisplatin, Journal of Materials Chemistry B 3 (2015) 3447-3458. 
• Kura AU, Hussein MZ, Fakurazi S, Arulselvan P, Layered double hydroxide nanocomposite for 
drug delivery systems; bio-distribution, toxicity and drug activity enhancement, Chemistry 
Central Journal 8 (47) (2014) 1-8. 
• Kwak S-Y, Jeong Y-J, Park J-S, Choy J-H, Bio-LDH nanohybrid for gene therapy, Solid State Ionics 
151 (2002) 229-234. 
• Lacerda L, Raffa S, Prato M, Bianco A, Kostarelos K, Cell penetrating CNTs for delivery of 
therapeutics, Nanotoday 2 (6) (2007) 38-43. 
• Ladewig K, Xu ZP, Lu GQ, Layered double hydroxide nanoparticles in gene and drug delivery, 
Expert Opinion Drug Delivery 6 (9) (2009) 907-922. 
• Ladewig1 K, Niebert M, Xu ZP, Gray PP, Lu GQ, Controlled preparation of layered double 
hydroxide nanoparticles and their application as gene delivery vehicles, Applied Clay Science 
48 (2010) 280-289. 
• Ladewig2 K, Niebert M, Xu ZP, Gray PP, Lu GQM, Efficient siRNA delivery to mammalian cells 
using layered double hydroxide nanoparticles, Biomaterials 31 (2010) 1821-1829. 
• Lee D-J, Kessel E, Lehto T, Liu X, Yoshinaga N, Padari K, Chen Y-C, Kempter S, Uchida S, Radler 
JO, Pooga M, Sheu M-T, Kataoka K, Wagner E, Systemic delivery of folate-PEG siRNA lipoplexes 
with enhanced intracellular stability for in vivo gene silencing in leukemia, Bioconjugate 
Chemistry 28(9) (2017) 2393-2409, DOI: 10.1021/acs.bioconjchem.7b00383. 
119 
 
• Li1 B, Wu P, Ruan B, Liu P, Zhu N, Study on the adsorption of DNA on the layered double 
hydroxides, Spectrochimica Acta Part 1: Molecular and Biomolecular Spectroscopy, 121(2014) 
387-393. 
• Li C, Wei M, Evans DG, Duan X, Recent advances for layered double hydroxides (LDHs) 
materials as catalysts applied in green aqueous media, Catalysis Today 247 (2015) 163-169. 
• Li L, Gu W, Chen W, Xu ZP, Co-delivery of siRNAs and anti-cancer drugs using layered double 
hydroxide nanoparticles, Biomaterials 35 (2014) 3331-3339. 
• Li S, Li J, Wang CJ, Wang Q, Cader MZ, Lu J, Evans DG, Duan X, ‘O Hare D, Cellular uptake and 
gene delivery using layered double hydroxide nanoparticles, Journal of Materials Chemistry B 
1 (2013) 61-68. 
• Liang W and Lam JKW, Endosomal Escape Pathways for Non-Viral Nucleic Acid Delivery 
Systems, Molecular Regulation of Endocytosis, Dr. Brian Ceresa (Ed.) (2012), InTech, DOI: 
10.5772/46006. Available from: http://www.intechopen.com/books/molecular-regulation-
of-endocytosis/endosomal-escape-pathways-for-non-viral-nucleic-acid-delivery-systems. 
• Liu J, Harrison R, Zhou JZ, Liu TT, Yu C, Lu GQ, Qiao SZ, Xu ZP, Synthesis of nanorattles with 
layered double hydroxide core and mesoporous silica shell as delivery vehicles, Journal of 
Materials Chemistry 21 (2011) 10641-10644. 
• Liu H-C, Yang X-Y, Ran G-P, Min E-Z, Liu J-K, Ying P-L, Xin Q, Li C, Structure and base properties 
of calcined hydrotalcites, Chinese Journal of Chemistry 17 (4) (1999) 319-330. 
• Lu M, Shan Z, Andrea K, Macdonald B, Beale S, Curry DE, Wang L, Wang S, Oakes KD, Bennett 
C, Wu W, Zhang X, Chemisorption mechanism of DNA on Mg/Fe layered double hydroxides 
nanoparticles: Insights into engineering effective siRNA delivery systems, Langmuir 32 (11) 
(2016) 2659-2667. 
• Luan L, Liu S, Sun D, Dispersion control and nematic ordering of Ni/Al layered double hydroxide 
suspensions, Journal of solid State Chemistry 182 (2009) 1462-1467. 
• Lv H, Zhang S, Wang B, Cui S, Yan J, Toxicity of cationic lipids and cationic polymers in gene 
delivery, Journal of Controlled Release 114 (2006) 100-109. 
120 
 
• Lv W, Du M, Ye W, Zheng Q, The formation mechanism of layered double hydroxide 
nanoscrolls by facile trinal-phase hydrothermal treatment and their adsorption properties, 
Journal of Materials Chemistry A 3 (2015) 23395-23402. 
• Malherbe F, Besse J-P, Investigating the effects of guest-host interactions on the properties of 
anion-exchanged Mg-Al hydrotalcites, Journal of Solid State Chemistry 155 (2) (2000) 332-
341. 
• Mallakpour S and Dinari M, Using Mg-Al-Layered double hydroxide intercalated with chiral 
dicarboxylic acid for the reinforcement of isoleucine amino acid containing poly(amide-imide), 
Polymer Composites 37 (11) (2016) 3288-3295. 
• Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD, Passenger-Strand Cleavage Facilitates 
Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes, Cell 123 (4) (2005) 607-
620. 
• Matulis D, Rouzina I, Bloomfield VA, Thermodynamics of DNA binding and condensation: 
isothermal titration calorimetry and electrostatic mechanism, Journal of Molecular Biology 
296 (2000) 1053-1063. 
• Medina-Juárez O, García-Sánchez MA, Arellano-Sánchez U, Kornhauser-Straus I and Rojas-
González F, Optimal surface amino-functionalization following thermo-alkaline treatment of 
nanostructured silica adsorbents for enhanced CO2 adsorption, Materials 9 (11) (2016) 898 
doi:10.3390/ma9110898. 
• Meng Z, Luan L, Kang Z, Feng S, Meng Q, Liu K, Histidine-enriched multifunctional peptide 
vectors with enhanced cellular uptake and endosomal escape for gene delivery, Journal of 
Materials Chemistry B 5 (2017) 74-84. 
• Meyn M, Beneke K, Lagaly G, Anion exchange reactions of layered double hydroxides, 
Inorganic Chemistry 29 (1990) 5201-5207. 
• Meyn M, Beneke K, Lagaly G, Anion exchange reactions of hydroxyl double salts, Inorganic 
Chemistry 32 (1993) 1209-1215. 
• Millange F, Walton RI, O’ Hare D, Time resolved in situ X-Ray diffraction study of the liquid-
phase reconstruction of Mg-Al-carbonate hydrotalcite-like compounds, Journal of Materials 
Chemistry 10 (2000) 1713-1720. 
121 
 
• Mills SJ, Christy AG, Genin JMR, Kameda T, Colombo F, Nomenclature of the hydrotalcite 
supergroup: natural layered double hydroxides, Mineralogical Magazine 76 (2012) 1289-1336. 
• Misra C and Perrotta AJ, Composition and properties of synthetic hydrotalcites, Clays and Clay 
Minerals 40 (2) (1992) 145-150. 
• Miyata S and Kumura T, Synthesis of new hydrotalcite-like compounds and their physio-
chemical properties, Chemistry Letters (1973) 843-848. 
• Miyata S, Synthesis of hydrotalcite-like compounds and their structures and physico-chemical 
properties - The systems Mg2+ -Al3+ -NO3- and Mg2+ -Al3+ -Cl-, Mg2+ -Al3+ -ClO4-, Ni2+ -Al3+ -Cl- and   
Zn2+ -Al3+ -Cl-, Clays and Clay Minerals 23 (1975) 369-375. 
• Miyata S and Okada A, Synthesis of hydrotalcite-like compounds and their physico-chemical 
properties - The systems Mg2+-Al3+ -SO42- and Mg2+ -Al3+ -CrO42-, Clays and Clay Minerals 25 
(1977) 14-18. 
• Miyata S, Anion exchange properties of Hydrotalcite-like compounds, Clay and Clay Minerals 
31 (4) (1983) 305-311. 
• Mohanambe L and Vasudevan S, Inclusion of poly-aromatic hydrocarbon (PAH) molecules in 
a functionalized layered double hydroxide, Journal of Chemical Sciences 118 (1) (2006) 105-
115. 
• Mondal S, Dasgupta S, Maji K, MgAl- Layered double hydroxide nanoparticles for controlled 
release of salicyclate, Materials Science and Engineering C 68 (2016) 557-564. 
• Mora M, Jiménez-Sanchidrián C, Ruiz JR, Raman Spectroscopy study of Layered-double 
hydroxides containing magnesium and trivalent metals, Materials Letters 120 (2014) 193-195 
• Morachis JM, Mahmoud EA, Sankaranarayanan J, Almutairi A, Triggered Rapid Degradation 
of Nanoparticles for gene delivery, Journal of Drug Delivery (2012) doi: 
10.1155/2012/291219. 
• Mosmann T, Rapid colorimetric assay for cellular growth and survivals: application to 
proliferation and cytotoxicity assays, Journal of Immunological Methods 65 (1983) 55-63. 
• Mout R, Moyano DF, Rana S, Rotello VM, Surface functionalization of nanoparticles for 
nanomedicine, Chemical Society Reviews 41 (2012) 2539-2544. 
122 
 
• Mulens V, Morales MP, Barber DF, Development of magnetic nanoparticles for cancer gene 
therapy: A comprehensive review, ISRN Nanomaterials (2013) 1-14. 
• Musumeci AW, Mortimer GM, Butler MK, Xu ZP, Minchin RF, Martin DJ, Fluorescent layered 
double hydroxide nanoparticles for biological studies, Applied Clay Science 48 (2010) 271-279. 
• Nagaraj VJ, Sun X, Mehta J, Martin M, Ngo T, Dey SK, Synthesis, characterization and in vitro 
drug delivery capabilities of (Zn, Al)-based layered double hydroxide nanoparticles, Journal of 
Nanotechnology (2015) Article ID 350370, 10 pages. 
• Naicker K, Ariatti M, Singh M, PEGylated galactosylated cationic liposomes for hepatocytic 
gene delivery, Colloids and Surfaces B: Biointerfaces 122 (2014) 482-490. 
• Nakayama H, Wada N, Tsuhako M, Intercalation of amino acids and peptides into MG-Al 
layered double hydroxide by re-construction method, International Journal of Pharmaceutics 
269 (2004) 469-478. 
• Nalawade P, Aware B, Kadam VJ, Hirlekar RS, Layered double hydroxides: A review, Journal of 
Scientific and Industrial Research 68 (2009) 267-272. 
• Natoli M, Leoni BD, D’Agnano I, Zucco F, Felsani A, Good CACO-2 cell culture practices, 
Toxicology in Vitro 26 (2012) 1243-1246. 
• Newman SP and Jones W, Synthesis, characterization and applications of layered double 
hydroxides containing organic guests, New Journal of Chemistry (1998) 105-115. 
• Newman SP and Jones W, Comparative study of some layered hydroxide salts containing 
exchangeable interlayer anions, Journal of Solid State Chemistry 148 (1999) 26-40. 
• Newman SP, Jones W, O’ Conner P, Stamires DM, Synthesis of the 3R2 polytypeof a 
hydrotalcite-like mineral, Journal of Materials Chemistry 12 (2002) 153-155. 
• Nimesh S, Kumar R, Chandra R, Novel polyallylamine-dextran sulfate-DNA nanoplexes: Highly 
efficient non-viral vector for gene delivery, International Journal of Pharmaceutics 320 (2006) 
143-149. 
• Nguyen J, Steele TWJ, Merkel O, Reul R, Kissel T, Fast degrading polyesters as siRNA nano-
carriers for pulmonary gene therapy, Journal of Controlled Release 132 (2008) 243-251. 
• Oh JM, Hwang SH, Choy JH, The effect of synthetic conditions on tailoring the size of 
hydrotalcite particles, Solid State Ionics 151 (2006) 285-291. 
123 
 
• Ostolska I, Wiśniewska M, Application of the zeta potential measurements to explanation of 
colloidal Cr2O3 stability mechanism in the presence of the ionic polyamino acids, Colloid and 
Polymer Science 292(10) (2014) 2453-2464 doi:10.1007/s00396-014-3276-y. 
• Palmer SJ, Frost RL, Spratt HJ, Synthesis and Raman spectroscopic study of Mg/Al, Fe 
hydrotalcites with variable cationic ratios, Journal of Raman Spectroscopy 40 (9) (2009) 1138-
1143. 
• Pan B, Cui D, Xu P, Chen H, Liu F, Li Q, Huang T, You X, Shao J, Bao C, Gao F, He R, Shu M, Ma 
Y, Design of dendrimer modified carbon nanotubes for gene delivery, Chinese Journal of 
Cancer Research 19(1) (2007) 1-6. 
• Pan B, Cui D, Xu P, Ozkan C, Feng G, Ozkan M, Huang T, Che B, Li Q, He R, Hu G, Synthesis and 
characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and 
their application in gene delivery systems, Nanotechnology 20 (2009) 1-9. 
• Park D-H, Jaeyong C, Kwon O-J, Yun C-O, Choy J-H, Biodegradable inorganic nanovector: 
passive versus active tumor targeting, Angewandte Chemie International Edition 55 (14) 
(2016) 4582-4586. 
• Patel VB, Patel KN, Shah MM, Mayank B, Spectrophotometric determination of histidine 
hydrochloride monohydrate in pharmaceutical formulations, International Journal of 
PharmTech Research 1 (3) (2009) 852-856. 
• Perera J, Weerasekera M, Kottegoda N, Slow release anti-fungal skin formulations based on 
citric acid intercalated layered double hydroxides nanohybrids, Chemistry Central Journal 9:27 
(2015) doi:10.1186/s13065-015-0106-3. 
• Perez C, Sanchez A, Putnam D, Ting D, Langer R, Alonso MJ, Poly (lactic acid)-poly (ethylene 
glycol) nanoparticles as new carriers for the delivery of plasmid DNA, Journal of Controlled 
Release 75 (2001) 211-224. 
• Pérez-Bernal ME, Ruano-Casero RJ, Benito F, Rives V, Nickel-Aluminium layered double 
hydroxides prepared via inverse micelles formation, Journal of Solid State Chemistry 182 
(2009) 1593-1601. 
124 
 
• Perioli1 L, Posati T, Noccetti M, Bellezza F, Costantino U, Cipiciani A, Intercalation and release 
of anti-inflammatory drug diclofenac into nanosized ZnAl hydrotalcite-like compound, Applied 
Clay Science 53 (2011) 374-378. 
• Perioli2 L, Ambrogi V, di Nauta L, Noccetti M and Rossi C, Effects of hydrotalcite-like 
nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: 
The case of flurbiprofen, Applied Clay Science 51 (2011) 407-413. 
• Posati T, Bellezza F, Tarpani L, Perni S, Latterini L, Marsili V, Cipiciani A, Selective 
internalization of ZnAl-HTlc nanoparticles in normal and tumor cells. A study of their potential 
use in cellular delivery, Applied Clay Science 55 (2012) 62-69. 
• Prevot V, Forano C, Besse JP, Synthesis and thermal and chemical behaviors of tartrate and 
succinate intercalated Zn3Al and Zn2Cr layered double hydroxides, Inorganic Chemistry 37(17) 
(1998) 4293-4301. 
• Prevot V, Forano C, Besse JP, Reactivity of oxalate with ZnAl layered double hydroxides 
through new materials, Journal of Materials Chemistry 9 (1999) 155-160. 
• Qian L, Lu Z, Xu T, Wu X, Tian Y, Li Y, Huo Z, Sun X, Duan X, Trinary Layered Double Hydroxides 
as High-Performance Bifunctional Materials for Oxygen Electrocatalysis, Advanced Energy 
Materials 5 (2015) 1500245. doi: 10.1002/aenm.201500245. 
• Qiu T, Li H, Cao Y, Pre-staining thin layer chromatography method for amino acid detection, 
African Journal of Biotechnology 9 (50) (2010) 8679-8681. 
• Qu J, Zhang Q, Li X, He X, Song S, Mechanochemical approaches to synthesize layered double 
hydroxides: a review, Applied Clay Science 19 (2016)185-192. 
• Ragusa A, Garcia I, Penades S, Nanoparticles as nonviral gene delivery vectors, IEEE 
Transactions on Nanobioscience 6(4) (2007) 319-330. 
• Rajamathi M, Thomas GS, Kamath PV, The many ways of making anionic clays, Proceedings 
of the Indian Academy of Science 13 (5-6) (2001) 671-680. 
• Ren L, Hu J-S, Wan L-J, Bai C-L, A simple method to synthesize double hydroxide nanoscrolls, 
Materials Research Bulletin 42 (2007) 571-575. 
• Richardson MS, Layered Double Hydroxides as Anion and Cation Exchanging Materials, Ph.D. 
Thesis (2007) University of North Texas, USA. 
125 
 
• Riley MK and Vermerris W, Recent advances in nanomaterials for gene delivery – A Review, 
Nanomaterials 7 (94) (2017) doi:10.3390/nano7050094. 
• Rives V and Ulibarri MA, Layered double hydroxides (LDH) intercalated with metal 
coordination compounds and oxometalates, Coordination Chemistry Reviews 181 (1999) 61-
120. 
• Rojas R, Bedoya DA, Vasti C, Giacomelli CE, LDH nanoparticles: synthesis, size control and 
applications in nanomedicine, in Layered Double Hydroxides (LDHs) Synthesis, 
Characterization and Application, Edited by Sherman IT (2015) ISBN:978-1-63482-040-0. 
• Rossi C, Schoubben A, Ricci M, Perioli L, Ambrogi V, Latterini L, Aloisi GG, Rossi A, Intercalation 
of the radical scavenger ferulic acid in hydrotalcite-like anionic clays, International Journal of 
Pharmaceutics 295 (2005) 47-55. 
• Ruiz-Hitzky E, Aranda P, Darder M, Rytwo G, Hybrid materials based on clays for 
environmental and biomedical applications, Journal of Materials Chemistry 20 (2010) 9306-
9321. 
• Saber O and Tagaya1 H, New layered double hydroxide, Zn-Ti LDH: Preparation and 
Intercalation Reactions, Journal of Inclusion Phenomena and Macrocyclic Chemistry 45 (2003) 
109-116. 
• Saber O and Tagaya2 H, Preparation and intercalation reactions of Zn-Sn LDH and Zn-Al-Sn 
LDH, Journal of Porous Materials 10 (2003) 83-91. 
• Sajid M and Basheer C, Layered double hydroxides: Emerging sorbent materials for analytical 
extractions, Trends in Analytical Chemistry 75 (2016) 174-182. 
• Salak AN, Tedim J, Kuznetsova AI, Ribeiro JL, Vieira LG, Zheudkevich ML, Ferreira MGS, 
Comparative X-ray Diffraction and infrared spectroscopy study of Zn-Al layered double 
hydroxides: Vanadate vs nitrate, Chemical Physics 397 (2012) 102-108. 
• Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F, The CACO-2 cell line as a 
model of the intestinal barrier: influence of cell culture-related factors on CACO-2 cell 
functional characteristics, Cell Biology and Toxicology 21 (2005) 1-26. 
126 
 
• Sarijo SH, Jadam ML, Saleh FM, Intercalation of Fenoprofen into Layered Double Hydroxide for 
the Formation of Controlled Release Anti-Inflammatory Drug, Advanced Materials Research 
1142 (2017) 230-233. 
• Seftel EM, Popovici E, Mertens M, De Witte K, Van Tendeloo G, Cool P, Vansant EF, Zn-Al 
layered double hydroxides:  Synthesis, characterization and photocatalytic application, 
Microporous and Mesoporous Materials 113 (2008) 296-304. 
• Senapati S, Thakur R, Verma SP, Duggal S, Mishra DP, Das P, Shripati T, Kumar M, Rana D, 
Maiti P, Layered double hydroxides as effective anticancer drugs and tailoring release rate 
through interlayer anions, Journal of Controlled Release 224 (2016) 186-198. 
• Senra JD, Silva AC, Santos RV, Malta LFB, and Simas ABC, Palladium on Layered Double 
Hydroxide: A Heterogeneous System for the Enol Phosphate Carbon-Oxygen Bond Activation 
in Aqueous Media, Journal of Chemistry, vol. 2017 (2017) Article ID 8418939, 10 pages, 
doi:10.1155/2017/8418939. 
• Sertsova AA, Subcheva EN, Yurtov EV, Synthesis and study of structure formation of layered 
double hydroxides based on Mg, Zn, Cu and Al, Russian Journal of Inorganic Chemistry 60 (1) 
(2015) 23-32. 
• Shafiei S, Birgani ZT, Darvish A, Azimi MS, Solati-Hashjin M, Layered double hydroxides for 
diagnostic applications, International Congress of Medical Diagnosis Modern Technologies 
(2008) 1-16. 
• Shang L, Nienhaus K, Nienhaus GU, Engineered nanoparticles interacting with cells: size 
matters, Journal of Nanobiotechnology 12 (5) (2014) doi: 10.1186/1477-3155-12-5. 
• Shi J, Schellinger JG, Johnson RN, Choi JL, Chou B, Anghel El, Pun SH, Influence of histidine 
incorporation on buffer capacity and gene transfection efficiency of HPMA-co-oligolysine 
brush polymers, Biomacromolecules 14 (6) (2013) 1961-1970. 
• Si J, Ping P, Xie H, Yang W and Lu H, The influence of multiwalled carbon nanotubes-NiCoAl 
layered double hydroxide hybrids on fire safety performance of poly (ethylene-co-vinyl 
acetate) composites,  Polymer Composites (2017)  doi:10.1002/pc.24281. 
• Singh R, Pantarotto D, McCarthy D, Chaloin O, Hoebeke J, Partidos CD, Briand JP, Prato M, 
Bianco A, Kostarelos K, Binding and condensation of plasmid DNA onto functionalized carbon 
127 
 
nanotubes: toward the construction of nanotube-based gene delivery vectors, Journal of the 
American Chemical Society 127 (12) (2005) 4388-4396. 
• Smith J, Zhang Y, Niven R, Toward development of a non-viral gene therapeutic, Advanced 
Drug Delivery Reviews 26 (1997) 135-150. 
• Soenen SJ, Rivera-Gil P, Montenegro J-M, Parak WJ, De Smedt SC, Braeckmans K, Cellular 
toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity 
evaluation, Nano Today 6 (2011) 446-465. 
• Spector AA, Yorek MA, Membrane lipid composition and cellular function, The Journal of Lipid 
Research 26 (1985) 1015-1035. 
• Stimpfling T, Vialat P, Hintze-Bruening H, Keil P, Shkirskiy V, Volovitch P, Ogle K, Leroux F, 
Amino acid interleaved layered double hydroxides as promising hybrid materials for AA2024 
corrosion inhibition, European Journal of Inorganic Chemistry (2016) 2006-2016. 
• Suzuki E, Idemura S, Ono Y, Properties of hexacyanocobaltate(III)-exchanged hydrotalcite-like 
minerals, Clays and Clay Minerals 37(2) (1989) 173-178. 
• Tada H, Shiho O, Kuroshima K-I, Koyama M, Tsukamoto K, An improved colorimetric assay for 
interleukin 2, Journal of Immunological Methods 93(2) (1986) 157-165. 
• Takagi K, Shichi T, Usami H, Sawaki Y, Controlled photocycloaddition of unsaturated 
carboxylates intercalated in hydrotalcite clay interlayers, Journal of the American Chemical 
Society 115 (1993) 4339-4344. 
• Tao Q, Zhang Y, Zhang X, Yuan P, He H, Synthesis and Characterization of Layered Double 
Hydroxides with a High Aspect Ratio, Journal of Solid State Chemistry 179 (2006) 708-715 
• Taylor HFW, Segregation and Cation-Ordering in Sjögrenite and Pyroaurite, Mineralogical 
Magazine 37 (287) (1969) 338-342. 
• Templeton NS, Cationic liposome-mediated gene delivery in vivo, Bioscience Reports 22 
(2002) 283-295. 
• Tronto J, Bordonal AC, Naal Z, Valim JB, Conducting Polymers / Layered Double Hydroxides 
Intercalated Nanocomposites, In: Materials Science - Advanced Topics, Y. Mastai, (Ed.), 
InTech, (2013), 2-30. 
128 
 
• Trujillano R, Holgado MJ, Pigazo F, Rives V, Preparation, physicochemical characterisation and 
magnetic properties of Cu–Al layered double hydroxides with CO32- and anionic surfactants 
with different alkyl chains in the interlayer, Physica B 373 (2006) 267–273. 
• Twentyman PR, Luscombe M, A study of some variables in a tetrazolium dye (MTT) based 
assay for cell growth and chemosensitivity, British Journal of Cancer 56 (3) (1987) 279-285. 
• Tyner KM, Schiffman SR, Giannelis EP, Nanobiohybrids as delivery vehicles for camptothecin, 
Journal of Controlled Release 95 (2004) 501-514. 
• Vacarri A, Preparation and catalytic properties of cationic and anionic clays, Catalysis Today 
41 (1998) 53-71. 
• Valente JS, Hernandez-Cortez J, Cantu MS, Ferrat G, López-Salinas E, Calcined layered double 
hydroxides Mg-Me-Al (Me: Cu, Fe, Ni, Zn) as bifunctional catalysts, Catalysis Today 150 (2010) 
340-345. 
• Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R, Control of translation and mRNA 
degradation by miRNAs and siRNAs, Genes & Development 20 (2006) 515-524. 
• Velu S and Swamy CS, Synthesis and physicochemical properties of new copper-manganese-
aluminium ternary hydrotalcite-like compound, Journal of Materials Science Letters 15 (19) 
(1996) 1674-1677. 
• Vucelic M, Jones W, Moggridge GD, Cation ordering in synthetic layered double hydroxides, 
Clays and Clay Minerals 45 (6) (1997) 803-813. 
• Wang G-H, Zhao YZ, Tan J, Zhu S-H, Zhou K-C, Arginine functionalized hydroxyapatite 
nanoparticles and its bioactivity for gene delivery, Transactions of Nonferrous Metals Society 
of China 25 (2015) 490-496. 
• Wang G, Rao D, Li K, Lin Y, UV Blocking by Mg-Zn-Al layered double hydroxides for the 
protection of asphalt road surfaces, Industrial and Engineering Chemistry Research 53 (11) 
(2014) 4165-4172. 
• Wang1 L, Wang F, Xu L, Layered double hydroxides based on different cations as catalysts for 
synthesis of poly(1,5-pentadiol) carbonate diols, Indian Journal of Chemistry 54A (2015) 607-
612. 
129 
 
• Wang H, Liang X-H, Zhao R-X, Feng L-D, Li H, Spectrophotometric determination of arginine in 
grape juice using 8-hydroxyquinoline, Agricultural Sciences in China 7 (10) (2008) 1210-1215. 
• Wang Q, Tang SVT, Lester E, O’Hare D, Synthesis of ultrafine layered double hydroxide (LDHs) 
nanoplates using continuous-flow hydrothermal reactor, Nanoscale 5 (2013) 114-117. 
• Wang S, Huang J, Chen F, Study on Mg-Al hydrotalcites in flame-retardant paper preparation, 
Bioresources 7 (1) (2012) 997-1007. 
• Wang Z, Wang E, Gao L, Xu L, Synthesis and properties of Mg2Al layered double hydroxides 
containing 5-fluorouracil, Journal of Solid State Chemistry 178 (2005) 736-741. 
• Wei P-R, Kuthati Y, Kankala RK, Lee C-H, Synthesis and Characterization of Chitosan-Coated 
Near-Infrared (NIR) Layered Double Hydroxide-Indocyanine Green Nanocomposites for 
Potential Applications in Photodynamic Therapy, International Journal of Molecular Science 
16 (2015) 20943-20968. 
• Weyermann J, Lochmann D, Zimmer A, A practical note on the use of cytotoxicity assays, 
International Journal of Pharmaceutics 288 (2005) 369-376. 
• Wilson, AJC, X-ray diffraction index for the identification of materials: an appeal for new data, 
Journal of Scientific Instruments, 24(4) (1947) 110. 
• Wong Y, Markham K, Xu ZP, Chen M, Lu GQ, Bartlett PF, Cooper HM, Efficient delivery of siRNA 
to cortical neurons using layered double hydroxide nanoparticles, Biomaterials 31 (2010) 
8770-8779. 
• Wu GY, Wu CH, Receptor-mediated in vitro gene transformation by a soluble DNA carrier 
system, The Journal of Biological Chemistry 262 (10) (1987) 4429-4432. 
• Wu GY, Wu CH, Receptor-mediated gene delivery and expression in vivo, The Journal of 
Biological Chemistry 263 (29) (1988) 14621-14624. 
• Wu P, Li W, Zhu Y, Tang Y, Zhu N, Guo C, The protective effect of layered double hydroxide 
against damage to DNA induced by heavy metals, Applied Clay Science 100 (2014) 76-83. 
• Wypych F, Chemical Modifications of Clay Surfaces, In: Clay Surfaces, Fundamentals and 
Applications, Edited by F. Wypych and KG Satyanarayana, (2004) Elsevier Academic Press, 
London. 
130 
 
• Xu X, Li D, Song J, Lin Y, Lv Z, Wei M, Duan X, Synthesis of Mg-Al-carbonate layered double 
hydroxide by an atom-economic reaction, Particuology 8 (3) (2010) 198–201. 
• Xu ZP, Zhang J, Adebajo MO, Zhang H, Zhou C, Catalytic applications of layered double 
hydroxides and derivatives, Applied Clay Science 53 (2011) 139-150. 
• Xu ZP, Niebert M, Porazik K, Walker TL, Cooper HM, Middelberg APJ, Gray PP, Bartlett PF, Lu 
GQ, Subcellular compartment targeting of layered double hydroxide nanoparticles, Journal of 
Controlled Release 130 (2008) 86-94. 
• Xu R, Progress in nanoparticle characterization: sizing and zeta potential measurement, 
Particuology 6 (2008) 112-115. 
• Xu ZP and Lu GQ, Layered double hydroxide nanomaterials as potential cellular drug delivery 
agents, Pure Applied Chemistry 78 (9) (2006) 1771-1779. 
• Xu ZP, Zeng QH, Lu GQ, Yu AB, Inorganic nanoparticles as carriers for efficient cellular delivery, 
Chemical Engineering Science  61 (2006) 1027-1040. 
• Xu ZP, Walker TL, Liu KL, Cooper HM, Lu GQ, Bartlett PF, Layered double hydroxide 
nanoparticles as cellular delivery vectors of supercoiled plasmid DNA, International Journal of 
Nanomedicine, 2 (2) (2007) 163-174. 
• Yan M, Zhang Z, Cui S, Lei M, Zeng K, Liao Y, Chu W, Deng Y, Zhao C, Improvement of 
pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating 
with PEGylated phospholipid membrane, International Journal of Nanomedicine 9 (1) (2014) 
4867-4878. 
• Zhang S, Zhao B, Jiang H, Wang B and Ma B, Cationic lipids and polymers mediated vectors for 
delivery of siRNA, Journal of Controlled Release 123 (2007) 1-10. 
• Zhang Y, Garzon-Rodriguez W, Manning MC, Anchordoquy TJ, The use of fluorescence 
resonance energy transfer to monitor dynamic changes of lipid-DNA interactions during 
lipoplex formation, Biochimica et Biophysica Acta 1614 (2003) 182-192. 
• Zhang H, Ouyang D, Murthy V, Wong Y, Xu Z, Smith SC, Hydrotalcite intercalated siRNA: 
Computational characterization of the interlayer environment, Pharmaceutics 4 (2012) 296-
313. 
131 
 
• Zhang K, Xu ZP, Lu J, Tang ZY, Zhao HJ, Good DA, Wein MQ, Potential for layered double 
hydroxide-based, innovative drug delivery systems, International Journal of Molecular 
Sciences 15 (2014) 7409-7428. 
• Zhao Y, Li F, Zhang R, Evans DG, Duan X, Preparation of layered double hydroxide 
nanomaterials with a uniform crystallite size using a new method involving separate 
nucleation and aging steps, Chemistry of Materials 14 (2002) 4286-4291. 
• Zheng H, Tang C, Yin C, Exploring advantages/disadvantages and improvements in 
overcoming gene delivery barriers of amino acid modified trimethylated chitosan, 
Pharmaceutical Research 32 (6) (2015) 2038-2050. 
• Zümreoglu-Karan B and Ay AN, Layered double hydroxides – multifunctional nanomaterials, 
Chemical Papers  66(1) (2012) 1-10. 
• https://en.wikipedia.org/wiki/HEK_293_cells (Date accessed: 15th September 2017). 
• https://en.wikipedia.org/wiki/Hep_G2 (Date accessed: 15th September 2017). 
• https://en.wikipedia.org/wiki/Caco-2 (Date accessed: 15th September 2017). 
• https://en.wikipedia.org/wiki/HeLa (Date accessed: 15th September 2017). 
• http://www.pharmainfo.net/book/emerging-trends-nanotechnology-pharmacy-
physicochemical-characterization-nanoparticles/zeta (Date accessed: 31st August 2017). 
• www.hepG2.com (Date accessed: 15th September 2017). 
• www.hek293.com (Date accessed: 15th September 2017). 
 
 
 
 
 
 
 
132 
 
APPENDIX  
 
Table A1:  Masses of cationic nitrates used to prepare samples. 
  Mass (g) of precursor salt 
Compound Ratio M2+:M3+ M2+ M3+ 
MgAl 0.25 3:1 25.6 18.75 
MgAl 0.33 2:1 25.6 12.38 
MgFe 0.25 3:1 25.6 20.02 
MgFe 0.33 2:1 25.6 13.33 
ZnAl 0.25 3:1 29.75 18.75 
ZnAl 0.33 2:1 29.75 12.38 
 
 
Table A2:  Masses of cationic nitrates and amino acids used to prepare amino acid   
       functionalized hydrotalcites. 
  Mass (g) 
Compound Ratio M2+:M3+:amino acid M2+ M3+ Amino Acid 
MgAlArg 0.25 3:1:1 5.12 3.76 2.11 (L-arginine hydrochloride) 
MgAlArg 0.33 2:1:1 5.12 2.46 1.38 (L-arginine hydrochloride) 
MgAlHist 0.25 3:1:1 5.12 3.76 1.92 (L-histidine hydrochloride) 
MgAlHist 0.33 2:1:1 5.12 2.46 1.26 (L-histidine hydrochloride) 
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Figure A1 XRD diffractogram of MgAl 0.25. 
 
 
Figure A2 XRD diffractogram of MgAlArg 0.25. 
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Figure A3 XRD diffractogram of MgAlHist 0.25. 
 
 
Figure A4 XRD diffractogram of MgAlArg 0.33. 
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Figure A5 XRD diffractogram of MgAlHist 0.33. 
 
 
Figure A6 XRD diffractogram of MgFe 0.25. 
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Figure A7 XRD diffractogram of MgFe 0.33. 
 
 
Figure A8 XRD diffractogram of ZnAl 0.25. 
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Figure A9 XRD diffractogram of ZnAl 0.33. 
 
 
Figure A10 Standard curve for histidine determination. 
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Figure A11 Standard curve for arginine determination. 
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